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RESUMEN EN ESPAÑOL 
 
Para percibir el mundo exterior, uno de los sentidos de los cuales nos valemos es LA 
VISTA. La visión se inicia con la llegada de luz a la retina, más específicamente, a las 
células fotorreceptoras, que son neuronas altamente especializadas y 
compartimentalizadas. En el compartimento o segmento externo de éstas, se produce la 
conversión de la señal lumínica a una señal eléctrica. La captura de un fotón excita el 
cromóforo de la molécula rodopsina, el pigmento visual, desencadenando una cascada 
de amplificación enzimática conocida como fototransducción, que en último término 
provoca una bajada en los niveles de cGMP y el cierre de los canales iónicos sensibles 
a cGMP en la membrana plasmática. Por lo tanto, la luz reduce la entrada de Na+ y Ca2+ 
causando una hiperpolarización transitoria de los fotorreceptores, señal que es 
transmitida a neuronas de orden superior y al cerebro, dónde esta información es 
integrada en la corteza visual. La cinética de los procesos de fototransducción marcan la 
sensibilidad y la resolución del sistema visual en su conjunto. Por tanto, es 
imprescindible una regulación muy fina y rápida de todo el proceso, para 1) detectar 
pequeñas oscilaciones en los niveles de luz, y 2) no saturar el sistema cuando los 
niveles de luz se mantienen en el tiempo. De forma que no sólo la activación eficiente de 
la cascada de fototransducción es vital, sino también su inactivación, y una condición 
sinequanone para permitir la reapertura de los canales de Na+/Ca2+ es el 
restablecimiento de los niveles de cGMP. 
Las proteínas encargadas de la síntesis de ésta molécula, cGMP, en conos y bastones 
son las Guanilato Ciclasas de retina (RetGC). Y a su vez, las Proteínas Activadoras de 
Guanilato Ciclasa (GCAPs) confieren sensibilidad a Ca2+ a las RetGCs. GCAPs, pues, 
juegan un papel fundamental en la restauración de la respuesta a la luz y la adaptación 
a ésta, mediante su rol como intermediarias entre la síntesis de cGMP y los niveles de 
Ca2+ libre en la célula. 
Las GCAPs, de ~25KDa, fueron descubiertas a finales de los 80 y caracterizadas 
durante los años 90. Pertenecen a la familia de proteínas neuronales sensoras de calcio 
(NCS), por lo que presentan N-miristoilación, y además poseen cuatro dominios EF de 
unión a Ca2+, aunque el primero de ellos, en el extremo N-terminal, no une Ca2+. Se ha 
visto, en cambio, que está implicado en el reconocimiento de RetGC por parte de las 
GCAPs. El resto de dominios EF cuando no unen Ca2+ unen Mg2+. 
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Se han identificado hasta ocho isoformas de GCAPs diferentes en varias especies, 
aunque las más abundantes en mamíferos son GCAP1 y GCAP2. Éstas presentan una 
similitud de secuencia del 40%. Tal como se ha ido perfilando con diversos estudios in 
vitro e in vivo (con los modelos transgénicos de ratón y zebrafish), a pesar de tener 
características bioquímicas muy parecidas, la acción individual de cada una de ellas no 
compensa funcionalmente ni a todos los niveles la ausencia de la otra. 
Nos centraremos en GCAP1 y GCAP2. Ambas isoformas forman dímeros en su forma 
libre de Ca2+. Cuando vuelven a unir Ca2+, estos dímeros se mantienen en GCAP1, pero 
revierten en GCAP2, correlacionándose la formación de dímeros con la capacidad de 
activar retGC en GCAP2. Además, tanto GCAP1 como GCAP2 están unidas a 
membrana independientemente de la concentración de [Ca2+]free. En conjunto, todo 
apunta a un modelo en que las proteínas GCAPs están constitutivamente unidas a 
RetGC en el segmento externo, pero oscilan entre la forma activa e inactiva según los 
niveles de Ca2+ libre en la célula. Por otra parte, se ha descrito que GCAP2 se fosforila 
en la serina 201. La importancia fisiológica de esta fosforilación se desconoce, aunque 
se ha visto in vitro que la proteína se fosforila cuando se encuentra libre de Ca2+ y unida 
a Mg2+ y que esta fosforilación no afecta a la activación de RetGC. 
Estudios in vitro han determinado que la [Ca2+] necesaria para producir la transición de 
un estado de inactivación de RetGC a uno de activación es diferente para GCAP1 y 
para GCAP2, siendo EC50~130nM para GCAP1 y EC50~50nM para GCAP2. Los niveles 
de Ca2+ en el compartimento externo de bastones en oscuridad son de ~250nM y estos 
niveles caen hasta ~25nM, diez veces por debajo de los niveles de oscuridad, en 
condiciones de luz saturante. Al inicio de la fotorrespuesta, cuando el Ca2+ celular se 
reduce progresivamente y alcanza la concentracion de ~130 nM, GCAP1 pasa de unir 
Ca2+ a unir Mg2+ activando RetGC y, por tanto, empieza a promover la síntesis de 
cGMP. El Ca2+ continúa bajando, y al alcanzar [Ca2+] ~50 nM, GCAP2 pasa a su 
conformación activa, activando también a su vez RetGC. Es decir, en la activación de 
RetGC las GCAPs actuan de forma secuencial, por lo que a este mecanismo se le ha 
denominado “relevo de Ca2+”. In vivo, este mecanismo de acción de las GCAPs se ha 
visto confirmado en modelos de ratón y de zebrafish. Por tanto, GCAP1 jugaría un papel 
importante en la primera fase de la respuesta, mientras que GCAP2 es fundamental 
cuando la luz es más intensa. 
Aunque ambas proteínas se encuentran en toda la célula fotorreceptor, su localización 
es más abundante en el segmento externo. La presencia de GCAP1 es predominante 
en las células de cono y la de GCAP2, en las de bastón. Se desconocen los 
mecanismos que determinan la localización de GCAPs, pero se ha visto que en 
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ausencia de las proteínas RetGCs, las GCAPs no son transportadas al segmento 
externo. De hecho, en ratones knockout para la proteína rd3 (retinal degeneration 3) de 
23KDa, asociada a una de las distrofias hereditarias de retina más severas, la 
Amaurosis Congénita de Leber tipo 12, que colocaliza e interacciona con las RetGCs, se 
ha observado que los niveles de RetGCs y de GCAPs se ven muy reducidos y no se 
transportan al compartimento externo. RD3 une RetGCs y es responsable de su 
transporte al segmento externo. El transporte de las proteínas GCAP, por tanto, 
depende del transporte de las RetGCs. 
Se han identificado mutaciones en GCAPs asociadas a distrofias hereditarias de retina. 
Para el gen GUCA1A, que codifica GCAP1, se han descrito diez mutaciones 
heterocigotas que conllevan a distrofias de cono y bastón autosómicas dominantes 
(adCORD). En la mayoría, la activación de retGC por parte de GCAP1 se ve alterada, 
puesto que las mutaciones se hallan en los dominios EF-hand de unión a Ca2+ o en las 
hélices que los preceden o siguen. D100E y N104K afectan directamente el dominio de 
unión a Ca2+ EF3. L151F y E155G afectan el de EF4.  E89K, Y99C, T114I, I143NT, 
G159V afectan las hélices α que los preceden o suceden. Por otra parte, en P50L se ve 
afectada la estabilidad térmica de GCAP1 y no su capacidad de unir y activar RetGC.  
Mientras, para GUCA1B que codifica GCAP2, únicamente se ha encontrado una 
mutación asociada a retinitis pigmentosa autosómica dominante G157R de la que se 
desconoce la causalidad de la patología. 
En el caso de GCAP1, se ha visto que las mutaciones causantes de degeneración 
retinal reducen la afinidad de unión de Ca2+ a la proteína, alterando la sensibilidad a 
Ca2+ de la regulación de RetGC por GCAP1 in vivo. El resultado es la síntesis 
ininterrumpida de cGMP y la consiguiente toxicidad para la célula por los elevados 
niveles de cGMP y de Ca2+. Sin embargo, el efecto de la mutación G157R en GCAP2 
aún no se ha investigado. 
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1.1. THE EYE AND THE RETINA 
1.1.1. The eye works as a camera 
Vision begins with the formation of an external world image at the back of the eye, on a 
thin layer of neurons called RETINA. 
 
Figure I.1. Diagram of the different parts of a human eye. From Bionic Vision Australia  
(http://bionicvision.org.au/eye/healthy_vision) 
 
Light enters the eye through the cornea. The cornea protects the eye from dust, germs, 
etc. and is responsible for refracting rays of light and bending them through the pupil. 
The iris regulates the amount of light entering the eye. In dim light the iris expands the 
pupil and allows more light to come in. On the contrary, in bright light, the iris contracts 
the pupil and less light penetrates the eye. Light crosses the lens which focuses the light 
upon the retina. The lens changes its shape depending on the distance of the object 
from the eye, making possible to “fine-tune” the focus. Afterwards, light crosses the 
vitreous gel, a jelly-like substance that fills the body of the eye, and it crosses the retina 
until reaching photoreceptor cells (Figure I.1). Photoreceptors are responsible for 
transforming light stimuli into an electric signal, which is then transmitted to higher order 
neurons in the retina, and subsequently to the visual cortex of the brain through the optic 
nerve (Rodieck 1998). 
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A homology of the eye with a photo camera is usually established. According to that 
functional comparison, the iris would be the diafragm regulating the entry of light, and 
the cornea and lens would act as the camera lens, focusing light on the thin layer of 
tissue covering the back of the eye, the retina, which would be the equivalent to the 
photographic film on which the image is impressed. 
 
1.1.2. Rod and cone photoreceptors are compartmentalized neurons 
Retina is formed by a set of different cells: photoreceptors, horizontal cells, bipolar cells, 
amacrine cells and ganglion cells (Rodieck 1998). 
In vertebrates, there are two types of classical photoreceptors: rods and cones (Figure 
I.2.), although in mammals, we have a third type of retinal photoreceptor: the 
photosensitive ganglion cells at the inner retina (Yaun and Hardie 2009). 
 
Figure I.2. Diagram of photoreceptor cell morphology: rod (left) and cone (right). Adapted from 
(O’Brien 1982). 
 
These classical photoreceptors are highly specialized and compartmentalized neurons: 
they have four cell regions in which specific functions are carried out. The outer 
segment, where phototransduction takes places, contains a stack of membrane discs 
that are continuously renewed. The visual pigment, which is the most abundant protein 
in this compartment [at a concentration of about ~[3mM] (Otto Bruc et al. 1998)], is 
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embedded at disc membranes. In the case of rods, the non-nascent discs are not in 
touch with the plasma membrane, they are internalized, and the pigment is rod opsin (ó 
rhodopsin). However the three different types of cones in human eyes have their specific 
cone opsin embedded in cone invaginating membrane discs. In fact, membrane folding 
at cone outer segments allows having much more surface exposed, thus facilitating 
substances exchange, such as cromophore to regenerate the pigment or fast calcium 
dynamics which are key points during light adaptation (Figure I.2) (Fu and Yau 2007). 
 
Figure I.3. Scheme of the layered organization of the different cell types in a human retina. Different 
cell types in the retina organize in layers. The retinal pigment epithelium is adjacent to the retinal 
photoreceptor cells and nourishes them.  Light-sensitive photoreceptor cells [rods(R) and cones(C)] 
organize in four layers: the outer segment layer (aligned outer segment compartments); inner segment layer 
(aligned metabolic, inner segment of the cells); outer nuclear layer (cell nuclei organized in rows); and 
plexiform layer (photoreceptor presynaptic terminals in contact with bipolar (B) and horizontal (H) cells 
dendrites). Bipolar and horizontal cell bodies locate at the inner nuclear layer alongside amacrine (A) and 
Müller glia (M) cell bodies, separated by the inner plexiform layer from the inner cell layer constituted by 
ganglion (G) cells. The ganglion cell layer continues to the optic nerve fiber layer. Astrocytes (As) are found 
in the ganglion cell and nerve fiber layers. Adapted from (Odgen 1989). 
 
The outer segment, where phototransduction takes place, is separated by a thin 
connecting cilium from the inner segment, the nucleus and the synaptic terminal. This 
implies that all phototransduction proteins, that are synthesized at the inner segment, 
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must pass through the cilium to get to the light sensitive compartment, the outer 
segment. The inner segment contains protein synthesis machinery (endoplasmic 
reticulum, Golgi apparatus) and an elevated number of mitochondria to supply the high 
amounts of proteins and energy demands. Then, it follows the nucleus, in the outer 
nuclear region, and finally, the synaptic terminal (Figure I.2), responsible for transmitting 
the change in membrane potential caused by light to the rate of neurotransmitter release 
to the second-order neurons: bipolar and horizontal cells. In response to light, there is 
hyperpolarization of the cell and a decrease in the rate of glutamate release at the outer 
plexiform layer. This signal travels really fast through the inner nuclear layer, to bipolar 
and ganglion cells in the direct pathway, to convey in the optic nerve (Figure I.3). 
Furthermore, horizontal and amacrine cells enrich the variety of connections established 
between photoreceptors, bipolar and ganglion cells (Rodieck 1998). 
While photoreceptor cells “measure” the light intensity at different points of the visual 
image, this information is transmitted to bipolar and ganglion cells in a way in which 
some important integration occurs, so that the output of ganglion cells to the brain is 
based on contrasts of light intensity, and on movement, rather than on the light intensity 
of the natural world. The integration of visual information starts at the retina, and in that 
sense the retina is usually referred to as an “outpost” of the brain (Rodieck 1998). 
 
1.2. THE PHOTOTRANSDUCTION CASCADE 
1.2.1. Activation and recovery phase 
Our visual system relies on the two types of photoreceptor cells described above: rods 
and cones, to cover the broad range of light intensities present in the natural world. As 
rods are more abundant in humans and higher mammals (97% in mouse retina) than 
cones, phototransduction has been better studied in rods (Fu and Yau 2007). Rods 
cover the range of dim light intensities. They are extraordinarily sensitive to light, and 
saturate at much dimer light intensities than cones, that cover the range of bright light 
(Fu and Yau 2007). 
Therefore, when one photon of light is captured by the chromophore of rhodopsin, it 
causes its photoisomerization from 11-cis retinal to all-trans retinal, and a conformational 
change in the rhodopsin protein, that acquires its functional state (Rodieck 1998). 
In its active state, rhodopsin activates the G
α
 subunit protein of transducin, by promoting 
the exchange of GDP for GTP in its α subunit and causing its separation from G
β
 and G
γ 
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subunits. G
α
-GTP activates PDE6, retina-specific phosphodiesterase, whose catalytic 
sites cleave cGMP into GMP (Figure I.4). A single activated rhodopsin molecule 
activates ~20 G
α 
molecules, or what it is the same, ~ 0.2% of them (Krispel et al. 2006), 
producing a substantial amplification of the signal. cGMP-gated channels, which have a 
high probability of being in the open state in darkness, opened when they have 4 
molecules of cGMP bound to them, allow the entrance of Ca2+ and Na2+ to the cell. The 
reduction of cGMP levels caused by the activation of rhodopsin promotes the closure of 
the channels reducing the entry of cations (Na+ and Ca2+) and therefore causing the 
hyperpolarization of the cell (Yaun and Hardie 2009). This hyperpolarization decreases, 
or even stops, the release of glutamate neurotransmitter which is sensed by the 
secondary neurons. One single activated rhodopsin molecule causes a reduction of 
~0.7%, which corresponds to the closure of ~2% of the channels that are normally open 
in the dark state (Rodieck 1998). 
As the exposure to light ends, everything that has been activated has to be inactivated 
in order to restore the darkness equilibrium. Photoactivated rhodopsin is phosphorylated 
by a rhodopsin kinase, GRK1 (G protein-coupled-receptor-kinase 1), and quenched by 
arrestin. In the case of the effector complex formed by transducin G
α 
and PDE in rods, 
inactivation resides in a GAP (GTPase activating complex) consisting of RGS9 (G-
protein signaling 9), a RGS9-anchoring protein (R9AP) and an orphan G protein β 
subunit (Gβ5) that accelerate the intrinsic GTPase activity of G
α
 subunit, promoting the 
exchange of GTP for GDP (Yaun and Hardie 2009). Also, the cGMP levels have to be 
reestablished to the dark levels to reset the sensitivity of photoreceptors when the light 
ceases. cGMP is restored to dark levels by activation of retGCs by GCAPs, this causes 
the reopening of cGMP channels thus allowing the entrance of Na+ and Ca2+, and the 
dark current and membrane potential, and also the levels of intracellular Ca2+ to 500nM 
(Figure I.4) (Lucas et al. 2000). 
The plasma membrane potential in photoreceptors is determined, in part, by the number 
of cGMP open channels which depends on the levels of cGMP in the cytoplasm, and 
that is ultimately controlled by the opposing effects of PDE6 and retGCs: when light 
leads to the activation of PDE producing cGMP hydrolysis and a drop in [cGMP], light 
also sets in motion a Ca2+ feedback loop that activates RetGCs in order to replenish 
cGMP levels in the cell and ultimately restore sensitivity to photoreceptors (Lucas et al. 
2000). This Ca2+ feedback loop to cGMP synthesis mediated by RetGC/ GCAPs, by 
opposing the effect of light, constitutes an essential step of termination of the light-
response, and of light adaptation (Dizhoor 2000). 
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Figure I.4. Activation and deactivation of the phototransduction cascade.  In darkness, rhodopsin (R), 
transducin (G
α
, Gβ and Gγ subunits), and PDE (α, β and γ subunits) are in their inactive form, as 
represented in the upper disc membrane. Light causes the photoactivation of rhodopsin, leading to the 
dissociation of GTP-bound transducin alpha (G
α
) from the Gβ and Gγ subunits. G
α
-GTP in turn activates 
cGMP-PDE by forming the so-called “effector complex”, as illustrated in the middle disc membrane. Once 
the photoreceptor cell has responded to light, when the light ceases every protein that has acquired an 
active state must be deactivated in order to restore the darkness equilibrium. Deactivation reactions are 
illustrated in the lower disc membrane: R* is inactivated through phosphorylation by rhodopsin kinase (RK) 
followed by arrestin (Arr) binding; the effector (transducin/PDE) inactivation is mediated by a GAP- complex: 
the RGS9-1–Gβ5–R9AP, that catalyzes the intrinsic GTPase activity of G
α
.  Also required to restore the 
darkness equilibrium is the reinstatement of cGMP to the dark levels by new synthesis.  The Guanylate 
cyclase/GCAP complex (RetGC/GCAP) are responsible for de novo cGMP synthesis in photoreceptor cells, 
here illustrated at the plasma membrane. Modified from (Burns and Arshavsky 2005) 
 
1.2.2. Mechanisms of light adaptation 
As the intensity of light in the surface of the planet varies over ten orders of magnitude, 
photoreceptors respond constinuously to changes in background light intensity. As 
mentioned before, rods cover the low range (scotopic vision). They are extraordinarily 
sensitive to light, with a threshold of one photon every 85 minutes, and saturate at 
relatively low intensities; whereas cones are less sensitive to light but can operate over a 
broader range of light intensities. Cones carry out daylight response to light (photopic 
vision), but they are not as sensitive as rods. Cones have better temporal resolution than 
rods and are responsible for color vision (Rodieck 1998). 
GCAP 
GCAP 
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In order to prevent saturation, and be able to respond to light in the natural world at 
highly varying ambient light intensities, photoreceptors adjust their sensitivity depending 
on the background light intensity. This sensitivity adjustment is mediated by a Ca2+ 
negative feedback to the transduction cascade that serves to counteract the effect of 
light. As light leads to cGMP- channel closure, the Ca2+ influx is reduced, while Ca2+ 
extrussion continues through the Na+/Ca2+ exchanger. Therefore there is a decrease in 
the [Ca2+] during the light response. This drop in Ca2+ is sensed at different steps in the 
phototransduction cascade: it serves to release recoverin from its interaction with GRK1, 
therefore accelerating rhodopsin phosphorylation and inactivation. It serves to increase 
the affinity for cGMP of the cGMP-gated channels, through the action of CaM, and most 
importantly it serves to cause the transition of the GCAP proteins from their inhibitory to 
their activator state of the RetGCs, therefore accelerating cGMP synthesis (Pugh et al. 
1999) (Fain et al. 2001) (Burns et al. 2002). 
The synthesis of cGMP contributes to the opening of cGMP-channels, therefore serving 
to restore a fraction of the dark current even in the presence of a background light, so 
that makes it possible to respond to an overimposed light stimulus. This process of 
adjusting light sensitivity to the intensity of the ambient light is known as light adaptation 
(Pugh et al. 1999). 
 
1.3. THE GUANYLATE CYCLASE ACTIVATING PROTEINS, 
GCAPS 
1.3.1. GCAPs are Neuronal Calcium Sensor proteins 
Guanylate cyclase activating proteins (GCAPs) belong to the neuronal calcium sensor 
(NCS) family. NCS proteins transduce Ca2+ signals into different changes in neuronal 
function (Koch 2012). Ca2+ changes in neurons can vary greatly in magnitude, space 
and time.  Neuronal calcium sensor proteins selectively respond to defined Ca2+ signals 
due to variations in their on-rate kinetics, Ca2+-affinities and localization (Burgoyne and 
Haynes 2012). 
The NCS protein family is encoded by 14 genes in the human genome 
(http://www.liv.ac.uk/physioogy/ncs/index.html) that carry out distinct non-redundant 
roles. (McCue et al. 2010). NCS proteins are about 22 kDa proteins, with 30-70 percent 
protein sequence identity to each other. They are high-affinity Ca2+-binding proteins that 
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act as Ca2+ sensors rather than Ca2+ buffers.  The NCS proteins possess four EF-hands, 
a helix-loop-helix motif, of which only two or three bind Ca2+ (Haynes and Burgoyne 
2010). 
 
Subgroup First 
appearance 
in evolution 
Mammalian 
protein 
Expressed 
human 
splice 
variants 
Proposed functions 
A Yeast NCS-1 1 Regulation of neurotransmission, stimulation of constitutive 
and regulated exocytosis, learning, short-term synaptic 
plasticity, Ca2+ channel and Kv4 channel regulation, 
phosphoinositide metabolism, dopamine D2 receptor 
endocytosis, GDNF signalling, neuronal growth and survival 
B Nematodes Hippocalcin 1 Anti-apoptotic, AMPA receptor recycling in LTD, MAPK 
signalling, learning 
Neurocalcin-δ 1 GC activation 
VILIP1 1 GC activation and recycling, traffic of nicotinic receptors, 
increase of cAMP levels and secretion 
VILIP2 1 Regulation of P/Q-type Ca2+ channels 
VILIP3 1 Unknown 
C Fish Recoverin 1 Light adaptation by inhibition of rhodopsin kinase 
D Fish GCAP1 1 Regulation of retGCs 
GCAP2 1 Regulation of retGCs 
GCAP3 1 Regulation of retGCs 
E Insects KchIP1 3 Regulation of Kv4 and Kv 1.5 channels, repression of 
transcription 
KchIP2 5 Regulation of Kv4 and Kv 1.5 channels, repression of 
transcription 
KchIP3 2 Regulation of Kv4 channels, presenilin processing, APP 
processing, repression of transcription, pro-apoptotic, 
regulates ER Ca2+ 
KchIP4 6 Regulation of Kv4, presenilin processing, channels, repression 
of transcription 
 
Table I.1. Neuronal Calcium Sensor proteins and their proposed functions in mammalian systems. From 
(Burgoyne 2007). 
 
Specifically, the N-terminal EF-hand does not bind Ca2+ in all family members.  Many 
members of the family are N-terminally myristoylated.  In many cases, this modification 
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facilitates the protein association to membranes, thereby facilitating the regulation of its 
target (Ames and Lim 2012). 
Five different NCS classes have been characterized in higher organisms: class A 
encompasses NCS-1; class B, visinin-like proteins (VSNLs); class C, recoverin; class D, 
GCAPs and class E, K+ channel-interacting proteins (KChIPs) (Table I.1) (Burgoyne 
2007) . 
Depending on sequence variations in their EF domains, N- and C-terminal regions and 
protein structure, each type differ among the others in its Ca2+-affinity.  Nevertheless, 
they all show cooperation in calcium binding in vitro, responding to subtle oscillations in 
intracellular Ca2+.  Consequently, NCS proteins undergo conformational changes upon 
Ca2+ binding, thus regulating their targets. (Burgoyne et al. 2004) 
 
1.3.2. Historical perspective: purification, cloning and biochemical 
characterization of GCAPs 
By the late 70s it was known that illumination of bovine rod outer segment membrane 
preparations or amphibian intact photoreceptors led to changes in cGMP and Ca2+ 
(Papermaster et al. 1978). These two molecules were the prime candidates to carry the 
message from the photon absorption by the visual pigment at the disc membrane to the 
ion channels at the plasma membrane of photoreceptor outer segments.  It was in the 
mid-eighties, with the identification, purification and functional reconstitution of the cyclic 
GMP-dependent channel from rod photoreceptors, that cGMP was established as the 
second messenger of phototransduction (Fesenko et al. 1985).  It was clear that light, by 
causing the photoisomerization of the chromophore in rhodopsin, initiated an enzymatic 
amplification cascade that culminated with the hydrolysis of cGMP.  This drop of cGMP 
caused the closure of a fraction of cGMP-gated channels at the plasma membrane, 
reducing the inward current of Na+ and Ca2+ and leading to the hyperpolarization of the 
cell.  Once cGMP was established as the second messenger for light transduction, 
numerous studies followed to show that Ca2+ ions played an important role at promoting 
the recovery of the light response and mediating light adaptation, that is, adjusting 
photoreceptor sensitivity to the level of background illumination. 
Since cGMP levels drop during the light response, recovery of the dark state once the 
light is dimmed or extinguished requires that cGMP levels are restored through new 
synthesis. cGMP is synthesized by the retinal guanylate cyclase (RetGCs) enzyme, an 
integral membrane protein. 
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RetGCs are transmembrane proteins located in the disc membranes of photoreceptor 
cells that are active as dimers. An extracellular domain lies within the lumen of the disc 
membranes, but unlike homologous GCs in other tissues that are activated by ligand 
binding to the extracellular domain; no ligand has been identified for RetGC1 and 
RetGC2 (Dizhoor 2000). In fact, they can be activated even when the extracellular 
domain, or the transmembrane domain, have been truncated (Laura et al. 1996). 
Instead, retGCs are regulated by GCAPs, as it was discovered in the late eighties 
(Dizhoor 2000). 
In 1988, a seminal paper in Nature by Karl-Wilhelm Koch and Lubert Stryer showed that 
cGMP synthesis in bovine rod outer segment membranes (bovROS) was steeply 
dependent on Ca2+, in the physiological range of intracellular Ca2+ concentrations (Koch 
and Stryer 1988).  The rate of cGMP synthesis increased 5 to 20-fold when [Ca2+] was 
changed from 1µM to 10nM.  This Ca2+ regulation of RetGC activity was not direct, but 
mediated by a soluble factor.  Ca2+-regulation was lost when membranes were washed 
with a hypotonic solution, and restored when the washed fraction (containing the 
proteins stripped from the membrane) was restored to membranes.  This pioneering 
study predicted the existence of a soluble Ca2+-binding protein in photoreceptor cells 
that would activate RetGC upon sensing the drop in Ca2+ that happens in response to 
light.  That is, this protein would maximally activate RetGC upon losing Ca2+, therefore 
working in the opposite direction from CaM regulation of its targets, and it would do so 
with high Ca2+ cooperativity (Koch and Stryer 1988). 
In 1994, two independent groups at the University of Washington, Seattle, were able to 
purify the Ca2+-binding proteins responsible for RetGC regulation from the soluble 
fraction of bovine rod outer segments.  They did so by subjecting the low salt-wash 
fraction of bovROS to a series of chromatographic steps, and identifying the fraction that 
retained GC stimulating activity.  Two related but not identical proteins were purified, of 
21 and 24 kDa, that were termed guanylate cyclase activating protein 1 (Subbaraya et 
al. 1994) (Gorczyca et al. 1995) and guanylate cyclase activating protein 2  (Dizhoor et 
al. 1994) (Dizhoor et al. 1995), that were shown to decrease the sensitivity, time-to-peak 
and recovery time of the light response following their introduction into intact 
photoreceptor cells. 
The subsequent molecular cloning of GCAPs from different species revealed that these 
~200 aminoacidic proteins presented strong sequence conservation at four EF-hand 
motifs, out of which only EF-2 to EF-4 bind Ca2+, and revealed its relation to Ca2+-
binding proteins of the NCS superfamily (Figure I.5).  In GCAPs, the N-terminal EF-1 
domain does not bind Ca2+, and is instead involved in RetGC1 recognition (Gorczyca et 
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al. 1995) (Ermilov et al. 2001).  GCAP1 and GCAP2 show overall 40% identity and they 
are both myristoylated at the NH2 terminus. 
 
Figure I.5. Aminoacid sequence alignment of bovine GCAP2 and GCAP1. For optimal alignment of the 
two proteins, several gaps (hyphens) were introduced. Predicted calcium binding domains are shaded in 
gray, while amino acids on black background represent identity or conservative replacement (L = I = V = M; 
Y = F; K = R; S = T = A). From (Gorczyca 1995) 
 
Because GCAPs associate to membranes independently of the [Ca2+]free, GCAPs are 
thought to form a stable complex with RetGC independent of the [Ca2+]free (Peshenko et 
al. 2008).  These complexes may switch between two conformations, active and 
inactive, with the binding and dissociation of Ca2+. GCAPs activate the cyclase at free 
Ca2+ concentrations below 100nM characteristic of light adapted rods, and inhibit the 
cyclase at free Ca2+ concentrations above 500nM characteristic of the dark-adapted 
photoreceptors.  In contrast to other known EF-hand proteins which regulate their 
effectors in their Ca2+-loaded form, GCAPs activate RetGC in their Ca2+-free (Mg2+-
bound) form, and inhibit RetGC in their Ca2+-loaded form (Peshenko and Dizhoor 2004) 
(Peshenko et al. 2004a) (Peshenko and Dizhoor 2006) 
To study the mechanism of Ca2+-sensitive modulation of RetGC, the role of individual 
EF-hands of GCAP1 and GCAP2 in RetGC inactivation was analyzed by mutagenesis.  
Individual EF-hands of GCAP1 and GCAP2 play similar but not identical roles.  Disabling 
mutations in EF-3 and EF-4 domains of GCAP1 impair GCAP1 convertion from activator 
to inhibitor of RetGC, with the mutants retaining partial constitutive activity.  Therefore, 
EF-3 and EF-4 hand-motifs are the most critical domains for Ca2+-sensitive inactivation 
in GCAP1, while EF-2 contributes little to Ca2+-sensitive GCAP1 inactivation (Rudnicka-
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Nawrot et al. 1998) (Sokal et al. 1999) (Peshenko and Dizhoor 2007).  In contrast, all 
three EF-hands of GCAP2 contribute to the inhibitory effect of Ca2+ (Dizhoor and Hurley 
1996) (Ames et al. 1999).  GCAP1 and GCAP2 are thought to interact with RetGC at the 
same or at a partially overlapping binding site, based on the fact that both GCAP1 and 
GCAP2 in their Ca2+-loaded forms can compete the constitutive activity of the GCAP1 
mutant with disabled EF-hands (Peshenko et al. 2008). 
Another property of GCAPs relevant to understand their mode of action is that both 
GCAP1 and GCAP2 can form dimers upon Ca2+ dissociation (Olshevskaya et al. 1999b).  
It has been shown that the capacity to dimerize in GCAP2 correlates with the ability to 
activate RetGC.  That is, GCAP2 has to form a dimer to be active.  A subtle difference is 
that while in GCAP2 dimerization is reversed by Ca2+ binding, GCAP1 dimerization is 
resistant to the presence of Ca2+ (Olshevskaya et al. 1999b).  This implies that Ca2+ 
triggers different conformational changes in GCAP1 and GCAP2 in the RetGC-GCAP 
complexes. 
Figure I.6. Model of retGC regulation by GCAPs. RetGCs are active as dimers (Yu et al. 1999). GCAPs 
are presumed to be permanently bound to RetGC, regulating its catalytic activity as they bind or release 
Ca2+.  The Ca2+-loaded form of the GCAP proteins, typical of the high Ca2+ levels in the dark-adapted state, 
(left), inhibit the catalytic activity of RetGC. The Ca2+-free form of GCAPs that would emerge as a result of 
light exposure as Ca2+ drops (Ca2+-free, Mg2+-loaded GCAP form, right) robustly stimulate RetGC activity by 
promoting the dimerization of retGC catalytic domains (CD).  KHD (kinase homology domain), ECD 
(extracellular domain). 
 
Taken together, these biochemical results point to a RetGC model of regulation by 
GCAPs in which GCAPs are permanently bound to RetGCs, and oscillate between an 
activator and an inhibitor state depending on the [Ca2+]free (Figure I.6). 
GCAP 
Dark                           Light                          
GTP 
cGMP 
 [Ca 2+] 
Ca 2+ 
RetGC 
CD 
KHD 
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GCAP1 
1   MGNIMDGKSVEELSSTECHQWYKKFMTECPSGQLTLYEFRQFFG 
45   LKNLSPWASQYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKV 
89   EQKLRWYFKLYDVDGNGCIDRDELLTIIRAIRAINPCSDSTMTA 
133   EEFTDTVFSKIDVNGDGELSLEEFMEGVQKDQMLLDTLTRSLDL 
177   TRIVRRLQNGEQDEEGASGRETEAAEADG 
 
GCAP2 
1    MGQQFSWEEAEENGAVGAADAAQLQEWYKKFLEECPSGTLFMHE 
45    FKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLV 
89    LRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACS 
133    VEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARR 
   177    DKWVMKMLQMDLNPSSWISQQRRKSAMF 
_________________ 
__________________ 
________________________________ 
EF-1 
EF-2 
EF-3 
EF-4 
EF-1 
EF-2 
EF-3 
EF-4 
___________ 
____ _______ 
__________________ 
_____
_________ 
___________ 
____ 
direction 
of  calcium- switch 
_______________ 
____ 
_____ 
 
Figure I.7. Map of functional domains in GCAP1 and GCAP2.  Regions necessary for RetGC activation 
are underlined in green, with essential sequences in green font.  Regions necessary for RetGC inhibition 
underlined in red.  The interdomain region between EF-2 and EF-3 determines the direction of the calcium 
switch in GCAP2.  
 
Several biochemical studies then addressed the mapping of functional domains in 
GCAP1 and GCAP2 involved in activation or inhibition of RetGC by analysis of deletion 
mutants and chimeric proteins in which different regions of the GCAP proteins were 
substituted by the corresponding regions of recoverin or neurocalcin (Olshevskaya et al. 
1999a) (Krylov et al. 1999). 
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It was determined that several regions of the GCAP molecules are required for RetGC 
activation (Figure I.7): a) a region whithin the N-terminal region starting at Trp21 
(numbering corresponding to GCAP1) that comprises a 5 to 7 amino acid stretch 
preceding EF-1, the EF-1 domain -non-functional at Ca2+ coordination- and some 
additional amino acids; b) the region between EF-hands 2 and 3, representing the 
“interdomain” or “hinge” region between the NH2- and COOH- terminal globular domains 
in the structure of GCAPs, is required for activation and determines the direction of the 
Ca2+-switch in GCAP2; and c) a stretch of about 20 amino acids starting at Phe156 
immediately adjacent to EF-4 within the COOH-terminal domain (Olshevskaya et al. 
1999a) (Krylov et al. 1999).  
Whithin these domains, the stretches of amino acids Trp21-Thr27 preceding EF-1 in the 
NH2-terminal region, and Thr177-Arg182 within the COOH-terminal region  in GCAP1 
(Krylov et al. 1999), and the corresponding regions in GCAP2, appear to be critical for 
RetGC activation (Olshevskaya et al. 1999a).  Therefore, a picture is emerging in which 
the signal in the GCAP proteins involved in RetGC recognition is discontinuous, 
involving the NH2- and COOH-terminal regions. 
In contrast, inhibition of RetGC requires the first 9 aa of GCAP1 (Krylov et al. 1999), and 
the EF-1 domain in GCAP2 (Olshevskaya et al. 1999a). 
 
1.3.3. GCAPs regulation of RetGCs: the calcium relay model 
Two to eight different GCAP isoforms have been identified in species from fish to 
human, for example, GCAP3 is specifically found in human and zebrafish retinas 
(Imanishi et al. 2002). Surprisingly it is in fishes where we see more variety, probably 
arising from gene duplications: in zebrafish there are 6 isoforms (GCAP1–5, GCAP7) 
and 8 in pufferfish and carp (GCAP4-8). In frogs, we find a GCAPs homolog, Guanylate 
Cyclase Inhibiting Protein (GCIP) (Imanishi et al. 2004). GCAP1 and GCAP2 are the 
major isoforms in higher mammals.  When two different isoforms of a protein are 
expressed in the human retina, the first question to address is whether one isoform 
might be specific for rods and the other for cones.  However, in the case of GCAP1 and 
GCAP2 it was established that they are both expressed in rod and cone cell types (see 
GCAPs localization for details).  This apparently redundant expression of GCAP1 and 
GCAP2 was initially puzzling, since they exhibited very similar biochemical properties.  
However, when mice became available that lacked either GCAP1 or GCAP2, their 
electrophysiological recordings indicated that these neuronal calcium sensors had 
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somewhat different roles in shaping the light response of a rod cell.  GCAP1 was 
responsible for the initial rapid recovery phase, while GCAP2 was responsible for the 
slower recovery to the baseline [ (Mendez and Chen 2002) (Howes et al. 2002) (Pennesi 
et al. 2003), see GCAP physiological functions revealed by the study of mouse models 
for details].  At about the same time as the initial electrophysiological report, more 
detailed biochemical studies showed that the Ca2+-sensitivity of the RetGC activation 
profile of bovine GCAP1 differed from that of GCAP2 (Hwang et al. 2003).  It was 
determined that the EC50 for Ca2+ inhibition of retGC stimulation was higher for GCAP1 
than for GCAP2 [Ca2+ EC50 for GCAP1 ~130nM; for GCAP2 ~50nM], providing a 
molecular basis for the interpretation of the electrophysiological data (Peshenko et al. 
2011b).   
Light exposure results in up to a 10-fold decline in the intracellular free [Ca2+], from 
~250nM in darkness to 23nM in saturating light in mouse rod outer segments.  The 
difference in the EC50 values means that this Ca2+ decrease is first sensed at GC/GCAP 
complexes comprising GCAP1 (Ca2+ EC50 for GCAP1 ~130nM) and successively, when 
Ca2+ has dropped to lower levels, at those comprising GCAP2 [Ca2+ EC50 for GCAP2 
~50nM], in a sequential mode of action that is today referred to as “the Ca2+-relay 
model” (Kock and Dell’Orco 2013).   
In a physiological context, during the single flash response of a rod cell, the Ca2+ 
concentration drops from its dark value to below 100nM.  Within the first 50ms the 
cytoplasmic Ca2+ has dropped but has not reached its final value.  During this 
“intermediate state” the activation of GCAP1 is triggered, causing a first pulse of cGMP 
synthesis responsible for the characteristic “fast recovery phase” that is absent in mice 
lacking GCAP1.  A further decrease in cytoplasmic Ca2+ on a time-scale of 0.5-1s 
triggers the dissociation of Ca2+ from GCAP2 causing its conformational change to the 
activator state and stimulating the cGMP synthesis that restores the rod sensitivity to its 
baseline (Kock and Dell’Orco 2013).   
That is, the regulation of retGC by GCAPs is a two-step process in which GCAP1 
mediates the first-response as [Ca2+]i starts to fall with illumination, whereas GCAP2 
provides additional retGC stimulation of cGMP synthesis only after [Ca2+]i drops 
substantially (e.g. in brighter light).  Altogether, the rate of cGMP synthesis upon light 
exposure is stimulated up to ~12-fold over its basal levels, serving to restore the cGMP 
levels and to reopen the channels during the recovery of the light response and light 
adaptation (Peshenko et al. 2012b).   
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This Ca2+ relay mode of operation of GCAPs makes the cell highly responsive to 
changes in intracellular calcium along the wide range of physiological Ca2+ 
concentrations. 
 
1.3.4. GCAPs structure 
To complement the biochemical characterization of GCAPs, structural studies have 
aimed in recent years at elucidating the Ca2+-induced conformational changes in GCAP1 
that control activation of RetGC by pursuing the atomic resolution structures of GCAP1 
in both the Ca2+-bound (inhibitor) and Mg2+-bound (activator) states.  The structure of the 
Mg2+-bound activator state of GCAP1 has been elusive so far, due to this form of the 
protein being highly unstable and difficult to maintain in solution.  Neither the crystal 
structure nor the  nuclear  magnetic resonance  (NMR)  structure of the activator state of  
 
 
Figure I.8. Crystal structure of myrGCAP1 in its Ca2+ bound (inhibitor) state. A and B represent the 
front and back view, respectively, of myrGCAP1. N-terminal helix is coloured in red and C-terminal helix is 
coloured in green. The N-terminal globular domain, which encompasses EF-1 and EF-2 is orange, while the 
C-terminal domain, containing EF-3 and EF-4, is yellow. Ca2+ ions are shown as dark green spheres and the 
myristoyl group is represented by dark blue space-filling spheres.  C and D are surface representations of 
front and top views of myrGCAP1, respectively. Semitransparent surface reveal the cartoon representation 
(already described for A and B) and the buried myristoyl group.See text for details. From (Stephen et al. 
2007) 
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GCAP1 could be determined so far.  Only the structure of the Ca2+-bound (inhibitor) 
state of GCAP1 has been obtained.  The crystal structure of myristoylated GCAP1 in its 
Ca2+-bound form has been resolved at a 2.0 Å resolution (Stephen et al. 2007). 
In this crystal structure, the four EF-hand motifs are arranged in two domains in Ca2+-
bound myrGCAP1.  EF-1 (residues 17-42) and EF-2 (residues 50-82) form the N-
terminal domain, whereas EF-3 (residues 87-118) and EF-4 (residues 130-160) form the 
C-terminal domain.  A short loop between EF-2 and EF-3 links these domains together 
(Stephen et al. 2007). 
The overall structure of myrGCAP1 is quite compact.  In contrast to Ca2+-bound 
recoverin, the myristoyl group in Ca2+-bound GCAP1 (blue in Figure I.8) is completely 
buried in the core of the N-terminal domain.  The binding pocket for the myristoyl group 
in Ca2+-bound GCAP1 is formed by hydrophobic side chains contributed from residues 
from EF-1 (W20, F38, and F42), EF-2 (V55, M58, F62, Y75, L79 and V82), the N-
terminal helix (M4, V9 and L12) and the C-terminal portion of the kinked C-terminal helix 
(L174, I177, V178 and I181).  The link between the N- and C- terminal domains is 
strengthened by an interaction between the N- and C-terminal helices.  The C-terminal 
helix (green in Figure I.8) is partially unraveled and sharply kinked and it interacts in an 
antiparallel orientation with the N-terminal helix (red in Figure I.8) tying the two domains 
together (Stephen et al. 2007) (Lim et al. 2009). Note: see Appendix for amino acid code 
and properties table. 
The packing of the myristoyl group in Ca2+-bound GCAP1 is opposite to what is 
observed for the acyl group in the Ca2+-bound recoverin. This is also attributable to Ca2+-
bound GCAP2 (Hughes et al. 1998) (Ames et al. 1999).  In myr-recoverin the acyl group 
is completely exposed in the Ca2+-bound state, and it is the transition to its Ca2+-free 
conformation that is accompanied by sequestration of the acyl group in its N-terminal 
domain, in the so-called “calcium-myristoyl switch”.  That way recoverin is soluble in the 
Ca2+-free state (myristoyl group buried) and is recruited to the membrane in the Ca2+-
bound state, where it regulates its target.  In GCAP1, an analysis of the solvent 
exposure of the acyl group has determined that the myristoyl group is buried in the 
molecule both in the Ca2+-bound and in the Ca2+-free states.  There is no “calcium-
myristoyl switch” regulating the membrane association of GCAP1. Amino-terminal 
myristoylation of GCAP1 is required for full activity at physiological concentrations of 
Ca2+ (Otto-Bruc et al. 1997) (Hwang and Koch 2002) (Peshenko et al. 2012a). The 
GCAP1 structure shows that the myristoyl group is a central feature in the hydrophobic 
core of the N-terminal domain, that by contacting the kinked C-terminal domain it helps 
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to stabilize the bridge between N- terminal residues and the C-terminal residues 175-
183, previously identified as crucial for GCAP1 activity (Figure I.8 –important domains 
involved in RetGc activation) (Stephen et al. 2007) (Lim et al. 2009).  Therefore, the 
myristoyl group in GCAP1 is crucial to provide structural stability and to tune 
GCAP1/Ret-GC complex affinity and activation (Peshenko et al. 2012b). Instead, 
myristoylation of GCAP2 affects its overall structural stability without affecting RetGC 
regulation (Hwang and Koch 2002) (Olshevskaya et al. 2007) (Schröder et al. 2011). 
Overall, the crystal structure of GCAP1 points to the clustering of the N- and C-terminal 
helices and the myristoyl group as responsible for GCAP1 inhibition of photoreceptor 
RetGC at high concentrations of Ca2+.  It also suggests that a transition to the Ca2+-free 
state of GCAP1 might pull these two helices apart, yielding the conformation responsible 
for RetGC activation at low Ca2+ concentrations (Stephen et al. 2007). 
This prediction based on the crystal structure could be somewhat confirmed with the 
recent determination of the NMR structure of a functional mimic of GCAP1 in the Ca2+-
free/Mg2+ bound activator state (the D144/D148G mutant or EF4 mutant).  As mentioned 
above, the Ca2+-free/Mg2+ bound GCAP1 protein is unstable and tends to aggregate 
under NMR conditions, but a mutant with the EF-4 hand inactivated that is constitutively 
active in reconstituted assays turned out to be more stable under NMR conditions.  A 
comparison of NMR chemical shifts for the inhibitor and activator states of GCAP1 
revealed that residues at the GCAP1 domain interface (exiting helix of EF2 and entering 
helix of EF3) have broad NMR resonances indicating they are conformationally dynamic, 
and pointing to a Ca2+-induced domain swiveling (that would separate N- and C-terminal 
helices apart) taking place, albeit to a much lesser extent than the reported for recoverin.  
Single mutations in some residues of the domain interface (V77, A78, L82, W94) abolish 
or dramatically decrease cyclase activity, emphasizing the importance of the swiveling 
between domains (Lim et al. 2013). 
These results are also in line with earlier biochemical studies of the Ca2+-induced 
conformational changes in GCAP2, that showed that the Ca2+-free form of GCAP2 or its 
functional mimic EF-GCAP2 present a more exposed C-terminal helix as revealed by the 
exposure of the C-terminus to a protein kinase that phosphorylates GCAP2 at Ser201, 
and to limited proteolysis. The physiological significance of Ser201 phosphorylation is 
not known yet (Peshenko et al. 2004b).  
Biochemical analysis of Ca2+-induced conformational changes in GCAP1 had also 
revealed that at high [Ca2+]free the central portion of the protein was protected from 
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proteolysis, while at low [Ca2+]free the central portion of the protein was more vulnerable 
to proteolysis. 
Taken together, structural analysis of GCAP1 and GCAP2 point to a more compact and 
stable structure of these proteins in their Ca2+-bound (inhibitor) form, and a more open 
structure in which the N- and C-terminal helixes pull apart in the Mg2+-bound (active) 
form.  The myristoyl group would be buried in the N-terminal domain in both states, 
contributing to the thermal stability of the protein (Orban et al. 2013). 
 
1.3.5. GCAPs localization in rods and cones 
GCAP1 and GCAP2 are present at different levels in the retina. In bovine retinas, the 
GCAP1: GCAP2 ratio is estimated to be between 3:1 and 4:1. Furthermore, initial 
localization studies of GCAP1 and GCAP2 in different species showed that both 
isoforms are present at the rod outer segment compartment of rods and cones, where 
phototransduction takes place, albeit at apparently different levels.  Although the 
localization of GCAP1 and GCAP2 might differ in different species, there is the 
consensus that GCAP1 is more abundant at cone outer segments than at rod outer 
segments in higher mammals, whereas GCAP2 localizes primarily to rods and at lower 
levels in cones (Howes et al. 1998) (Cuenca et al. 1998) (Kachi et al. 1998). 
Besides localizing to rod outer segments, GCAPs are also present at proximal 
compartments of the cell.  GCAP1 is present (to a lesser extent than at rod outer 
segments) at the inner segment and synaptic terminals of cones and rods, where its 
function is unknown (Howes et al. 1998).  GCAP2 localization in rods is not restricted to 
rod outer segments either.  GCAP2 is present at rod inner segments at the same or 
higher levels, and at lower levels in more proximal compartments of the cell like the 
synaptic terminal.  However, because the range of [Ca2+]i at synaptic terminals is 
considerably higher than that at rod outer segments, a function of GCAPs in stimulation 
of cGMP synthesis was deemed unlikely.  The role of GCAPs at the synaptic terminal is 
currently unknown.  Therefore our interest in pursuing the identification of new GCAP 
protein interactors, in order to identify new GCAPs molecular targets at this 
compartment. 
The mechanisms that determine GCAPs subcellular distribution are largely unknown, 
but it has been reported that GCAPs localization to the rod outer segments (where 
phototransduction takes place) requires RetGC1 and RetGC2 expression (two RetGCs 
are expressed in retinal photoreceptors) (Karan et al. 2010). GCAP1 preferentially 
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activates RetGC1 in vivo, while GCAP2 seems to bind to the two retGCs identified in 
mammalian rod and cone cells. RetGC2 is expressed at a lower molar ratio, although 
this ratio differs among species. RetGC1:RetGC2 ratio in bovine ROS is 25:1, while in 
murine ROS is 4:1 (Helten et al. 2007). In the double knockout mice in RetGC1 and 
RetGC2, both GCAP1 and GCAP2 appear to be excluded from the outer segment and 
accumulate at the inner segment. Mutations in RetGC1 (GUCY2D) are associated with 
one of the most severe forms of inherited blindness that accounts for approximately 5% 
of all retinal dystrophies: Leber’s Congenital Amaurosis type 1 (LCA-1), characterized by 
extinguished scotopic and photopic ERGs at very early onsets (Jacobson et al. 2013).  
In mice, the RetGC1/RetGC2 double knockout phenotypically resembles human LCA1 
with extinguished ERGs and rod/cone degeneration.  In these mice, GCAPs fail to be 
transported to the outer segment and accumulate at the inner segment (Coleman et al. 
2004) (Baehr et al. 2007). This observation suggests that GCAPs are transported to the 
sensory compartment following their association to Ret-GCs (as GCAP/RetGC 
complexes) (Baehr et al. 2007).  It has been proposed that the RetGC proteins may 
contain ciliary trafficking signals, and could guide a subtype of vesicular transport 
carriers from the endoplasmic reticulum to the cilium that would carry the peripheral 
membrane proteins involved in cGMP metabolism (Karan et al. 2010). 
However, an attempt to map these ciliary targeting sequences in RetGC1 by generating 
fusion proteins of its C-terminal region or its cytosolic domains with GFP and studying 
whether they are targeted to rod outer segments in transgenic frogs failed to define a 
linear targeting signal.  These results suggest that either the signal is discontinuous or 
there are accessory proteins in this RetGC1 guided trafficking to the cilium (Karan et al. 
2011). 
Actually, it was recently found that the protein of 23 kDa responsible for Leber’s 
Congenital Amaurosis type 12 in patients and for a blindness phenotype in a naturally 
occurring strain of mice called rd3, interacts and colocalizes with RetGC1 (Friedman et 
al. 2006). The absence of the protein RD3 (retinal degeneration 3) in naturally occurring 
rd3 mice causes a dramatic decrease in RetGC1 and RetGC2 protein levels and their 
absence at the outer segment compartments of rods and cones (Peshenko et al. 
2011a). Interestingly, and consistent with the observations in RetGC1/RetGC2 double 
knock-out mice, RD3 absence also causes a decrease in GCAP protein levels and their 
exclusion from the outer segments.  It was suggested that RD3 has the ability to recruit 
RetGC1 from the ER to endosomal vesicles, by interacting with a small stretch of amino 
acids at the RetGC1 COOH-terminal domain, in the cytosolic fragment of the protein 
(Karan et al 2010) (Azadi et al. 2010) (Molday et al. 2013). When RD3 binds RetGC, 
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avoids RetGC/GCAPs activity, independent of Ca2+ levels.  Therefore RD3 is a RetGC1 
binding protein required for the stable expression and membrane vesicle trafficking of 
RetGCs (and consequently of GCAPs) in photoreceptors (Azadi et al. 2010) (Peshenko 
et al. 2011a).  
 
1.3.6. GCAP physiological functions revealed by the study of mouse models 
A number of mouse models have been developed to study the role of GCAP proteins in 
vivo.  The first mouse model consisted on the abrogation of expression of both genes 
(GCAP1 and GCAP2), to target the Ca2+ feedback to RetGC activity in order to 
determine its kinetic contribution to termination of the light response and to the process 
of light adaptation. Because the genes encoding GCAP1 and GCAP2 (GUCA1A and 
GUCA1B respectively) are organized in a tail-to-tail array (Surguchov et al. 1997), 
suggesting ancient gene duplication and inversion events (see Figure I.9) (Howes et al. 
1998), individual knock-outs were not pursued in this original study, because the double 
knockout would have never been obtained by the breeding of individual knockouts.  
Therefore, a double knockout in GCAP1 and GCAP2 was obtained with a single 
replacement vector (Mendez et al. 2001) (Mendez and Chen 2002) (Figure I.9). 
GCAPs-/- mice preserved a mostly normal retinal morphology (Figure I.9 C) The 
expression levels of other genes involved in cGMP turnover, such as RetGCs and PDE 
were not affected in these mice, indicating that GCAPs ablation did not lead to 
noticeable compensatory changes (Figure I.9 B) (Mendez et al. 2001) (Mendez and 
Chen 2002).  
Rods from these mice were much more sensitive to light than wildtype rods.  Dim flash 
responses from GCAPs-/- mice rose for a longer time and to a larger peak amplitude 
than wildtype responses (Burns et al. 2002).  The mean single photon response 
amplitude in GCAP1/GCAP2-/- mice was nearly five times larger than that of wildtype 
rods (Figure I.10).  The flash strength required to elicit a half-maximal response, was 
about 8-fold lower in the GCAPs-/- rods.  That is: GCAPs-/- mice gave much larger 
responses than wildtype mice to the same light stimulus; or, put it in the other way, they 
required much lower light intensities than wildtype mice to elicit the same response.  It 
was concluded that Ca2+ feedback to GC via GCAP1 and GCAP2 potently reduces the 
flash sensitivity of wildtype dark-adapted rods, and significantly shortens the dark-
adapted flash response (Mendez et al. 2001) (Mendez and Chen 2002). 
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Figure I.9. Development of GCAP1 and GCAP2 knockout mice. A. Targeting strategy to replace. 6.3 kb 
of genomic DNA (GCAP1 exons 2 to 4 and GCAP2 exons 3 to 4) for a neomicyn resistance cassette by 
homologous recombination. B. Immunoblots analysis of GCAPs +/+, GCAPs +/- and GCAPs -/- retinal 
homogenates detecting GCAPs, RetGCs, and PDE subunits . C. Light micrographs of GCAPs+/+ (wt) and -
/- retinal sections of 3 month-old mice. os, outer segment; is, inner segment; onl, outer nuclear layer. From 
(Mendez et al. 2001). 
 
GCAP1 and GCAP2 were then individually restored in the GCAPs-/- background, and 
although there was some variability in the flash responses due to small variations in 
transgene expression levels from cell to cell, it was clear that the initial rapid recovery 
phase observed in wildtype responses was observed when GCAP1 individual 
expression was restored (Howes et al. 2002) (Pennesi et al. 2003), but not when 
GCAP2 individual expression was restored.  However, after exposure to saturating light 
intensities, GCAP2 alone could drive maximal RetGC activity and restore current to its 
baseline (Mendez and Chen 2002).  
These studies were basically confirmed and further expanded more recently with the 
generation of individual GCAP1 and GCAP2 knockout mice by the group of Alexander 
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Dizhoor (Makino et al. 2008) (Makino et al. 2012).  In the absence of GCAP1, the initial 
rapid recovery phase of dark-adapted responses was absent, but given enough time, 
responses recovered to the baseline due to the action of GCAP2 (Makino et al. 2012).  
In contrast, responses of rods that lacked GCAP2 maintained the initial rapid component 
of the recovery, but presented abnormally prolonged responses in the sense that 
restoration of current to the baseline took longer times (Makino et al. 2008). 
 
Figure I.10. Overimposed single photon responses from GCAPs -/-, GCAPs +/- and GCAPs +/+ 
mouse rods. From (Mendez et al. 2001) 
 
These results where the origin of the Ca2+-relay model, a model that was subsequently 
confirmed by the detailed biochemical characterization of GCAP1 and GCAP2, as 
outlined in previous sections (Peshenko et al. 2011b).  
The Ca2+-relay model has been further ratified in the zebrafish model (Scholten and 
Koch 2011). Zebrafish have three types of cones: double cones (long-wavelength 
sensitive), long single cones (short-wavelenght sensitive) and short single cones (UV-
sensitive) which express six different zGCAP isoforms (1-5 and 7) (Table I.2). 
Each zGCAP has a different EC50 for Ca2+regulation of RetGC: they have either EC50 
~30 nM (zGCAP1, 2 and 3) or around EC50 ~400 nM (zGCAP4, 5 and 7) (Table I.2).  As 
shown in the table below, each type of cone has at least a GCAP isoform with a high 
EC50 and at least one GCAP isoform with a low EC50, so that RetGC activation is 
regulated on a step-by-step basis (Koch 2013). 
 
2
1
0
pA
2.01.51.00.50.0
Time (s)
 GCAPs -/- (15)
 GCAPs +/- (14)
 +/+ (10)
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EC50 (nm) 
Level of activation (x-fold activation) 
Double cones Long single 
cones 
Short single 
cones 
~30 zGCAP3   +++ 
 
zGCAP3   +++ 
 
zGCAP1     ++ 
zGCAP2   ++++ 
zGCAP3    +++ 
~400 zGCAP4  ++++ 
zGCAP5     + 
zGCAP7      + 
zGCAP4  ++++ 
zGCAP5     + 
zGCAP7      + 
zGCAP4   ++++ 
zGCAP5      + 
zGCAP7      + 
 
Table I.2. Summary of zGCAP expression in different cone types. Some isoforms of zGCAPs regulate 
GC with a low IC50 value (around 30 nM free [Ca2+]) (in red), and others regulate GC with a high IC50 around 
400 nM [Ca2+] (in blue). Their levels of activation (x-fold) corresponds to >10-fold: ++++; 5–10-fold: +++; 3–5-
fold: ++; <3-fold +, in the different cone types:  double cones (long-wavelength sensitive), long single cones 
(short-wavelength sensitive) and short single cones (UV-sensitive). Adapted from (Scholten and Koch 2011). 
 
1.3.7. Molecular basis of inherited retinal dystrophies: GCAPs mutations and 
disease. 
Inherited retinal dystrophies affect 1 in 4000 individuals worldwide. Mutations may 
primarily affect rods and lead to retinitis pigmentosa (RP, characterized by night 
blindness), or may primarily affect cone function and lead to cone-dystrophies, cone-rod 
dystrophies or macular degeneration (Hamel et al. 2006).  Mutations that affect essential 
proteins for both rod and cone function are associated to a severe form of congenital 
blindness, Lebers Congenital Amaurosis (LCA) (den Hollander et al. 2008).   
Retinitis pigmentosas are the most prevalent forms of inherited retinal dystrophies, and 
are genetically and clinically very heterogeneous disorders (Chang et al. 2011).  Twenty-
five genes have been associated to adRP (30-40% of total RP), and forty-three genes 
linked to arRP (50-60%), whereas three different genes have been associated to X-
linked RP (5-15%) (https://sph.uth.edu/Retnet/sum-dis.htm#B-diseases) (Hartong et al. 
2006).  Therefore, more than 70 different genes when mutated lead to RP, and all 
possible patterns of inheritance are possible. Mutations associated to RP commonly 
affect rod function first, initially causing the loss of peripheral sight and nyctalopia (night 
blindness).  As the disease progresses with age, once a certain threshold of rod cell 
death is reached, cones start dying as well (as a result of the loss of rod’s support or 
rod’s function), and central vision and visual acuity are affected ultimately leading to total 
blindness.  The rate of progression of the disease may vary considerably depending on 
the mutation, and it could take years or decades from initial symptons of nyctalopia (in 
the adolescence or young adulthood), to the loss of central vision (adulthood) (Hartong 
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et al. 2006).   These diseases may also manifest incomplete penetrability, with variable 
clinical manifestations between affected members of the same family, indicating the 
existence of modifier genes (Hartong et al. 2006) (Chang et al. 2011). 
A sample of genes that have been associated to RP follows (Figure I.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Autosomal-recessive RP, 50-60% of cases 
Autosomal-dominant RP, 30-40% of cases 
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Figure I.11. Prevalence of gene mutations contributing to autosomal recessive retinitis pigmentosa 
(arRP), autosomal dominant retinitis pigmentosa (adRP). and X-linked retinitis pigmentosa (X-linked 
RP). From (Hartong et al. 2006).  The GUCA1B gene encoding GCAP2 is highlighted in a red square.  
 
LCA (Leber’s Congenital Amaurosis) is a severe retinal dystrophy leading to visual 
impairment in the first year of life (Perrault et al. 1996). In fact, it is the most common 
cause of blindness in kids. Affected children present normal fundus, but an almost flat 
ERG, as both rod and cone function is typically affected.  They also present nystagmus 
and amaurotic pupils. Other symptoms, such as night blindness or photoaversion show 
high variability between patients suffering the disease. At later stages of the disease, the 
retina could have a similar appearance to that of final RP (Chapple et al. 2001) (den 
Hollander et al. 2008).  
LCA was first reported by Theodore Leber in 1869 (Leber 1869) (van der Spuy et al. 
2002). Today, there are 21 genes that have been identified as causative of LCA when 
mutated: GUCY2D(LCA1), RPE65(LCA2), SPATA7(LCA3), AIPL1(LCA4), LCA5(LCA5), 
RPGRIP1(LCA6), CRX(LCA7), CRB1(LCA8), NMNAT1(LCA9), CEP290(LCA10), 
IMPDH1(LCA11), RD3(LCA12), RDH12(LCA13), LRAT(LCA14), TULP1(LCA15), 
KCNJ13(LCA16), IQCB1, KCNJ3, OTX2, CABP4, DTHD1, (Figure I.12) (Weleber et al. 
updated 2013) (https://sph.uth.edu/Retnet/sum-dis.htm#B-diseases) . 
Autosomal dominant cone/rod dystrophies (adCORDs) are diseases characterized by 
the loss of color vision and central visual acuity in the first decade of life (as cones 
degenerate first), with the retention of peripheral sight, that eventually lead to total 
blindness, usually at the age of 50 or earlier (Hamel 2007).   
Mutations in GCAP1 cause autosomal dominant cone dystrophies or cone/rod 
dystrophies (in agreement with the more abundant localization of GCAP1 in cones, see 
GCAPs localization in rods and cones). Ten mutations in GCAP1 and one in GCAP2 
have been linked to inherited retinal dystrophies to date (see below, and Table A.2. in 
Appendix). 
X-linked RP, 5-15% of cases 
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CEP290 (LCA10) 20%
RDH12 (LCA13) 4%
GUCY2D (LCA1) 6-21%
Unknown prevalence/ 
Unknown genes
RPE65 (LCA2) 3-16%
AIPL1 (LCA4) 4-8 %
LCA5 (LCA5) 1-2%
RPGRIP1 (LCA6) 5%
CRX7 (LCA7) 3%
 
 
Figure I.12. Prevalence of gene mutations contributing to Leber’s Congenital Amaurosis (LCA). 
Based on data from (Weleber et al. updated 2013). 
 
Despite the importance of GCAPs-mediated Ca2+-feedback on cGMP synthesis in the 
control of sensitivity, deletion of GCAP1 and GCAP2 in mice does not lead to significant 
effects on retinal morphology (see GCAP physiological functions revealed by the study 
of mouse models).  This indicates that GCAPs are not essential for the development or 
maintenance of retinal organization. However, mutations in the GCAP1 and GCAP2 
genes have been linked to inherited autosomal dominant retinopathies.  So far, ten 
heterozygous mutations in the GUCA1A gene encoding GCAP1 have been identified to 
cause autosomal dominant cone dystrophy (adCD), cone rod dystrophy (adCORD) or 
macular degeneration (adMD): P50L, Y99C, N104K, T114I, I143NT, L151F, E155G, 
G89K, D100E and G159V (Dizhoor et al. 1998) (Downes et al. 2001) (Jiang et al. 2005) 
(Jiang et al. 2008) (Kitiratschky et al. 2009) (Michaelides et al. 2005) (Nishiguchi et al. 
2004) (Payne et al. 1998) (Sokal et al. 2005) (Wilkie et al. 2001).   Until now, only one 
mutation in the GUCA1B gene, G157R, has been associated to autosomal dominant 
retinitis pigmentosa (adRP) (Sato et al. 2005) (Figure I.13). 
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Figure I.13. Genetic mutations in Guanylate Cyclase Activating Proteins (GCAPs) that have been 
linked to human blindness.  In green, mutations that have been described in GUCA1A encoding GCAP1.  
In black, mutation described in GUCA1B encoding GCAP2.  Most of the mutations (E89K,Y99C, D100E, 
N104K, T114I,E143NT, L151F, E155G, G159V) directly or indirectly affect GCAPs Ca2+ binding affinity and 
have been shown to affect their thermal stability and activity.   Others are predicted to affect primarily the 
folding of the protein (P50L, G157R) and lead to a conformational disorder. In the case of E143NT and 
P50L it has been suggested that the conformation of the mutant proteins are unstable and susceptible to 
proteolysis. 
 
Most of these mutations map at EF-hand domains and affect Ca2+ coordination directly 
(like D100E and N104K at EF-3 or L151F and E155G at EF-4 (Wilkie et al. 2001) (Jiang 
et al. 2005) (Jiang et al. 2008) (Kitiratschky et al. 2009)),  or map at the incoming or 
outgoing α-helixes in EF-3 and EF-4 domains, like E89K, Y99C, T114I, I143NT and 
G159V (Payne et al. 1998) (Nishiguchi et al. 2004) (Kitiratschky et al. 2009), causing 
conformational distorsions that make Ca2+ binding less favorable.  These mutations shift 
the Ca2+ IC50 of GC activation to higher free [Ca2+], so that in vitro the mutant proteins 
fail to switch to the inhibitory state and lead to persistent activation of RetGC in the 
whole physiological range of [Ca2+]i.   
In vitro studies anticipated that the molecular basis of these disorders in vivo would be 
the abnormal elevation of cGMP levels in rod outer segments that would lead to an 
increase in the number of open cGMP-gated channels, a subsequent increase in [Ca2+]i 
and the trigger of apoptosis (Wilkie et al. 2001) (Olshevskaya et al. 2004) (Dizhoor et al. 
1998) (Sokal et al. 1998) (Kitiratschky et al. 2009). It has been demonstrated in vivo that 
this mechanism accounts for the pathology of Y99C, which was the first mutation to be 
identified by 1998 (Payne et al. 1998) (Dizhoor et al. 1998), and E155G GCAP1 
mutations.  Expression of these mutants in transgenic mice resulted in a shift in the Ca2+ 
sensitivity of the cyclase, above 100 μM in some cases, that lead to sustained cGMP 
synthesis in vivo, with the subsequent elevation of both cGMP and Ca2+ in rods, and a 
retinal degeneration that could be significantly prevented by conditions that promoted 
constitutive stimulation of cGMP-PDE either by equivalent light generated by the G90D 
P50L 
G157R 
Y99C E143NT E155G 
E89K D100E 
G159V 
L151F 
N104K 
T114I 
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rhodopsin mutant or by constant light exposure (Olshevskaya et al. 2004) (Woodruff et 
al. 2007) (Dizhoor et al. 2008) (Buch et al. 2011). 
Another example of a different pathogenic mechanism for naturally occurring mutations 
affecting GCAPs is the P50L mutation in GCAP1 that activates RetGC with the same 
Ca2+-sensitivity as the wildtype protein in vitro (Newbold et al. 2001) but shows reduced 
thermal stability by circular dicroism and in in vitro GC assays (Newbold et al. 2001). 
Therefore this autosomal dominant mutation in GCAP1 anticipates that some GCAP 
mutations will also cause rod and cone cell death by a mechanism distinct from cGMP 
accumulation, likely related to conformational instability.  In this respect, the G157R 
mutation in the EF-4 domain of GCAP2, which has been associated with autosomal 
dominant retinal dystrophies ranging from retinitis pigmentosa to macular degeneration 
in the Japanese population (Sato et al. 2005), has not been explored in vitro or in vivo.  
 
1. 4. GCAP2 AT THE SYNAPTIC TERMINAL 
1.4.1. Photoreceptor synapses must sustain tonic neurotransmitter release 
Because light intensities in the natural world can vary over ten orders of magnitude, one 
fundamental ability of rod and cone photoreceptor cells is to sense and reliably transmit 
fine gradations in light intensity covering a broad dynamic range. To accomplish this, 
photoreceptor cells avoid spikes and finely grade the quantized synaptic output with 
graded changes in membrane potential (Parsons 2003) (Thoreson 2007).  Like sensory 
receptors in the auditory and vestibular systems, they rely on specialized synapses that 
support the continuous neurotransmitter release at high rates (von Gersdorff 2001) 
(Prescott and Zenisek 2005). A hallmark of these synapses is a specialized structure, 
the “ribbon” or “dense body”, a plate-like proteinaceous scaffold that anchors to the 
active zone just adjacent to the clustered voltage-gated calcium channels, anchoring 
synaptic vesicles to it (Figure I.14) (Tom Dieck and Brandstatter 2006) (LoGiudice and 
Matthews 2009) (Schmitz 2009) (Zanazzi and Matthews 2009).  Ribbons presumably 
facilitate focal exocytosis at high throughput by targeting vesicular fusion and the 
molecular components that trigger this fusion to the proximity of sites of Ca2+ influx 
(Zenisek et al. 2004) (Snellman et al. 2011) (Zampighi et al. 2011).  In mammalian rods 
there is a single synaptic ribbon at the terminal, of about 0.77 μm2 (35nm thick, 1µm in 
height and several micrometers in length) and about 770 synaptic vesicles bound to it. 
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This planar, plate-shaped structure is not anchored directly to the plasma membrane, 
but through the arciform density (Sterling and Matthews 2005) (Schmitz et al. 2009). 
The vesicles that are close to the presynaptic membrane and are primed (ready to 
fusion) are considered the readily releasable pool (RRP). The release rate at 
mammalian rods has been stimated at about 500 vesicles/s/ribbon at high Ca2+ levels in 
the dark, as compared to other synapses at the hippocampus, for instance, where 
maximal release rate is about 20 vesicles/s/ribbon.  This high rate of exocytosis of 
synaptic vesicles at rods sustains high neurotransmitter tonic release in darkness, so 
that gradual changes in membrane potential caused by small changes in the light 
stimulus can generate detectable changes in glutamate release.  That way, 
photoreceptors are able to transduce a broad bandwidth of stimulus intensities by 
avoiding spikes and causing gradual changes in neurotransmitter release instead, 
through fine gradations in membrane potential that determine the intracellular Ca2+ 
levels at the synaptic terminal (Heidelberger et al. 2005). 
 
Figure I.14. Ultrastructure of synaptic ribbons. (A) Transmission electron micrographs and diagrams of 
rod synapses from murine retinas (pictures from our lab).  Cross-section (left) shows a  bar-shaped synaptic 
ribbon (sr) anchored at the arciform density (ad).  Saggital section (right) shows the horseshoe-shaped 
plate-like nature of ribbons.  Numerous synaptic vesicles associate with the ribbon. Hc, horizontal cell; bc, 
bipolar cell. (B) GCAP2 C- terminal interacts with hinge2 region of RIBEYE, the protein scaffold. Sketch 
based on (Venkatesan et al. 2010). 
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The specific mechanism by which ribbons increase the rate of synaptic vesicle release is 
not clear yet, and it has been suggested that they may serve to secure or accelerate the 
RRP at the proximity of the Ca2+ voltage channels (Diamond 2011).   
 
1.4.2. Ribbon morphology and dynamics 
 
Figure I.15. Scheme  of retinal ribbon changes in relation to ambient lighting conditions. In the dark, 
when synaptic activity is high, the horseshoe-shaped ribbons are large and do not show protrusions. Soon 
after light exposure (beginning of light phase in the upper image or light1 in the lower image), when synaptic 
activity is depressed, protrusions develop at the outer circumference of the ribbon and detach from it (middle 
of light phase in the upper image or light2 in the lower image), resulting in smaller ribbons. After dark 
exposure, the changes are reversed.  (Upper) A disassembling synaptic ribbon (sr). The bar-shaped 
synaptic ribbon (sr) disassembles through  synaptic spheres (ss), which “bud off” from the distal end of the 
ribbon in response to light.  (Lower) The insets show the synaptic vesicles in relation to the ribbon and 
detached spheres also surrounded by synaptic vesicles (inset in the upper right-hand corner). ad, arciform 
density. The upper image is modified from (Adly et al. 1999) and the lower image from (Spiwoks-Becker et 
al. 2004). Both images are also included in a more recent review (Schmitz 2009) 
 
Synaptic ribbons are heterogeneous organelles present in various forms in different cell 
types, such as spherical, ellipsoid, or bar-shaped structures, with different shapes in hair 
cells being associated with different functional properties (von Gersdorff 2001) 
(LoGiudice and Matthews 2009).  In rod synapses of the mouse retina of the albino 
Balb/c strain synaptic ribbons undergo dynamic turn-over changes depending on 
illumination.  Ribbons tend to disassemble in response to illumination by releasing 
ribbon material in spherical modules; and elongate by regaining ribbon material during 
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dark-adaptation (Vollrath and Spiwoks-Becker 1996) (Vollrath et al. 2001) (Balkema et 
al. 2001) (Spiwoks-Becker et al. 2004). In darkness, synaptic ribbons are large and 
smooth, and during illumination they are smaller and may present spherical and club-
shaped forms, forms that are considered “disassembly intermediates” due to the release 
of protrusions (Figure I.15) (Adly et al. 1999).  This illumination-dependent ribbon 
remodeling was reported to affect visual function in Balb/c mice (Balkema et al. 2001).  
Whether these light-dependent ribbon turn-over changes can be regarded as a general 
mechanism for light adaptation is questioned, based on the variability observed between 
mouse strains. Illumination-dependent ribbon remodeling changes are less dramatic in 
pigmented C57Bl/6 mice compared to Balb/c (Fuchs et al. 2012). Therefore the 
physiological significance of the light-dependent ribbon turn-over changes is not yet 
clear. 
Mechanistically, the illumination-dependent disassembly of ribbons is known to depend 
on the drop in intracellular Ca2+ at the synapse caused by the light-triggered 
hyperpolarization of the cell.  Disassembly has been experimentally induced in in situ 
retinas by chelating extracellular Ca2+ with EGTA/BAPTA (Vollrath and Spiwoks-Becker 
1996) (Vollrath et al. 2001) (Spiwoks-Becker et al. 2004) (Regus-Leidig et al. 2010a).  
A breakthrough in the study of the molecular composition of the ribbon structure came 
with the discovery from Frank Schmidt´s group in the year 2000 that a 120 kDa protein 
named RIBEYE with the ability to self-associate constituted the main protein component 
(the scaffold) of the ribbon (Schmitz et al 2000).  RIBEYE has two domains: an N-
terminal RIBEYE(A) domain that contains three different domains for RIBEYE-RIBEYE 
interaction, and a C-terminal RIBEYE(B) domain that is identical to the transcription 
factor CtBP2 (Figure I.16).  This C-terminal domain binds NAD(H), and is also involved 
in RIBEYE-RIBEYE interactions.  By establishing homodomain and heterodomain 
RIBEYE-RIBEYE interactions, RIBEYE self-associates and constitutes the scaffold to 
which other protein constituents of the ribbon bind, modelling a plastic, dynamic 
macromolecular structure (Magupalli et al. 2008). 
Figure I.16. Scheme of RIBEYE structure. RIBEYE is composed by two parts: an N-terminal A domain 
and a C-terminal B domain which is identical to CtBP2 and binds nicotinamide adenine dinucleotide (NADH) 
by nicotinamide binding domain (NBD). RIBEYE B also has a substrate binding domain (SBD). From 
(Venkatesan 2010) 
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RIM1 and RIM2, Munc13, ELKC/CAST/ERC, bassoon and piccolo are other important 
proteins located at ribbons. RIM1 and 2 are important for vesicle priming and Ca2+-
dependent synaptic vesicle release. They interact with Munc 13 and ELKC/CAST/ERC. 
CAST also binds bassoon and piccolo. Bassoon is responsible for anchoring the ribbon 
to the synaptic membrane, occupying the proximal part of the ribbon. Piccolo is 
responsible for the refilling of the ribbon, the distal half of it.  It has been suggested that 
the formation of protrusions at the distal part of the ribbon could be to diminish piccolo 
levels at the synapse.  KIF3A is also found at ribbons, with an unknown function 
(Schmitz et al. 2009) (Zanazzi and Matthews 2009). 
As mentioned in GCAPs localization in rods and cones, GCAP1 and GCAP2 are also 
localized in synaptic terminals of photoreceptor cells. However, because the range of 
[Ca2+]i at synaptic terminals is considerably higher than that in rod outer segments, a 
function of GCAPs in stimulation of cGMP synthesis was deemed unlikely.  Therefore, 
the function of GCAPs at the synaptic terminal is currently unknown (Howes et al. 1998) 
(Venkatesan et al. 2010). 
Three years ago, Frank Schmidt´s group, in a search for RIBEYE interactors identified 
GCAP2.  It was reported that the C-terminus of GCAP2 interacts with the hinge 2 region 
of RIBEYE B domain.  Based on this observation, it was hypothesized that GCAP2 could 
be mediating the ribbon plasticity due to the chelation of Ca2+ by GCAP2 at the proximity 
of the ribbon.  This observation raised the important question of whether the GCAPs 
proteins may be playing a novel role in light adaptation by regulating the dynamic 
plasticity of ribbon structures (Venkatesan et al. 2010). 
 
1.5. 14-3-3 PROTEINS 
14-3-3 proteins are highly conserved acidic proteins of ~28-33 KDa in eukaryotes, 
initially identified in brain lysates where they are very abundant (Boston and Jackson 
1980) (Steinacker et al. 2011), but expressed in many different tissues. They owe their 
name to the particular migration pattern on 2D DEAE-cellulose chromatography. There 
are seven homologs or isoforms in mammals, named with greek letters: (α) β, γ, (δ), ε, ζ, 
η, τ, σ, (being α and δ the phosphorylated forms of β and ζ, respectively), depending on 
the order of elution by HPLC. The seven isoforms are almost identical to each other 
(Aitken 1996). 
14-3-3 proteins are phosphobinding proteins, that work as dimers (homo or 
heterodimers) with a rigid structure that forms a groove with two separate binding sites 
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that allows the binding of one protein after two coincident phosphorylation events, or the 
simultaneous binding of two independent phosphorylated client proteins, which are then 
linked by their interaction with 14-3-3 (Figure I.17).  Phosphorylation of client proteins at 
Ser or Thr residues at consensus sequences drastically increases the affinity of 14-3-3 
binding to these sites, although prior phosphorylation of the substrate is not required in 
all cases (Muslin et al. 1996). 
A comparison with known 14-3-3 binding proteins revealed consensus sequences 
capable of mediating interactions with all 14-3-3 isoforms. Mode I binding sites have the 
consensus sequence R(S/X)XpSXP and mode II have the consensus sequence 
RXXXpSXP, where X denotes any aminoacid residue and pS denotes phosphorylated 
serine.  Binding motif III is the same as motif I but lacking the C-terminal proline, 
RXXpSX -COOH.  Client proteins that bind to 14-3-3 that lack these consensus 
sequences have also been described (Smith et al. 2011).  
 
Figure I.17. Dynamic nature of the 14-3-3 dimers. Crystal structure of the apo-β isoform. The two binding 
grooves are represented in an open and closed conformation for the individual monomers indicating that by 
modifying its groove conformation 14-3-3 proteins are flexible and adapt to their interactor . From (Yang et 
al. 2006) 
 
14-3-3 proteins are associated with a broad variety of functions in the cell. 14-3-3 
proteins are thought to modify the properties of client proteins by one of three functional 
mechanisms: clamping, masking and scaffolding. First, due to its inherent rigidity, the 
binding of 14-3-3 is thought to stabilize certain conformations of client proteins, refered 
to as clamping function. An example is how 14-3-3 fixes the active conformational state 
of the plant plasma membrane H+-ATPase (PMA), favoring the arrangement of PMA into 
large H+ conducting complexes.  Second, 14-3-3s could physically mask some specific 
sorting signals of target proteins. One well characterized example is how 14-3-3 regulate 
ER export of certain targets by binding to consensus binding sites adjacent to RXR 
motifs required for COPI binding, therefore interfering with COPI binding when masking 
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RXR motifs.  Third, 14-3-3 proteins may facilitate interactions between the target protein 
and other proteins, by providing a platform for protein anchoring (scaffolding). An 
example is 14-3-3 binding to nicotinic acetylcholine receptors, which triggers the 
asembly of a multi-subunit protein complex providing a link to the microtubule 
cytoskeleton.  By modifying target proteins in one of these ways, 14-3-3 proteins exert a 
diverse range of regulatory roles in protein stability, metabolism, trafficking or integration 
of cell survival versus cell death pathways (Smith et al. 2011). 
Importantly for the interpretation of our results in this study, a close association has been 
established between 14-3-3 proteins and progressive neurodegenerative diseases.  14-
3-3 proteins have been shown to colocalize with Alzheimer Disease (AD) neurofibrillary 
tangles that are composed primarily of hyperphosphorylated tau proteins (Layfield et al. 
1996) (Lee et al. 2001). In Parkinson´s disease (PD), 14-3-3 is detectable in Lewy 
bodies which accumulate α-synuclein (Kawamoto et al. 2002); and 14-3-3 colocalization 
was also reported with mutant ataxin in spinocerebellar  ataxia (SCA) (Chen et al. 2003).  
Furthermore, 14-3-3 zeta and epsilon binding to phosphorylated ataxin-1 at S776 was 
shown to aggravate neurodegeneration by stabilizing mutant ataxin, retarding its 
degradation and enhancing its aggregation in transfected cells and transgenic flies 
(Chen et al. 2003).  The requirement of 14-3-3 zeta for Htt86Q aggregate formation has 
also been established in cells (Omi et al. 2008).  In summary, 14-3-3 proteins have been 
shown to bind to conformationally unstable proteins with a tendency to form amyloid 
deposits.  By stabilizing thermally unstable proteins they seem to gradually promote their 
accumulation, and ultimaly they aggravate the pathology upon a certain threshold of 
toxic protein build-up. 
In the retina, 14-3-3 proteins are expressed in all cell types.  In photoreceptor cells they 
distribute to the cytosolic fraction of proximal cell compartments: the inner segment, 
perinuclear region and synaptic terminal of the cell, but they are excluded from the outer 
segment.  The only well-characterized role of 14-3-3 in the retina is the regulation of the 
intracellular distribution of phosducin, by retaining it at the inner segment and proximal 
compartments upon phosducin phosphorylation.  Phosducin is a protein that binds to 
transducing beta/gamma dimers, and by oscillating between phosphorylated and 
unphosphorylated states, it regulates the subcellular distribution of Gt
βγ
 during light/dark 
periods (Nakano et al. 2001).  Phosducin modulation of the localization of Gt
βγ
 dimers is 
one of the factors that determine the amount of Tr
αβγ
 trimer at rod outer segments, and, 
as such, one of the factors that modulate the sensitivity of rod photoreceptors (Thulin et 
al. 2001). 
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RESUMEN EN ESPAÑOL 
Las Proteínas Activadoras de Guanilato Ciclasa (GCAPs) juegan un papel fundamental 
en las células fotorreceptoras de la retina durante la terminación de la respuesta a luz 
y en el proceso de adaptación a luz, confiriendo sensibilidad a Ca2+ a la síntesis de 
cGMP. Además de su papel modulando la síntesis de cGMP en el compartimento 
fotosensible, GCAPs pueden desempeñar otras funciones en conos y bastones, dado 
que también localizan en el segmento interno y la terminal sináptica. Mutaciones en los 
genes GUCA1A y GUCA1B, que codifican GCAP1 y GCAP2, las isoformas 
mayoritarias en humanos, causan distrofias retinales. Nuestro principal objetivo fue 
abordar cómo mutaciones en GCAP conducen a enfermedades in vivo, y caracterizar 
nuevas posibles funciones de las proteínas GCAP en estas células. 
 
Objetivos específicos: 
1- El primer objetivo es investigar las bases de la patología en una línea 
transgénica de ratón que expresa en bastones una forma mutante de Proteína 
Activadora de Guanilato Ciclasa 2 (GCAP2) impedida para unir Ca2+: EF-
GCAP2, para entender mejor la patología causada por mutaciones en GUCA1A 
y GUCA1B asociadas a distrofias hereditarias de retina.  Nos basamos en las 
siguientes tres razones: 1) la mayoría de las mutaciones en GCAP asociadas a 
enfermedad afectan a la afinidad de unión de Ca2+ de GCAP; 2) GCAP2 es la 
isoforma más abundante en bastones; y 3) los bastones son más manejables 
que los conos para para estudios morfológicos, bioquímicos y fisiológicos en un 
sistema como el de ratón que es bastón-dominante.  
2- El segundo objetivo es caracterizar posibles nuevas funciones de la Proteína 
Activadora de Guanilato Ciclasa (GCAP2) en la terminal sináptica y 
compartimentos proximales de  la célula, mediante un análisis detallado del 
fenótipo de modelos de ratón de ganancia y pérdida de función. 
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AIMS 
Guanylate Cyclase Activating Proteins (GCAPs) play a fundamental role in 
photoreceptor cells of the retina during termination of the light response and in the 
process of light adaptation, by confering Ca2+ regulation to cGMP synthesis.  Besides 
their role in modulation of cGMP synthesis at the light sensitive compartment, GCAPs 
may have other roles in rods and cones, given that they also localize to the inner 
segment and synaptic terminal compartments.  Mutations in the GUCA1A and 
GUCA1B genes encoding GCAP1 and GCAP2, the major isoforms in humans, lead to 
retinal dystrophies.  Our main aim was to address how GCAP mutations lead to 
disease in vivo, and to characterize novel putative functions of GCAP proteins in these 
cells.   
 
Specific aims: 
1. First aim is to investigate the basis of the pathology in a mouse transgenic line 
expressing in rods a mutant form of Guanylate Cyclase Activating Protein 2 
(GCAP2) impaired to bind Ca2+: EF-GCAP2, to gain insight into the pathology 
caused by mutations in GUCA1A and GUCA1B associated to inherited retinal 
dystrophies.  Based on the following three reasons: 1) most GCAP mutations 
associated to disease affect GCAP binding affinity to Ca2+; 2) GCAP2 is the 
most abundant GCAP isoform in rods; and 3) rods are more amenable than 
cones for morphological, biochemical and physiological studies in the rod-
dominated murine system. 
 
2. Second aim is to characterize putative new roles of Guanylate Cyclase 
Activating Protein 2 (GCAP2) at the synaptic terminal and proximal 
compartments of the cell, by doing a detailed analysis of the synaptic 
phenotype of loss of function and gain of function of GCAP mouse models. 
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3.1. Mouse Genetic Models used in the study 
The care and use of animals was done in compliance with Acts 5/1995 and 214/1997 
for the welfare of experimental animals of the Autonomous Community (Generalitat) of 
Catalonia, and approved by the Ethics Committee on Animal Experiments of the 
University of Barcelona. To do these studies the following mouse strains were used: 
 
Line  
nomenclature  
Chapter 1 
Line 
nomenclature 
Chapter 2 
Background GCAP1 and GCAP2 
expression levels 
(expressed as a 
function of 
endogenous level) 
C57Bl/6 (WT) C57Bl/6 (WT) GCAPs +/+ GCAP1  1 
GCAP2  1 
bGCAP2 E GCAP2 + GCAPs +/+ GCAP1  1 
GCAP2  2 + 1    
- GCAP2 +/+ GCAPs +/+ GCAP1  1 
GCAP2  2 + 2 + 1 
bEF-GCAP2 (A) - GCAPs +/+ GCAP1  1  
GCAP2  1 
EF-GCAP2  2.76  
bEF-GCAP2 (B) - GCAPs +/+ GCAP1  1 
GCAP2  1  
EF- GCAP2  3.85 
GCAPs -/- GCAPs -/- GCAPs -/- GCAP1  0 
GCAP2  0 
GCAPs -/- bGCAP2 E GCAPs -/- GCAP2+ GCAPs -/- GCAP1  0 
GCAP2  2  
GCAPs -/- bEF-GCAP2 (A) - GCAPs -/- GCAP1  0  
EF-GCAP2  2.76 
GCAPs -/- bEF-GCAP2 (B) - GCAPs -/- GCAP1  0  
EF-GCAP2  3.85 
 
Table M.1. Compilation of transgenic mouse lines used in the study.  Given the number of transgenic 
lines used in the study, and their manipulation in the GCAPs+/+ and GCAPs-/- background as well as 
homozygosity or heterozygosity of the transgene, we here present a compilation of the used strains, that 
states the nomenclature used to refer to each line in each chapter, as well as the overall expression level 
(transgene + endogenous) of GCAP1, GCAP2 or EF-GCAP2. 
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The detailed description of the generation of these transgenic mice is found in Mouse 
models to study GCAP functions in intact photoreceptors (Mendez and Chen 2002).  
These mice were developed in accordance with the ARVO statement for the Use of 
Animals in Ophthalmic and Vision Research and approved by the Ethics Committee on 
Animal Experiments of the University of Southern California.  The GCAP2 expression 
vectors used to generate transgenic mice were obtained by assembling the 4.4 kb 
mouse opsin promoter with bovine wildtype GCAP2 cDNA or mutant bEF-GCAP2 
[GCAP2 E80Q/E116Q/D158N] (Dizhoor and Hurley 1996) cDNA (0.7 kb), and a 0.6 kb 
fragment containing the mouse protamine 1 polyadenylation sequence, into pBluescript 
II SK (Stratagene, La Jolla, California).  The resulting fusion gene, 5.7 kb in size, was 
excised from the plasmid, gel purified and microinjected at 1µg/ml into the pronuclei of 
C57Bl6/J x DBA/2J F1 hybrid mouse embryos (The Jackson Laboratories, Bar Harbor, 
Maine).  Injected embryos were implanted into pseudopregnant females, and progenie 
was screened for founders by PCR amplification of tail genomic DNA. 
A protocol to screen for transgene-positive mice by PCR amplification of tail DNA was 
developed, in order to a) identify founders, when the mouse colonies were developed, 
and b) genotype every new litter in subsequent generations. 
 
3.1.1.DNA purification 
A tiny piece of mouse tail (2 mm) was snipped off and collected in an eppendorf tube.  
Tails were digested in 200µl of “Tailing Buffer” (0.05% proteinase K, 50mM TrisHCl pH 
8.0, 100mM EDTA and 0.5% SDS) at 55ºC overnight. Hair particles were pelleted by 
centrifugation and supernatants were transferred to clean eppendorf tubes. 100µl 8M 
NH4OAc and 600µl of 96% ethanol were added and samples were vortexed. DNA 
precipitation occurred at this step. Samples were spinned for 5min at 13000 rpm. 
Supernatants were discarded and pellets were washed three times with 70% ethanol. 
Pellets were either air-dried or dried under the vacuum and resuspended in 100μl of TE 
buffer (10mM TrisHCl pH8.0, 0.1mM EDTA) or ddH2O. At this point, DNAs were ready 
for PCR genotyping. If storage was required, DNAs at this stage were kept at -20ºC. 
 
 
 
                                                                                           MATERIALS AND METHODS 
 
69 
 
3.1.2.PCR: polymerase chain reaction 
To amplify heterologous GCAP2 in transgenic mice, the following primer set was used: 
(~450bp amplification product) 
Rh1.1.: 5’GTGCCTGGAGTTGCGCTGTGGG3’  (forward)  
p24:  5’TGGCCTCCTCGTTGTCCGGGACCTT3’ (reverse). 
Equal volumes of both primers at a 20pmol/μl stock were mixed 1:1, and 0.5μl of the 
mix were used per 20μl-reaction. 
The reaction mixture combined 2 µL of 10x PCR buffer (Invitrogen), 0.6 µL 50mM 
MgCl2 (Invitrogen), 0.16 µL 25mM dNTPmix (Roche), 0.5µl of primer mix Rh1.1-p24 at 
10 pmol/ µl each (SIGMA), 0.12µM Taq DNA polymerase (Invitrogen), 15.62μl ddH2O 
and 1μl of DNA sample. 
PCR conditions: An initial dissociation step   95ºC,  3.5 min. 
30 cycles: Denaturing step  94ºC  1 min 
  Annealing step 64ºC 1.5 min 
  Extension  72ºC 1.5 min 
A final extension   72ºC 10 min 
PCR reactions were analyzed in 1% agarose gels in TAE (40mM Tris, 20mM acetic 
acid, and 1mM EDTA) to screen for the appearnce of the ~450bp-PCR amplification 
product that would indicate the presence of the transgene. 
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METHODS CHAPTER 1 
3.2. Determination of transgenic levels of expression in bEF-GCAP2 mice by 
Western Blot 
Founder mice were bred to C57Bl/6 mice to maintain the transgene in a pigmented 
wildtype genetic background, or to GCAPs-/- to generate GCAPs-/- bEF-GCAP2 mice.  
To detect transgenic GCAP2 expression by immunoblot, retinas from mice of each 
genotype were obtained at either postnatal day 22 (p22) (for WT and mice from line B) 
or p40 (lines A and E), and were homogenized in 100μl of homogenization buffer 
[80mM TrisHCl, pH 8.0, 4mM MgCl2, 0.5mg/ml Pefabloc SC, 0.5mg/ml Complete Mini 
protease inhibitors (Roche, Basel, Switzerland)]. After addition of SDS Laemmli sample 
buffer, samples were boiled for 5 min, and fractions corresponding to 1/40 of a retina 
were resolved by SDS-PAGE in a 12% tris-glycine gel and transferred to nitrocellulose 
membranes (Protran, Schleicher & Schuell, Keene, NH).  Membranes were incubated 
with polyclonal antibodies to bovine GCAP2 [p24ΔN (Dizhoor et al. 1995), a gift from A. 
Dizhoor, Pennsylvania College of Optometry, Elkins Park, Pennsylvania], [GC1 and 
GC2 (Yang et al. 1999), a gift from D. Garbers, HHMI and UT Southwestern Medical 
Center, Dallas] and PDE (αβγ2, Cytosignal, Irvine, CA). Immunopositive protein bands 
were detected with a peroxidase-conjugated goat anti-rabbit IgG with the ECL system 
(Amersham, UK).For determination of the precise level of expression of the transgene 
(expressed as a function of the endogenous), retinal extracts from mice from bEF-
GCAP2 line B and line A (2-fold serial dilutions of retinal extracts obtained as described 
above) were directly compared to retinal extracts from the bGCAP2 control line (2-fold 
dilutions). The expression level of bGCAP2 in this line was previously established as 2-
fold the endogenous levels (Mendez et al. 2001). The 2-fold serial dilutions in each 
sample were used to obtain the integration values of those bands present in the linear 
range in the same gel, for a direct comparison. The expression of bEF-GCAP2 line A 
was determined to be 2.76 + 0.12 –fold the endogenous levels (average + St Dev, 
n=3).  The expression of bEF-GCAP2 line B was estimated to be about 1.4-fold higher 
than line A, that is, about 3.85-fold the endogenous levels. 
 
3.3. Histology and Retinal Morphometry of ONL thickness 
Histological analysis of the retina by light microscopy and retinal morphometry 
measurements were performed as previously described (Concepcion, Mendez et al. 
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2002). The indicated mice (GCAPs-/-bEF-GCAP2 and GCAPs-/-bGCAP2 control mice) 
were either reared in constant darkness or under constant light exposure (fluorescent 
light, 1500 lux intensity) and processed for analysis at postnatal day 20 or 40. Eyecups 
were marked for orientation, embedded in epoxy resin and sectioned at 1 μm thickness 
as described (Concepcion, Mendez et al. 2002) (Lopez-del Hoyo, Fazioli et al. 2012).  
Measurements of ONL thickness were taken by making use of a camera lucida 
attached to a microscope, with the aid of a graphics tablet (WACOM, Vancouver, WA) 
and the Axiovision LE Rel.4.1. imaging software (Carl Zeiss Inc., Germany).   A stage 
micrometer (Klarmann Rulings, Litchfield, NH) was used for calibration.  Each retina 
half (superior and inferior) was divided into ten equal segments from the optic nerve to 
the tip (excluding a radius of 100 µm from the optic nerve, due to the natural thinning of 
the ONL at this region).  Three independent measurements were taken per segment, 
and the average value was obtained.  In this manner 60 independent measurements 
were obtained per section (20 segments x 3 measurements/segment).  The mice 
analyzed per genotype were:  GCAPs-/-bEF-GCAP2 line A, n= 4 for each dark and light 
conditions; GCAPs-/-GCAP2 line E, n= 3 for each dark and light conditions; and 
GCAPs -/- control line, n=2 for each condition. 
 
3.4. Electroretinogram 
Electroretinogram responses to flash stimuli were recorded on a Nicolet Electrovisual 
Diagnostic System.  Mice were dark-adapted for 12 h and then anesthesized under dim 
red light by intraperitoneal administration of Ketamine HCl (100mg/kg) and Xylazine 
HCl (10 mg/kg). Phenylephrine HCl (2.5%) and Tropicamide (0.5%) were applied to the 
cornea to dilate the pupils, and mice were dark-adapted again for 10 min previous to 
the recording. Following administration of Tetracaine HCl (0.5%) eyedrops as a topical 
corneal anesthetic, the mice are placed on a heated pad at 37oC in a Faraday cage.  
The corneal electrode consisted of a carbon-fiber moistened in saline.  A 1ms light 
flash was delivered through a fiber optic centered vertically over a few millimeter of the 
corneal surface.  Mice from the different genotypes were recorded over the course of 
eight months under identical conditions. 
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3.5. Guanylate Cyclase assays 
Guanylate cyclase activity was assayed in mouse retinal homogenates. Six retinas 
from dark-adapted mice of each genotype were dissected under infrared illumination, 
pooled and homogenized in 112μl of 2X assay buffer (100mM MOPS-KOH pH 7.5, 
16mM NaCl, 200mM KCl, 2mM IBMX, 20mM MgCl2, 14mM 2-β-mercaptoethanol).  
From this, 12.5µl aliquots were mixed with either 7.5μl of 1.33mM EGTA (for a final 
concentration of 0.4mM EGTA per reaction, the “low Ca2+” condition) or 7.5µl of 6.6μM 
CaCl2 (for a final concentration of 2μM Ca2+, the “high Ca2+” condition) and 
preincubated at 30oC for 10 min. Reactions were initiated by addition of 5µl of 5x 
substrate mix (1.0mM GTP, 0.2μCi/µl of [α-32P]GTP, 1.0mM ATP), and allowed to 
proceed for 15 min at 30oC. Reactions were terminated by addition of 500μl of ice-cold 
120mM Zn(OAc)2, neutralized with 500µl of Na2CO3, kept at –800 C for 15 min and 
centrifuged at 14,000g, 4oC for 20 min.  Radiolabeled cGMP in the supernatants was 
separated from radiolabeled GTP by alumina column chromatography as described 
(Domino et al. 1991).  Protein concentration in retinal homogenates was determined by 
Bradford. Results are the average and standard deviation of four independent 
experiments performed in duplicate, with mice that were between p20 and p30.  
Guanylate cyclase activity was also determined in all retinal homogenates after the 
addition of 3μM recombinant GCAP2 as a control for the presence of active RetGCs.    
 
3.6. Expression and purification of GCAP2 mutant proteins 
BovGCAP2 and its mutants (bovEF- GCAP2 and bovG161R GCAP2) were expressed 
in bacteria, by quemical transformation of E. coli BL21 (DE3) strain with pET-15b 
plasmids with the respective cDNAs. Protein expression was induced in bacterial 
cultures when OD600 = 0.6, by addition of IPTG to 1mM final concentration, and 
expression was allowed to proceed at 37ºC for 5 hours. Cell cultures were centrifuged 
for 30 minutes at 8000 rpm (JA-14 rotor from Beckman) and resuspended in lysis 
buffer (0.1M NaH2PO4, 0.01M TrisHCl, 1mM EDTA, 7mM β-mercaptoetanol, 50μM 
PMSF, 0.2 mg/mL lysozyme, pH 8). Bacteria lysis was performed by 6 to 12 pulses of 
sonication on ice, for 30 seconds each at an amplitude of 50 mAmp. Lysates were 
centrifuge at 15000 rpm (JA-20 rotor from Beckman) for 30 minutes and pellets were 
collected. This process was repeated 4-6 times, to gradually purify and collect inclusion 
bodies. Final pellets were solubilized in a denaturing buffer with a chaotropic agent 
(0.1M NaH2PO4, 6M Guanidinium-HCl, 10mM TrisHCl, 20mM imidazole, 2.5mM β-
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mercaptoetanol, pH8) and incubated for 1-2 hour at room temperature, with gentle 
stirring. Solubilized inclusion bodies were then clarified by centrifugation, at 15000 rpm 
(JA-20 rotor from Beckman) for 30 minutes, supernatants were loaded to 5ml His-
TrapTM Chelating HP Columns (GE Healthcare) pre-charged with Ni2+ and pre-
equilibrated in solubilization buffer. 
We then performed “on-column refolding” of GCAP2 and its mutants at the HPLC set, 
by subjecting the columns to a buffer exchange from 6M Guanidinium to 6M Urea, and 
then to a decreasing Urea gradient. First step, 5 CV (column volumes) of Refolding 
Buffer (0.1M NaH2PO4, 6M Urea, 10mM TrisHCl, 20mM imidazole, 2.5mM β-
mercaptoetanol, pH 8). Second step, 30CV gradient step from 100% Refolding Buffer 
to 100% Washing Buffer (0.1M NaH2PO4, 10mM TrisHCl, 20mM imidazole, 2.5mM β-
mercaptoetanol, pH 8). Third step, 5CV of Washing Buffer. Fourth step, gradient step 
for Elution, 4CV from 100% Washing Buffer to 100% Elution Buffer (0.1M NaH2PO4, 
10mM TrisHCl, 0.5M imidazole, 2.5mM β-mercaptoetanol, pH 8). Fifth step, 2CV of 
Elution Buffer. Fractions of 2.5ml were collected and analized by SDS-PAGE. Peak 
fractions were pooled and concentrated with centricones. Protein concentration was 
determined with a Bradford Assay. Proteins were stored at -80ºC in 50% glycerol. 
 
3.7. GCAP2 Immunoprecipitation and protein identification by LC-MS/MS 
For GCAP2 immunoprecipitation in order to identify protein interacting partners in the 
different phenotypes [GCAPs-/- bovGCAP2, GCAPs-/- bovEF-GCAP2 and GCAPs-/- 
control mice] forty retinas per phenotype were pooled and homogenized in HEPES 
buffer [10mM HEPES pH 8.0, 5mM KCl, 135mM NaCl, 1.5mM MgCl2, 4mM EGTA, 
1mM PMSF, 1mM NaF, 1mM β-mercaptoethanol, 1% Triton-X100 and a protease 
inhibitor cocktail (Complete Mini, Roche, Basel, Switzerland)], and clarified by 
centrifugation.  Supernatants were incubated with anti-GCAP2 monoclonal antibody-
covalently crosslinked to magnetic beads (Dynabeads, Life Technologies, Carlsbad, 
California) for 45 minutes at room temperature (anti-GCAP2 mAb2235, Millipore, 
Billerica, MA).  Following extensive washing, elution was performed with 0.2M Glycine-
HCl pH 2.5.  Elution fractions were neutralized and concentrated by ethanol 
precipitation, reduced and alkylated with 45mM DTT at 60oC followed by 100mM 
iodoacetamide at room temperature, dehydrated and rehydrated with sequencing 
grade trypsin in 25mM ammonium bicarbonate for 12h. For LC-MS/MS samples were 
resuspended in 0.1% formic acid and injected into a series Proxeon LC nanoEASY 
system (Thermo Fisher Scientific, West Palm Beach, Florida) coupled to a LTQ-Velos 
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Orbitrap (Thermo Fisher Scientific, West Palm Beach, Florida). The resulting mass 
spectral peak lists were searched with the Sequest search engine (v.2.1.04, Matrix 
Sciences, London, UK) against the merged BOVIN-MOUSE UP SP r 2011-1.fasta 
sequence library.  Immunoprecipitation assays and LC-MS/MS analysis with the 
indicated mouse phenotypes were performed in three independent experiments, with 
similar results. 
 
3.8. In vitro phosphorylation of GCAP2 and pull-down assays with mock- or 
phosphorylated-GCAP2.  
For in vitro phosphorylation of GCAP2 in the presence of radioactivity, 20µl reaction 
mixtures contained 8.5μg of purified recombinant wildtype bGCAP2, bEF-GCAP2 or 
bG161R/GCAP2, purified PKGIα (100 units, Calbiochem, Billerica, MA) and 3μCi of 
33P- γATP (Perkin Elmer, Massachusetts, USA) in phosphorylation reaction buffer 
(30mM Tris-HCl pH 7.5, 5mM MgCl2, 5mM sodium phosphate buffer pH 7.5, 6mM DTT, 
0.1mM EGTA and 10µM ATP).  For reactions in Ca2+ or EGTA conditions, the 0.1mM 
EGTA in the reaction buffer was substituted to 5mM CaCl2 or 2mM EGTA, respectively.  
cGMP was added to 500µM (to obtain phosphorylated GCAP2 or P-GCAP2) or not 
added (mock- controls). After incubation for 2 h at 30oC and overnight at 4oC, each 
reaction mixture was diluted with Laemmli buffer and resolved by 15% SDS-PAGE.  
Following transfer to a nitrocellulose membrane, an autoradiograph of the 33P 
phosphorylation products was obtained by 15 min of exposure to a Kodak X-ray film.  
The nitrocellulose membrane was subsequently incubated with a pAb anti-GCAP2 and 
IRDye 800CW Goat Anti-rabbit IgG for GCAP2 immunodetection.   
To obtain phosphorylated bGCAP2 or bEF-GCAP2 for pull-down assays in the absence 
of radioactivity, the same procedure was used except that 25µg of bGCAP2 or bEF-
GCAP2 protein and 230 units of purified PKGIα were used per reaction.  The product 
of each reaction was cross-linked to 2.5mg of magnetic beads (Life Technologies, 
Carlsbad, California) and used in pull-down assays with solubilized bovine retina.  Each 
sample was incubated with material corresponding to 1/8 of a bovine retina, previously 
homogenized in binding buffer (10mM HEPES, 135mM NaCl, 5mM KCl, 1mM PMSF, 
1mM NaFl, 1mM β-mercaptoethanol, 1% Triton X-100, 4mM EGTA, 2mM EDTA, 
Complete Mini protease inhibitors, pH 7.4) and pre-cleared by centrifugation. After 1h 
incubation at room temperature, beads were washed and bound proteins were eluted 
under acidic conditions, equilibrated and ethanol precipitated.  Samples were resolved 
by 15% SDS-PAGE and transferred to a nitrocellulose membrane.  For Western 
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detection of GCAP2 and 14-3-3 the following antibodies were used: a polyclonal anti-
GCAP2 (López-del Hoyo et al. 2012), a pAb to 14-3-3pan (JP18649, IBL International, 
Hamburg, Germany), a mAb to 14-3-3ε (EPR3918, abcam, Cambridge, UK), a IRDye 
800CW Goat anti-rabbit IgG and a IRDye 680CW Goat anti-mouse IgG (Tebu Bio, 
Offenbach, Germany).  Image was acquired at the Odyssey Imaging System (LI-COR, 
Lincol, Nebraska USA).  
 
3.9. In Situ phosphorylation assays 
All mice for in situ phosphorylation assays were 30-36 days old.  Mice were dark-
adapted for a minimum of 14h prior to use.  Retinas were dissected under infrared light 
(two retinas per phenotype per light condition) and incubated for 90 min in 600μl of 
bicarbonate-buffered Locke’s solution (112.5mM NaCl, 3.6mM KCl, 2.4mM MgCl2, 
1.2mM CaCl2, 10mM HEPES, 0.02mM EDTA, 20mM NaHCO3, 10mM glucose, 3mM 
sodium succinate, 0.5mM sodium glutamate, 0.1% vitamin and amino acids 
supplement) containing 1 mCi/ml [32Pi]H3PO4 (10mCi/ml, Perkin Elmer, Massachusetts, 
USA) in the dark in a 5% CO2 incubator to allow incorporation of 32P in the endogenous 
ATP pool.  Following incubation, retinas were washed with Locke´s solution and 
immediately homogenized in 200µl of solubilization buffer [10mM HEPES, 135 mM 
NaCl, 5mM KCl, 1mM PMSF, 2mM NaFl, 4 mM EGTA, 1.5mM MgCl2, 2mM EDTA, 1% 
Triton X100, Complete Mini protease inhibitors (Roche Applied Sciences, Basel, 
Switzerland), pH 7.4] in the dark, or exposed to bright white light for 5 min prior to 
homogenization.  Samples were clarified by centrifugation at 13,000g for 20 min at 4oC 
and supernatants were transferred to new tubes.  From these samples, 10ul aliquots 
were resolved by 15% SDS-PAGE to obtain an autoradiograph of the input samples.  
Visualization of inputs required 4h of exposure with a Kodak X-ray film.  The remaining 
volume of samples (180μl)  were used to immunoprecipitate GCAP2 with an anti-
GCAP2 monoclonal antibody (anti-GCAP2 mAb2235, Millipore, Billerica, MA) coupled 
to magnetic beads (Dynabeads, Life Technologies, Carlsbad, California) as described 
above.  After acidic elution of bound fractions, samples were neutralized and proteins 
precipitated with ethanol.  Protein pellets were resolved by 15% SDS-PAGE and 
transferred to a nitrocellulose membrane.  Visualization of phosphorylated proteins in 
the bound fractions by autoradiography required 4 days of exposure with a Kodak X-
ray film. The membrane was subsequently incubated with a polyclonal antibody anti-
GCAP2 and IRDye 800CW Goat Anti-rabbit IgG; and a polyclonal antibody to 14-3-
3pan (JP18649 IBL International, Hamburg, Germany) and IRDye 680CW Goat Anti-
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mouse IgG, and scanned at an Odyssey Image Acquisition system (LI-COR, Lincoln, 
Nebraska USA). 
 
3.10. Isoelectric focusing (IEF) 
Retinas from mice of the indicated phenotypes were dissected under infrared light, and 
each retina was solubilized in 150µl of buffer (10mM HEPES pH7.5, 1mM MgCl2, 
10mM NaCl, 0.1mM EDTA, 1% dodecyl-maltoside, 1mM DTT, 50mM NaFl) overnight 
at 4oC.  Samples were centrifuged at 14000 rpm for 5min, and a 15μl aliquot of the 
supernatant was loaded onto an isoelectrofocusing gel (pH range 3-8) on a Pharmacia 
FBE 300 flat bed apparatus, and focused for 2h at 23W. Proteins were transferred to a 
nitrocellulose membrane by capillary action and incubated with GCAP2 pAb.  Bands 
were visualized with the ECL system (Pharmacia). 
 
3.11. Size-exclusion chromatography. 
Sixteen freshly dissected retinas from GCAPs-/- bGCAP2 or GCAPs-/- bEF-GCAP2 
mice were solubilized in 500µl of buffer (10mM HEPES pH7.4, 135mM NaCl, 5mM KCl, 
1mM PMSF, 1% Triton X100 and Complete Mini protease inhibitors), precleared by 
centrifugation, filtered and injected into pre-equilibrated columns: Ultrahydrogel 500 
column coupled to Ultrahydrogel 250 column (Waters Corporation), in a Waters 2695 
Alliance HPLC separation module. Flow rate was 0.3mL/min and the fraction volume 
collected was 0.6mL.  For Triton X100 resistant, SDS-solubilized samples, the pellet 
fraction from the Triton-X100 preclearing step above was solubilized in SDS buffer 
(10mM Hepes pH7.4, 135mM NaCl, 5mM KCl, 1mM PMSF, 1% SDS and Complete 
Mini protease inhibitors), precleared, filtered and injected in the same column 
extensively pre-equilibrated with the SDS buffer.  Collected fractions were individually 
concentrated with 3000 MWCO Centricons (Millipore), precipitated with ethanol and 
resolved by 12% SDS-PAGE. Proteins were transferred to nitrocellulose membranes 
and sequentially incubated with: anti-GCAP2 pAb (visualized in green) and anti-14-3-3ε 
mAb (visualized in red) for Triton X100 sample-panels; and with GCAP2 mAb 
(visualized in red) and sequentially with anti-14-3-3ε mAb (also visualized in red) for 
SDS-sample-panels. 
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3.12. In vivo electroporation of plasmid DNA following its injection in the 
subretinal space 
Expression vectors for the mutants bS201G/EF-GCAP2 and bG161R/GCAP2  were 
obtained by site-directed mutagenesis of the expression vectors described above for 
bGCAP2 and bEF-GCAP2 based on the 4.4kb version of the mouse opsin promoter.  
Site-directed mutagenesis was performed with the QuikChange II site-directed 
mutagenesis kit (Agilent, Santa Clara, CA, USA) using primers:  
bGCAP2_S201G_Fw: CTCAGCAGAGGCGGAAAGGTGCCATGTTC; 
bGCAP2_S201G_Rv: GAACATGGCACCTTTCCGCCTCTGCTGAG;  
bGCAP2_G161R_Fw: CCTTCTGGTGGATGAAAATCGAGATGGTCAGCTG; 
and bGCAP2_G161R_Rv: CAGCTGACCATCTCGATTTTCATCCACCAGAAGG.  
Mutagenesis in each case was confirmed by sequencing.  Mice were electroporated at 
p0 according Matsuda and Cepko, (Matsuda and Cepko 2004) and processed at p28-
30. Briefly, 0.5μl at a concentration of 6μg/µl of DNA mix in PBS was injected into the 
subretinal space, by making use of a Nanojet microinjector and micromanipulator 
(Drummond Scientific, Broomall, PA).  The DNA mix consisted of the expression vector 
for the specific GCAP2 mutant (GCAP2, G161R/GCAP2, EF-GCAP2 or S201G/EF-
GCAP2) in circular form and a tracer plasmid [pL_UG, expressesing the green 
fluorescent protein (GFP) driven by the Ubiquitin C promoter, (Zavzavadjian, Couture 
et al. 2007) also in circular form, at a mass ratio of 2:1.  Electroporation was performed 
with a square-wave electroporator (CUI21, Nepagene, Japan) by triggering 5 pulses of 
80V with a 50ms duration and an interval time of 950ms.  Electroporated pups were 
raised under standard cyclic light conditions and sacrificed at p28-30 for 
immunofluorescence analysis.  Briefly, eyes were fixed in 4% paraformaldehyde in 
PBS at pH 7.4, embedded in acrylamide mix and frozen as described [34].  Retinal 
cryosections were obtained at 22µm thickness.  An antigen retrieval protocol was 
performed preceding the immunofluorescence studies: glass slides were incubated 
with proteinase K in PBS pH 7.4 (0.05mg/ml) for 2 min and heated at 70oC for 8 sec.  
Sections were incubated in blocking solution (1% BSA, 3% normal goat serum, 0.1% 
Triton X100, PBS pH 7.4); primary antibody solution (1% BSA, 3% normal goat serum, 
PBS pH 7.4 containing 0.01mg/ml polyclonal antibody to GCAP2 and 0.00025mg/ml 
mAb 1D4 to rhodopsin); and secondary antibody solution [1% BSA, 3% normal goat 
serum, PBS pH7.4 containing Alexa Fluor 647 anti-rabbit IgG (signal converted to red 
in figures); and Alexa Fluor 555 anti-mouse IgG (signal converted to blue in figures)]. 
Images were acquired in a Leica confocal microscope.  GCAP2 and rhodopsin signal 
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profiles were obtained for the individual cells shown by tracing a line along the inner 
segment compartment, and another line along the outer segment compartment, and 
plotting the summation of the red and the green signal along both lines from the 
collection of planes in a z-stack that covers the whole volume of the cell, by using the 
Leica confocal software (Leica Microsystems). 
 
3.13. Immunocytochemistry 
To obtain retinal sections for immunofluorescence analysis mouse eyecups were fixed, 
infiltrated in sucrose or acrylamide, embedded in OCT and cryosectioned as described 
(Lopez-del Hoyo, Fazioli et al. 2012) .  Sections were incubated with blocking solution 
(3% normal goat serum, 1% BSA, 0.3% Triton X100 in PBS pH 7.4, 1 h at room 
temperature);  primary antibody (14 h at 4oC), secondary antibody (1 h at room 
temperature), and fixed for 15 min in 4% paraformaldehyde prior to being mounted with 
Mowiol [Calbiochem, Billerica, MA].  An antigen retrieval treatment of retinal sections 
[incubation in 0.05mg/ml proteinase K in PBS pH 7.4 for 2 min at room temperature 
followed by a heat shock at 70oC for 10 sec] was needed for GCAP2 immunostaining. 
Antibodies used were: a polyclonal anti-GCAP2 (Lopez-del Hoyo, Fazioli et al. 2012), 
monoclonal anti-GCAP2 [mAb2235, Millipore, Billerica, MA], rabbit monoclonal anti-14-
3-3ε [EPR3918, abcam, Cambridge, UK]. Secondary antibodies for 
immunofluorescence were Alexa 488 goat anti-rabbit IgG and Alexa 555 goat anti-
mouse IgG [Molecular Probes, Eugene, Oregon]. Images were acquired at a laser 
scanning confocal microscope (Leica TCS-SL and TCS-SP2). 
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METHODS CHAPTER 2 
3.14. Immunofluorescence microscopy 
For immunofluorescence microscopy, mice were sacrificed and eyes were marked at 
the superior center for orientation purposes.  Immediately after enucleation the eyes 
were punctured with a needle and submerged in fixative: 4% paraformaldehyde; 0,02% 
glutaraldehyde in phosphate buffer saline at pH7.4.  At 5 min into the fixation step the 
cornea was excised, at 20 min the lens was removed and eye cups were further fixed 
for a total of 2h at room temperature.  Eye cups were infiltrated in acrylamide (8,4% 
acrylamide, 0,014% bisacrylamide in PBS pH7.4 for 14h before acrylamide 
polymerization was induced) or in sucrose (30% w/v in PBS pH7.4 for 14h), and 
included in OCT compound.  Cryosections along the vertical axis of the eyecup were 
obtained at 20μm-thickness using a CM1510S Leica cryostat (Leica Microsystems).  
Sections were incubated with blocking solution (3% normal goat serum, 1% BSA, 0,3% 
Triton X100 in PBS pH7.4, 1h at room temperature);  first antibody (14h at 4oC), 
secondary antibody (1h at room temperature), and fixed for 15 min in 4% 
paraformaldehyde prior to being mounted with Mowiol [Calbiochem 475904].  An 
antigen retrieval treatment of retinal sections [incubation in 0,05 mg/ml proteinase K in 
PBS pH7.4 for 2 min at room temperature followed by a heat shock at 70oC for 10 sec] 
was needed for GCAP2 immunostaining.  Images were acquired at a laser scanning 
confocal microscope (Leica TCS-SL and TCS-SP2). 
The GCAP2 antibody used in Western blots, indirect immunofluorescence assays and 
electron microscopic immunolocalization is a polyclonal antibody raised in rabbit 
against a His-tagged recombinant form of bovGCAP2 expressed in bacteria.  
Antibodies were affinity-purified with a recombinant GCAP2 affinity column.  For 
indirect immunofluorescence assays GCAP2 Ab was used at a 1:400 working dilution 
from a 1 mg/ml stock.  Ribeye immunolabeling of synaptic ribbons was performed with 
a monoclonal antibody anti-CtBP2 [BD biosciences 612044, 1:250]. The GCAP1 
antibody is a polyclonal antibody raised in rabbit against a His-tagged recombinant 
form of human GCAP1, and was affinity-purified. 
To label retinal cell types we used primary antibodies directed against the following 
molecules: Transducin Gγ c subunit [Cytosignal PAB-00801-G Ab, 1:200, for cone 
pedicules]; Calbindin D [Swant CB-38a Ab, 1:500, for horizontal cells]; Protein Kinase 
C α isoform, PKCα [Santa Cruz Biotechnology sc-10800 Ab, 1:100, for rod-on bipolar 
cells]; Bassoon [Stressgen VAM-PS003 mAb, 1:1000, for arciform densities in rods and 
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cones]; and Synaptophysin, SYP [Chemicon MAB5258 mAb, 1:1000, for rod spherules 
and cone pedicules].  Secondary antibodies for immunofluorescence were Alexa 488 
goat anti-rabbit IgG [Molecular Probes A-21206]; Alexa 555 goat anti-mouse IgG 
[Molecular Probes A-31570] and Alexa 633 goat anti-guinea pig IgG [Molecular Probes 
A-21105], used at a 1:100 dilution. 
 
3.14.1. OPL measurements 
For measurements of outer plexiform layer (OPL) thickness, pictures were taken at four 
different positions in the retinal vertical meridian (A, B, C and D).  These regions, at 
800 µm from the superior edge (A), equidistant from point A and the optic nerve (B), at 
750μm from the optic nerve in the inferior retina (C) and equidistant from C and the 
inferior edge (D) were marked at 10x magnification by photobleaching the fluorescent 
signal next to the point of interest.  By using the photobleached areas as a reference, 
pictures at A, B, C and D positions were taken at 63x magnification. Measurements of 
OPL thickness were taken at each point in the different phenotypes by determining the 
width of the GCAP2 (or RIBEYE) immunolabeled bands with the Leica LAS AF Lite 
image acquisition software. Three different measurements were taken per point to 
calculate the average for each retina specimen, and at least four mice per phenotype 
were analyzed to calculate the mean. 
 
3.15. Retinal preparation for light microscopy and electron microscopy 
For the ultrastructural analysis of rod synaptic terminals the different mouse lines were 
raised in constant darkness by maintaining cages in aerated dark cabinets.  They were 
sacrificed under dim red light at postnatal day 40 (dark conditions); or exposed to 1500 
lux white fluorescent light for 1 or 5h after pupil dilation with a mixture of 0.75% 
tropicamide and 2.5% phenylephrine hydrochloride (light conditions) and immediately 
sacrificed.  For orientation purposes, a mark was imprinted at the superior center of the 
eye before enucleation. Immediately after enucleation the eye was punctured with a 
30-G needle and fixed in 2% paraformaldehyde, 2.5% glutaraldehyde in 0.1M 
cacodylate buffer for 5 min. An incision was made arround the ora serrata and fixation 
was allowed to proceed for 1h. The cornea and lens were removed and the eye cup 
was further fixed for 12h at 4oC. After this fixation step, eye cups were washed with 
0.1M cacodylate buffer and fixed with 1% osmium tetroxide (OsO4) in 0.1M cacodylate 
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buffer for 2h at room temperature.  Specimens were dehydrated in ethanol (30-100%) 
or acetone, infiltrated with propylene oxide and embedded in Epoxi embedding medium 
(Fluka Analytical). To measure synaptic ribbons in GCAP2+ and WT littermate control 
mice, 4 GCAP2+ and 3 WT littermate controls were raised in 12h:12h dark-light 
standard cyclic light and were processed at p60 at the end of the dark period. 
Processing of the eyes for conventional electron microscopy was done as described. 
 
3.16. Ultrathin sectioning, image acquisition and analysis at the transmission 
electron microscope 
Ultrathin sections (70-90nm) in the vertical meridian of the eye cup were made using a 
Reichert Ultracut S ultramicrotome (Leica), collected on 200 mesh copper grids, 
counterstained with heavy metal staining (2% uranyl acetate in 50% ethanol for 30 min) 
and contrasted with 2% lead citrate for 10 min. Ultrathin sections were analyzed in a 
JEOL 1010 or a Tecnai Spirit Twin [FEI] 120 Kv LaB6 transmission electron 
microscope.  Images were obtained with a Bioscan Gatan wide angle slow scan CCD 
camera.  In order to determine the ribbon length in the different mouse lines, at least 
two different specimens were analyzed per phenotype.  Two to ten 16 x 16 μm frames 
at 8,000 x magnification were delimited per Epon block, that typically contained 10 to 
22 rod synaptic terminals.  At a given plane of sectioning along the vertical axis in the 
center of the eye cup, the synaptic ribbon was visible in about 60-70% of the synaptic 
terminals, and about 40% of all terminals presented ribbons discernible as resulting 
from transversal cuts (Supplementary Table I).  Contrary to ribbons from longitudinal or 
oblique cuts that result in variable shapes and sizes, transversal cuts are easily 
recognized as defined lines anchored at the arciform density between the two 
invaginating processes of horizontal cells, and their length should represent the length 
of the ribbon plate at any point.  Therefore, once the 8,000x magnification frames were 
delimited, all synaptic terminals contained in the frame were individually scanned at 
100,000x magnification, and length measurements were taken from ribbons resulting 
from tangential cuts by using the ImageJ software.  Cone synaptic terminals were 
excluded from the analysis. 
For determination of synaptic terminal size [µm2], micrographs of the OPL area were 
obtained at the electron microscope at low magnification [x8000], and the ImageJ 
software was used to obtain the dimensions of delimited regions of interest with the 
form of the synaptic terminals. 
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To determine the percentage of synaptic terminals containing a synaptic ribbon, the 
number of total synaptic terminals was determined in five 16x16 -μm2 frames per 
fenotype, and the number of terminals containing a longitudinal, transversal or sagittal 
ribbon were counted.  A percentage was calculated per frame, and the five results 
obtained per phenotype were averaged. 
 
3.17. Immunoelectron microscopy 
For immunoelectron labeling of GCAP2 and RIBEYE in GCAPs-/-GCAP2+ mice and 
GCAPs-/- negative control mice, dark-reared mice at p40 were sacrificed in dim light.  
The eyes were marked, enucleated and immediately fixed in 2% paraformaldehyde in 
phosphate buffer saline at pH 7.4 for 2h at room temperature, following the puncture 
and dissection steps described above. In order to preserve antigenicity while 
maintaining ultrastructure, immediately after fixation eye cups were processed by a 
progressive lowering temperature (PLT) protocol of dehydration and embedding in 
Lowicryl resin.  Dehydration protocol was: [0oC, 30 min 30% ethanol; -20oC, 60 min 
50% ethanol; -35oC, 60 min 70% ethanol; -35oC, 60 min 95% ethanol; -35oC, 60 min 
100% ethanol; -35oC, 60 min 100% ethanol].  Infiltration was performed with Lowicryl 
embedding media K4M: [-35oC, 60 min resin:ethanol 1:3; -35oC, 60 min pure resin; -
35oC, 16h pure resin]. The resin was polymerized by long wavelength UV irradiation for 
at least 24h. Ultrathin sections were incubated at room temperature in blocking solution 
(1% BSA, 20mM glycine in PBS pH7.4, for 30 min), first antibody (anti-RIBEYE Ab, for 
2h) and secondary antibody (5nm or 15nm gold-conjugated goat anti-mouse IgG, 
BBInternational, for 1h); and the process subsequently repeated for GCAP2 
immunolabeling, by repeating the blocking step and incubating with antibody (anti-
GCAP2 Ab, for 2h) and secondary antibody (5nm or 15nm gold-conjugated goat anti-
rabbit IgG, BBInternational, for 1h). After washes, sections in the gold grids were 
counterstained with heavy metal staining (2% uranyl acetate in 50% ethanol for 10 min) 
and contrasted with 2% lead citrate for 5 min.  
Sections were observed at a JEOL JEM1010 transmission electron microscope at 80 
Kv and images were obtained with a Bioscan Gatan wide angle slow scan CCD 
camera. 
To assess specificity of the association of gold-particles to GCAP2 antigenicity in the 
GCAPs-/-GCAP2+ specimens, the number of gold particles associated to synaptic 
ribbons were counted in 74 synaptic terminals randomly selected from two specimens, 
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and compared to that of GCAPs-/- negative control samples.  Out of 74 randomly 
selected synaptic terminals in the GCAPs-/-GCAP2+ sample, 12 out of 74 (about 16%) 
had at least one gold particle associated to the synaptic ribbon, and 20 out of 74 (about 
27%) showed association of gold particles to the presynaptic plasma membrane in 
apposition to the invaginated processes of horizontal cells; whereas in the GCAPs-/- 
only 6% of the ribbons analyzed showed associated gold particles and only 16% 
showed association of gold particles to the membrane delineating the invaginating 
horizontal dendritic processes.  Therefore, we consider the micrographs selected in Fig 
6 to be an accurate illustration of GCAP2 intracellular localization at the synaptic 
terminal. 
 
3.18. Electroretinogram analysis 
Electroretinogram (ERG) recordings were performed in 12h dark-adapted deeply 
anesthetized mice.  Recordings were acquired with a Burian-Allen mouse electrode set 
on a corneal lens specifically designed to fit the mouse eye (Hansen Ophthalmic 
Development Lab), with the reference electrode positioned at the mouth and the 
ground grasped on the tail.  Pupil from the right eye was dilated, and flash-induced 
ERG responses were recorded in response to light stimuli produced with a Gansfeld 
stimulator.  The intensity of light stimuli ranged from -4 to 2 log cd.s.m-2.  For each light 
intensity, responses from four consecutive light presentations were averaged.  The 
range of light intensities from -4 to -1,52 log cd.s.m-2 elicited rod-mediated responses.  
In the range from -1,52 to 0,48 log cd.s.m-2  ERG recordings reflected mixed responses 
from rods and cones.  Pure cone responses were recorded after inducing rod 
saturation by exposing the mouse to a 30cd/m2 background light for 10 min, and then 
applying light stimuli in the range of -0,52 to 2 log cd.s.m-2 superimposed to the 
background.  ERG signals were amplified and band filtered between 0.3 and 1000 Hz 
(Grass CP511 AC amplifier), digitized at 10kHz with a Power Lab data acquisition 
board (ADI instruments) and analyzed off-line by measuring the amplitudes of the a-
wave (from the baseline to the peak of the a-wave) and of the b-wave (from the peak of 
the a-wave to the peak of the b-wave).  ERG measurements were done on a blind 
basis with respect to the mouse phenotype.  
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3.19. Retinal Morphometry 
For retinal morphometry analysis of GCAPs-/- and GCAPs-/-GCAP2+ retinas, a high 
magnification picture of the whole retina under study was obtained by fusion (HUGIN 
software) of three 20x overlapping frames covering the length of a vertical section from 
central retina.  Pictures were taken with the ProgResCapturePro 2.6 software in a 
Stereo Lumar V12 stereoscopic microscope (Zeiss) coupled to a Jenoptik camera.  On 
whole retina-pictures, lines were traced from an imaginary point at the center of the 
retina semicircumference to the optic nerve and to the superior and inferior borders, 
dividing the retina in its superior and inferior quadrants; and then to marks traced at 
200 µm intervals starting from the optic nerve that divided the superior retina into 12 
equal divisions and the inferior retina into 11 divisions.  Marks were numbered 1 to 10 
starting at the second mark from the optic nerve towards the superior edge, and from -
1 to -10 at equivalent positions in the inferior retina.  At each marked position the onl 
thickness was determined by taking three measurements with the ProgResCapturePro 
2.6 software and averaging them. To obtain the graph comparing the morphometric 
analysis in GCAPs-/-GCAP2+ versus GCAPs-/-, at least three animals per phenotype 
were used. 
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RESUMEN EN ESPAÑOL 
Para estudiar el efecto in vivo de mutaciones en GCAP2 que afectan a su afinidad de 
unión a Ca2+, en este estudio llevamos a cabo la generación y caracterización de 
ratones transgénicos que expresan una forma mutada de GCAP2 con los tres 
dominios de unión a Ca2+ inactivados: GCAP2(E80Q/E116Q/D158N) ó bEF-GCAP2.  
Para discriminar el efecto de las mutaciones del efecto que la sobreexpresión del 
transgén pueda tener in vivo, se incluyó una línea transgénica control que 
sobreexpresa la isoforma bovina de GCAP2 wildtype.  Las líneas transgénicas en que 
se ha basado este estudio son: las líneas transgénicas bEF-GCAP2 A y B (con 
expresión del transgén a un ratio 2.76:1 y 3.85:1 con respecto a la expresión 
endógena de GCAP2) y la línea transgénica control bGCAP2 E (expresión 2.5:1).   
Las líneas transgénicas bEF-GCAP2 A y B condujeron a una degeneración retinal 
progresiva que se correlacionó con los niveles de expresión del transgén.  Esta 
degeneración se caracterizó haciendo un seguimiento de la morfología de la retina 
con la edad en las tres líneas, que reveló que el número de células fotorreceptor se ve 
aproximadamente reducido a la mitad en la línea B a los 40 días, y en la línea A a los 
tres meses.  En ambas líneas los ratones alcanzan la ceguera total (respuesta plana 
en electrorretinograma) entre los 5 y los 8 meses de edad.  Podemos afirmar con 
seguridad que esta degeneración se atribuye al efecto de las mutaciones (a un efecto 
de las proteínas mutantes en la célula) y no a un efecto de sobreexpresión heteróloga 
en fotorreceptores de la isoforma de GCAP2 bovina, porque la línea transgénica 
control no presenta degeneración. 
La proteína mutada GCAP2(E80Q/E116Q/D158N) ó bEF-GCAP2 conduce en ensayos 
de reconstitución in vitro a la actividad constitutiva del enzima guanilato ciclasa.  Este 
mutante se comporta in vitro como los mutantes en GCAP1 impedidos para unir Ca2+, 
es decir, al no unir Ca2+ la proteína se bloquea en su estado ‟activo”, y no adquiere su 
estado ‟inactivo” o ‟inhibidor de la ciclasa” en respuesta a las elevaciones en [Ca2+]i.  
Nuestra sorpresa fue que in vivo, en ensayos de actividad guanilato ciclasa realizados 
en homogenados de retina de ratones bEF-GCAP2, la proteína transgénica mutante 
no mostró actividad constitutiva. En realidad, no mostró una actividad apreciable en 
los ensayos, ni en condiciones de alto Ca2+ ni en ausencia de Ca2+.  La expresión de 
la proteína transgénica control, por el contrario, restauró la regulación de la guanilato 
ciclasa en ratones GCAPs-/- según lo esperado. 
El análisis de la localización de bGCAP2 en ratones transgénicos GCAPs-/-bGCAP2 
(línea control) en secciones de retina reveló que la proteína transgénica control 
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reproduce la localización de la proteína GCAP2 endógena en ratones wildtype.  Sin 
embargo en ratones transgénicos GCAPs-/-bEF-GCAP2, la proteína bEF-GCAP2 
(‟bloqueada” en su forma libre de Ca2+)  se acumula en el segmento interno y 
compartimentos proximales de la célula y no se transporta al segmento externo.  
Estos resultados, junto con los resultados de falta de activación de la guanilato ciclasa 
en homogenados de retina, apuntan a que la proteína mutante se acumula en forma 
inactiva en el segmento interno. 
Para investigar si la proteína mutante es retenida en el segmento interno por su 
interacción con alguna otra proteína, llevamos a cabo ensayos de inmunoprecipitación 
de GCAP2 y caracterización de las proteínas que coinmunoprecipitan por 
espectrometría de masas.  Los ensayos de inmunoprecipitación se llevaron a cabo en 
paralelo en ratones GCAPs-/-bGCAP2 y GCAPs-/-bEF-GCAP2, para identificar 
proteínas que interaccionaran específicamente con la forma mutada de GCAP2.  En 
este tipo de ensayos identificamos las proteínas 14-3-3 como interactores preferentes 
de GCAP2 en su forma libre de Ca2+. 
Dado que las 14-3-3 son proteínas que se unen a sus blancos de interacción en 
respuesta a la fosforilación de los mismos, investigamos si la forma libre de Ca2+ de 
GCAP2 se fosforila en extractos de retina de ratones transgénicos. Tanto ensayos de 
fosforilación in situ por marcado metabólico con 32Pi, como ensayos de resolución de 
extractos de retina por geles de  isoelectroenfoque, revelaron que la proteína bEF-
GCAP2 en retinas de ratones transgénicos se encontraba fosforilada a un nivel mucho 
mayor que la proteína bGCAP2.  Una sorpresa de los ensayos de isoelectroenfoque 
fue la revelación de que aproximadamente el 50% de la proteína GCAP2 endógena en 
ratones wildtype se encuentra fosforilada tanto en estadíos de luz como de oscuridad.  
En línea con estos resultados, ensayos de cromatografía de exclusión por tamaño de 
extractos de retina mostraron que bGCAP2 está asociado a 14-3-3 en ratones de la 
línea control, y que lo está también y en mayor medida la proteína bEF-GCAP2 en la 
línea mutante.  Por tanto, la fosforilación de GCAP2 y su unión a 14-3-3 es algo que 
ocurre en la proteína wildtype a cierto nivel (es, por tanto, un proceso fisiológico), y 
que ocurre de forma magnificada cuando la proteína GCAP2 se ve bloqueada en su 
forma libre de Ca2+. 
Dado que las distintas isoformas de 14-3-3 se localizan en células fotorreceptor en el 
segmento interno y compartimentos proximales pero excluídas del segmento externo, 
la fosforilación de GCAP2 y su interacción con 14-3-3 podría ser la causante de su 
retención en el segmento interno.  Para probar esta hipótesis recurrimos a una 
estrategia genética.  Expresamos el mutante de GCAP2: bS201G/EF-GCAP2 en 
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fotorreceptores de ratones GCAPs-/-, por transgénesis transitoria mediante inyección 
subretinal del DNA y electroporación in vivo.  El análisis de localización de la proteína 
en las células bastón transfectadas de esta forma en la retina reveló que la mutación 
de la Ser201 (el único residuo que se fosforila en GCAP2) revirtió la distribución de 
GCAP2, precluyendo su retención en el segmento interno.  La proteína bS201G/EF-
GCAP2 se localizó mayormente en el segmento externo. 
Conjuntamente, estos resultados nos llevan a proponer un modelo en que la 
distribución intracelular de GCAP2 está regulada por fosforilación y unión de 14-3-3.  
En condiciones fisiológicas, GCAP2 oscila entre su forma unida a Ca2+ (cuando el 
Ca2+ es alto, en oscuridad) y su forma libre de Ca2+ (cuando el Ca2+ baja durante 
exposiciones prolongadas a luz).  Proponemos que la fracción de GCAP2 que se 
sintetiza en el período de oscuridad une Ca2+ y es transportada al segmento externo, 
mientras que la fracción de GCAP2 que se sintetiza durante períodos lumínicos, al 
estar en su forma libre de Ca2+, es fosforilada y se une a 14-3-3, siendo retenida en el 
segmento interno y compartimentos proximales de la célula. De esta forma, los 
ratones wildtype que se mantienen en el estabulario en ciclos de luz-oscuridad 
estándar, resultan en células fotorreceptor que contienen aproximadamente un 50% 
de GCAP2 en el segmento externo y un 50% de GCAP2 en el compartimento interno.   
Aquellas condiciones que desequilibran esta regulación, como es el bloqueo de 
GCAP2 en su forma libre de Ca2+, no sólo producen un cambio en la distribución 
intracelular de GCAP2 (que se acumula fundamentalmente en el segmento interno), 
sino que conducen a una degeneración retinal rápida.   Proponemos que la causa de 
la toxicidad de la forma libre de Ca2+ de GCAP2 reside en su inestabilidad térmica y su 
tendencia a la agregación.   Una de las atribuciones descritas para 14-3-3 es su papel 
de chaperona para proteínas con tendencia a agregar y a formar depósitos amiloides, 
del tipo de los observados en Alzheimer, Parkinson, Huntington, etc.  Creemos que la 
toxicidad de las mutaciones que afectan a la unión de Ca2+ en GCAP2 es de carácter 
de desorden conformacional, e independiente del metabolismo de cGMP.  Este 
resultado, además de para las mutaciones descritas en el gen GUCA1B, tiene 
implicaciones para aquellas distrofias hereditarias de retina que resultan en un 
fenotipo ‟luz-equivalente” (un fenotipo que cabría esperar tras exposiciones a luz 
anormalmente altas o prolongadas).  Estas distrofias suelen resultar en una bajada 
prolongada en la [Ca2+]i, y por tanto resultarían en la acumulación de GCAP2 en su 
forma libre de Ca2+. 
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4.1. CONTRIBUCIONES  
Las líneas transgénicas descritas en este trabajo fueron generadas originalmente por 
A. Méndez en el laboratorio de la Dra. Jeannie Chen en la University of Southern 
California, Los Angeles, y trasladadas a Barcelona para su caracterización.  Los 
ensayos de actividad guanilato ciclasa y el análisis por ERG fueron realizados por A. 
Méndez.  Tanto la construcción de los plásmidos de expresión para la transgénesis 
transitoria de los mutantes bS201G/EF-GCAP2 y bG161R/GCAP2, como la 
electroporación de los plásmidos en retina in vivo, el análisis de la localización de las 
proteínas mutantes por ensayos de inmunofluorescencia y la obtención y análisis de 
imágenes al microscopio confocal fueron realizados por S. López-Begines.  Los 
ensayos de isoelectroenfoque fueron aportados por el laboratorio de la Dra. Jeannie 
Chen, USC, Los Angeles. 
La contribución experimental de N. López del Hoyo a este capítulo ha sido⁞ 1) el 
mantenimiento y genotipaje de rutina de las cepas de ratón descritas, 2) la puesta a 
punto de los ensayos de proteómica, tanto por inmunoprecipitación como por pull-
down seguidos de análisis de espectrometría de masas, y por tanto de la obtención de 
las Tablas de proteómica, 3) los pull-downs de verificación de la interacción GCAP2-
14-3-3, 4) la expresión y purificación de GCAP2 y sus mutantes en bacteria, 5) los 
ensayos de fosforilación in vitro e in situ por marcado metabólico de GCAP2, 6) los 
ensayos por cromatografía de exclusión en tamaño. 
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4.2. BRIEF INTRODUCTION 
Although GCAPs are not essential for the development and maintenance of retinal 
morphology (Mendez et al. 2011), mutations in GCAPs genes have been linked to 
inherited autosomal dominant retinopathies. Nine from ten mutations in GUCA1A gene, 
coding for GCAP1 (E89K, Y99C, D100E, N104K, T114I, E143NT, L151F, E155G and 
G159V), affect Ca2+binding affinity (directly or indirectly), producing cGMP elevated 
levels in vitro. In Y99C and E155G mutations it was proved in vivo that these abnormal 
cGMP levels cause rods and cones death. P50L, the other GCAP1 mutation, is 
predicted to affect the folding of the protein and hypothesized to cause cell death by 
another pathogenic mechanism. G157R, the only mutation identified in GUCA1B gene, 
has not been explored. 
To study the effect of mutations in GCAP2 that affect Ca2+ binding in vivo, we 
expressed a mutant form of GCAP2 with inactivated EF hands: 
GCAP2(E80Q/E116Q/D158N), hereafter referred to as bEF-GCAP2, in the rod 
photoreceptors of transgenic mice (Figure R.2A).  It was previously shown that 
inactivation of the three functional EF hands in bGCAP2 abolishes its capacity to bind 
Ca2+ (Dizhoor et al. 1996).  
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4.3. RESULTS 
4.3.1. Transgenic expression of bEF-GCAP2 in mouse rods leads to progressive 
retinal degeneration 
To generate transgenic mice we expressed the cDNA of the bovine GCAP2 isoform, 
so that the transgene product could be distinguished from the endogenous murine 
form by SDS-PAGE electrophoretic mobility.  To discriminate the effect of the 
mutations in GCAP2 from the effect that overexpression of GCAP2 might have on the 
cell, we included in the study a control transgenic line that expresses wildtype bovine 
GCAP2 (line E, Figure R.2A,B).  This line was reported to express wildtype bovine 
GCAP2 at a ~2:1 ratio relative to endogenous GCAP2 (Mendez et al. 2001). 
 
Figure R.1.  Determination of bEF-GCAP2 transgenic expression levels in lines A and B.  A. The 
level of expression of bEF-GCAP2 in line A was determined by direct comparison with that of bGCAP2 in 
line E, by loading in the same gel two-fold serial dilutions of a retinal homogenate representing 1/40 of a 
retina.  Expression of bEF-GCAP2 was determined to be 1.38-fold higher (+ 0.06 St Dev) than that of 
bGCAP2 in control line E.  Because line E was previously established to express 2-fold the endogenous 
levels of GCAP2 (Mendez et al. 2001), line A is determined to express 2,76-fold the endogenous levels of 
GCAP2. B.  Likewise, by comparison to line A, line B was determined to express 1.4-fold more transgene, 
or 3.86-fold the endogenous GCAP2 levels.   
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We established two independent transgenic lines that expressed different levels of 
bEF-GCAP2.  Line A expressed bEF-GCAP2 at a ratio of 2.76:1 relative to endogenous 
GCAP2, whereas line B had a higher relative level of expression (3.85:1 ratio), Figure. 
R.2B and Figure R1.1, see Methods.  
To assess whether bEF-GCAP2 expression in rods causes compensatory changes in 
the expression levels of other proteins involved in cGMP metabolism, we compared 
the level of expression of PDE6 and Ret-GCs in retinal homogenates from wildtype 
and transgenic mice from lines A and B (Figure R.2C).  Levels of PDE α, β and γ 
subunits, or GC1 and GC2 were mostly unaffected in mice from line A, whereas a 
reduction in all proteins was observed in line B at postnatal day 22 (p22), which can be 
explained by the dramatic shortening and disorganization of rod outer segments 
observed from a very early age in this line (Figure R.2D).  
Mice expressing bEF-GCAP2 showed a progressive retinal degeneration whose 
severity correlated with the level of expression of the transgene.  Figure R2.D shows 
normal retinal morphology in the control transgenic line E at p40 and at 3 months of 
age.  In contrast, clear signs of retinal degeneration were observed in mice expressing 
bEF-GCAP2 from lines A and B.  Mice from line B, which express the highest levels of 
bEF-GCAP2, presented a substantial shortening of rod outer segments and a 
noticeable reduction of outer nuclear layer (ONL) thickness as early as p40, with ONL 
thickness reduced to 6-7 rows of nuclei. Mice from line A showed a slower progression 
of the disease, noticeable at 3 months, when the ONL thickness was reduced to 7-9 
rows of nuclei. 
Because expression of wildtype bGCAP2 did not cause retinal degeneration for up to 
one year of age in line E (results not shown), the retinal degeneration observed in mice 
from lines A and B likely results from distinctive properties of the mutant form of 
GCAP2 impaired to bind Ca2+.  However, due to the different transgene expression 
levels, we could not exclude that the observed phenotype may result from 
overexpression of bGCAP2.  To rule out this possibility, we bred the control line E to 
homozygosity, to obtain a line that expressed bGCAP2 to equivalent levels as mutant 
line A.  This line showed normal outer segment length and organization, as well as 
normal outer nuclear layer thickness for up to six months of age when raised in cyclic 
light (López-del Hoyo et al. 2012).  From these results we conclude that mutations that 
impair Ca2+ binding in GCAP2 lead to retinal degeneration in vivo. 
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Figure R.2.  Transgene expression of EF-GCAP2 in rods leads to retinal degeneration. A. Design of 
transgene expression vector.  The cDNA of bovine GCAP2 with the three functional EF hands disrupted 
[GCAP2 (E80Q, E116Q, D158N) or EF-GCAP2] was expressed under the mouse opsin promoter (MOP), 
with the polyadenilation signal of the mouse protamine 1 (MP1) gene.  B.  Western showing the level of 
expression of the transgene in bGCAP2 line E and bEF-GCAP2 lines A and B, compared to wildtype mice.  
Equivalent fractions of a retina were resolved by SDS-PAGE from wt (22d of age), line E (40d) and lines A 
(40d) and B (22d, showed from independent gel).  An earlier time point was chosen for the strongest line 
(B) to reduce the effect that its rapid retinal degeneration has on total retinal protein content.  Bovine and 
murine GCAP2 differ in size by three amino acids and can be distinguished by mobility.  C.  
Compensatory changes in proteins involved in cGMP metabolism were not observed.  The levels of 
PDEα,β and γ subunits, or GC1 and GC2 were mostly unaffected in mice from line A, whereas a reduction 
in all proteins was observed in line B at 22d of age, due to the shortened outer segments in this line.  D.  
Light micrographs of retinal sections from mice expressing bGCAP2 (line E) or bEF-GCAP2 transgene 
(lines A and B) in the GCAPs+/+ background at 40d or 3m.   
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4.3.2. Retinal degeneration by bEF-GCAP2 is reproduced in the GCAPs -/- 
background, and correlates with the loss of visual function. 
Mutations in the GUCA1A and GUCA1B genes show an autosomal dominant pattern 
of inheritance of the associated retinal dystrophies.  Therefore, transgene expression 
of mutant GCAPs in the normal GCAPs+/+ genetic background should constitute good 
models of the disease.  However, the presence of the endogenous GCAPs interferes 
with the study of the mutant protein localization and function in the cell.  Hence we 
bred the transgenic lines to GCAPs-/- mice, to study the effects of the mutant protein 
on cell physiology.  
The relative levels of expression of the transgene in the independent transgenic lines 
were maintained in the GCAPs-/- background (Figure R.3A).  Expression of bEF- 
GCAP2 in the GCAPs-/- background slightly accelerated the rate of retinal 
degeneration observed in the GCAPs+/+ background.  Mice from the control lines 
GCAPs-/- and GCAPs-/- bGCAP2 E showed largely normal retinas with an outer 
nuclear layer (ONL) thickness of 10 rows of nuclei for up to 5 months of age (Figure 
R.3B), and preserved normal visual function when raised in cyclic light conditions as 
assessed by electroretinogram (ERG) (López-del Hoyo et al. 2012).  In contrast, 
GCAPs-/- expressing bEF-GCAP2 showed a progressive retinal degeneration that 
correlated with loss of visual function (Figure R.4).  In retinas from line B the ONL was 
reduced to six rows of nuclei and outer segments were much shorter than normal as 
early as p30 (Figure R.3B), when the A and B-wave amplitudes of ERG responses 
were half the size of normal responses from littermate controls (not shown).  At 3 
months of age the ONL was reduced to 4 rows of nuclei, and by 5 months it was limited 
to a single row.  Mice were unresponsive to light (flat ERG traces) by 7 months (Figure 
R.4).  A slightly slower retinal degeneration was observed in mice from line A that went 
from a normal outer nuclear layer thickness of 12 rows of nuclei at p30 to about 5 rows 
by 3 months of age.  ERG responses of these mice resembled normal responses at 
very early ages, but A- and B-wave amplitudes were reduced by half by 4 months, 
correlating with a dramatic cell loss in these mice between p20 and 5 months of age 
(Figure R.3B and Figure R.4).  Most of these mice are non responsive to light by ERG 
by 7-8 months (Figure R.4).   
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Figure R.3.  Transgenic expression and rate of retinal degeneration in the GCAPs-/- background.  
A. Levels of transgene expression in the GCAPs-/- background in mouse retinas from line E (ctrl 
bGCAP2) and lines A, B (bEF-GCAP2).  Equal fractions of the retina were loaded from mice at 30d of age.  
Transgene expression levels estimated in the GCAPs+/+ background were maintained in the GCAPs-/- 
background.  B. Light micrographs of retinal sections from mice of the indicated genotypes at 1, 3 and 5 
months of age, standard cyclic light rearing.  Lines A and B show a progressive retinal degeneration in the 
GCAPs-/- background, that reduces the ONL thickness to 4-5 rows of nuclei at three months, and to 3 
rows at five months (line A) or to a single row by five months of age (line B). 
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Figure R.4.  Timecourse for the loss of visual function in bEF-GCAP2 expressing mice as assessed 
by electroretinogram.  ERG B-wave amplitudes (µV) are plotted to postnatal age of mice (months).  
Representative ERG responses are shown for each phenotype at 4 and 7.5 months of age. 
 
4.3.3. bEF-GCAP2 protein accumulates in inactive form at the inner segment of 
the cell 
In vitro studies have shown that recombinant bEF-GCAP2 leads to maximal activation 
of RetGCs in reconstitution studies using washed bovine rod outer segment membrane 
preparations independently of free Ca2+ in the whole physiological range of [Ca2+] 
(Dizhoor and Hurley 1996). To assay whether the transgenic bEF-GCAP2 protein has 
the capacity to activate RetGC activity in retinal extracts from mice in a similar manner 
as in in vitro studies we performed guanylate cyclase activity assays in retinal extracts 
from the mutant or control mice obtained prior to significant retinal degeneration -
between p20 and p30- under 0µM Ca2+ or 2μM Ca2+ (Figure R.5). 
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Figure R.5.  Guanylate cyclase activity in retinal homogenates of transgenic mice at 0 [Ca2+] and 2μM 
[Ca2+].  Guanylate cyclase activity (pmol cGMP/min.mg prot) was determined in WT, GCAPs-/-, GCAPs-/- 
bGCAP2 line E and GCAPs-/- bEF-GCAP2 line A retinal extracts at 0 [Ca2+] or 2 µM [Ca2+] conditions, in 
the absence or presence of 3 µM recombinant GCAP2.  In WT retinal homogenates at 0 [Ca2+] the 
endogenous GCAPs activate RetGC activity about 8-fold over the activity at 2 μM [Ca2+].  This stimulation 
of RetGC activity at 0 [Ca2+] is lost in GCAPs-/- retinal homogenates, but restored in the GCAPs-/- 
bGCAP2 line E, which indicates that the control bGCAP2 protein expressed in vivo as a transgene is 
active in these assays.  However, retinal homogenates from GCAPs-/- bEF-GCAP2 line A mice showed 
greatly reduced RetGC activity at 0 [Ca2+] and no activity at 2 μM [Ca2+] conditions.  Addition of 3µM 
recombinant GCAP2 elicited activation of RetGC at 0 [Ca2+] in all retinal homogenates, indicating the 
presence of functional RetGC in all samples.  These results show that bEF-GCAP2 was present, but 
mostly inactive, in GCAPs-/- bEF-GCAP2 line A retinal homogenates.  Results show the mean and 
standard deviation of at least four independent experiments. 
 
Ca2+-dependent modulation of RetGC activity was observed in retinal homogenates 
from wildtype mice and control GCAPs-/- bGCAP2 E line. As expected, the Ca2+-
sensitive guanylate cyclase activity was undetectable in GCAPs-/- retinal extracts, 
indicating that the guanylate cyclase activity that is measurable in whole mouse retinal 
extracts originates essentially from photoreceptor cells in a GCAPs-dependent 
manner. As a control for the presence of functional RetGCs in retinal extracts, 
guanylate cyclase activity was also measured after addition of 3µM recombinant 
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bGCAP2, which restored robust activity in a Ca2+ dependent manner.  Surprisingly, 
retinal extracts from GCAPs-/- bEF-GCAP2 B mice resembled those of GCAPs-/-.  
They showed little detectable retGC activity at either 0 Ca2+ or high Ca2+. Even though 
the levels of Ret-GCs and bEF-GCAP2 were reduced to some extent in these retinal 
extracts due to the shortening of the rod outer segments in this line, the addition of 
recombinant bGCAP2 showed that there was functional RetGCs in these extracts at 
levels that were sufficient to elicit a measurable activity.  The results shown are the 
average of four independent experiments. These results indicate that while the 
transgenic bGCAP2 control protein expressed in the GCAPs-/- background 
reproduced normal activity, the transgenic mutant form of bGCAP2 impaired to bind 
Ca2+ showed very little detectable activity in vivo. 
Figure R.6.  bEF-GCAP2 mislocalizes in transgenic retinas, accumulating at the inner segment 
compartment of the cell.  Cryosections of central retina from WT, GCAPs-/-, GCAPs-/- bGCAP2 line E 
and GCAPs-/- bEF-GCAP2 line B, immunostained with an anti-GCAP2 polyclonal Ab.  Endogenous 
GCAP2 in WT retinas distributes to the cytosolic space of rod cells, at the rod outer segment, inner 
segment, outer nuclear and outer plexiform layers of the retina.  This pattern of staining is lost in GCAPs-/- 
retinas and restored in GCAPs-/-bGCAP2 line E retinas.  However, in GCAPs-/- bEF-GCAP2 line B the 
pattern of staining is shifted, with the GCAP2 signal being much stronger at the inner segment and 
proximal compartments of the cell than at the outer segment.  os, outer segment; is, inner segment; onl, 
outer nuclear layer. 
 
To study whether the bEF-GCAP2 protein reproduced the localization pattern of 
endogenous GCAP2 in transgenic mice, we immunostained GCAP2 in retinal 
cryosections.  Whereas transgenic bGCAP2 in the control line mimicked the 
localization of endogenous GCAP2 in wildtype retinas (staining the outer segment, 
inner segment, cytosol of outer nuclear layer and outer plexiform layers of the retina, 
with the signal being most intense at rod outer segments); this pattern was shifted in 
the case of bEF-GCAP2, with the signal being most intense at the rod proximal 
compartments, particularly at the inner segment layer (Figure R.6).  These results 
show that bEF-GCAP2, when expressed in the GCAPs-/- background, tend to 
accumulate at the metabolic compartment of the cell. 
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sustained cGMP hydrolysis would counteract unabated cGMP synthesis.  A.  Statistical comparison of 
ONL thickness at fixed regions along the central retina between bEF-GCAP2 transgenic mice reared in 
complete darkness or under constant light exposure (1,500 lux fluorescent light) at postnatal day 40.  
Measurements of ONL thickness (m) were taken at ten equal intervals along the superior and inferior 
hemispheres of the retina, indicated in abscissas as positive values (superior retina) and negative values 
(inferior retina) from the optic nerve (position 0). The superimposition of the red and black lines indicate 
that retinal degeneration (shortening of ONL thickness along the retina) was observed to the same extent 
in dark-reared or constant light-reared bEF-GCAP2 mice. ONL thickness in GCAPs-/- bGCAP2 line E 
control mice are shown as a reference of normal retina values. B. Representative pictures from central 
superior retinas of dark-reared and constant light-reared GCAPs-/- bEF-GCAP2 line A and control mice at 
20 and 40 postnatal days.  
 
These results indicate that bEF-GCAP2 in the retinas of transgenic mice has a greatly 
reduced capacity to activate the cyclase and accumulates at the inner segment of the 
cell, indicating that the pathology in these mice does not result from unabated cGMP 
synthesis.  Furthermore, the retinal degeneration in bEF-GCAP2 mice could not be 
prevented by raising the mice in constant light exposure that would counteract the 
increase in cGMP synthesis by continuous cGMP hydrolysis (Figure R.7), as was the 
case in Y99C-GCAP1 mice (Woodruff et al. 2007). 
Taken together, these results point to a mechanism independent of cGMP metabolism 
as the molecular basis for the neurodegeneration in these mice.  
 
4.3.4. bEF-GCAP2 protein is phosphorylated to high levels in vivo and binds to 
14-3-3 in a phosphorylation-dependent manner  
We reasoned that the accumulation of bEF-GCAP2 at the proximal compartments of 
the cell rather than its absence at the rod outer segment was the cause of the 
progressive retinal degeneration in these mice, given that the absence of GCAP1 and 
GCAP2 in GCAPs-/- mice does not affect gross retinal morphology (Mendez et al. 
2001).  To address why bEF-GCAP2 fails to be distributed to the rod outer segment 
and how its retention and accumulation at the inner segment leads to toxicity, we 
investigated the protein-protein interactions that the mutant form of the protein 
establishes in a specific manner.  Immunoprecipitation assays were conducted with an 
anti-GCAP2 monoclonal antibody cross-linked to magnetic beads, using Triton X100- 
solubilized whole retinal extracts from GCAPs-/- bGCAP2 E and GCAPs-/- bEF-
GCAP2 B mice.  Retinal extracts from GCAPs-/- mice were carried to define the 
background. The pool of proteins immunoprecipitated in each case was identified by 
directly subjecting the elution fractions to trypsin-digestion and liquid chromatography-
tandem mass spectrometry analysis (LC-MS/MS). We searched for proteins identified 
in the GCAPs-/- bEF-GCAP2 B sample with an spectral counting at least 1.5-fold  over 
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the GCAPs-/- bGCAP2 and GCAPs-/- control lines).  We found that only the distinct 
isoforms of 14-3-3 proteins fulfilled these criteria, being identified with a considerably 
higher number of peptides [1.33 to 3.2-fold higher] in the GCAPs-/-bEF-GCAP2 B than 
in control samples in at least two independent experiments (Table R.1). Spectral 
counting of 14-3-3 isoforms were between 1.6-fold and 5-fold higher in the GCAPs-/-
bEF-GCAP2 B samples than in control samples in the two experiments (Table R.2). 
 
    Exp 1 Exp 2 
Protein 
UniProtKB/ 
Swiss-Prot 
entry name 
Primary 
accession 
number 
Gene 
name 
line 
E 
line 
B ctrl 
line 
E 
line 
B ctrl 
GCAP 2 GUC1B-BOVIN P51177 GUCA1B 12 10 0 9 6 0 
14-3-3 protein  1433E-MOUSE P62259 Ywhae 11 19 6 5 10 5 
14-3-3 protein  1433G-MOUSE P61982 Ywhag 9 12 4 4 8 3 
14-3-3 protein / 1433Z-MOUSE P63101 Ywhaz 7 15 9 6 9 6 
14-3-3 protein / 1433B-MOUSE Q9CQV8 Ywhab 6 13 6 0 8 0 
14-3-3 protein 	 1433T-MOUSE P68254 Ywhaq 5 16 5 3 7 3 
 
Table R.1:  Proteins identified by LC-MS/MS in GCAP2 immunoprecipitation experiments. The table 
lists proteins identified in GCAP2 immunoprecipitation assays from retinal homogenates of GCAPs-/- 
GCAP2 line E, GCAPs-/- EF-GCAP2 line B and GCAPs-/- mice (ctrl).   Data is shown from two 
independent experiments (three columns per experiment).  Last six columns indicate the number of 
peptides identified for each protein in each sample, indicative of the relative levels of 
coimmunoprecipitated proteins. GCAP2 was immunoprecipitated to similar levels in control line E and 
mutant line B, but 14-3-3 isoforms coimmunoprecipitation with GCAP2 occurred substantially more 
efficiently in mutant line B than in control line E, indicating 14-3-3 selective binding to GCAP2 locked in its 
Ca2+-free form.  GCAP2, guanylate cyclase activating protein 2. 
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Table R.2:  Spectral counting of Proteins identified by LC-MS/MS in GCAP2 immunoprecipitation experiments 
 
 
    Exp 1 
    bGCAP2 ctrl line E bEF-GCAP2 Line B GCAPs -/- ctrl 
Ratio of spectra (EF-
GCAP2 / ctrl line E) 
normalized to ratio of 
GCAP2 spectra  (EF-
GCAP2 / ctrl line E) 
    peptides spectra peptides spectra peptides spectra   
Guanylate cyclase activating protein 2 GUC1B-BOVIN P51177 GUCA1B 12 49 10 140 0 0 x1 
14-3-3 protein epsilon 1433E-MOUSE P62259 Ywhae 11 28 19 134 6 12 x1.9 
14-3-3 protein gamma 1433G-MOUSE P61982 Ywhag 9 11 12 47 4 7 x1.6 
14-3-3 protein zeta/delta 1433Z-MOUSE P63101 Ywhaz 7 10 15 59 9 15 x2.1 
14-3-3 protein beta/alpha 1433B-MOUSE Q9CQV8 Ywhab 6 8 13 45 6 9 x2.1 
14-3-3 protein theta 1433T-MOUSE P68254 Ywhaq 5 7 16 50 5 8 x2.6 
14-3-3 protein eta 1433F_MOUSE P68510 Ywhah 5 7 13 40 3 6 x2 
14-3-3 protein sigma 1433S_MOUSE O70456 Sfn 3 5 4 22 0 0 x1.7 
       Exp 2    
    bGCAP2 ctrl line E bEF-GCAP2 Line B GCAPs -/- ctrl 
Ratio of spectra (EF-
GCAP2 / ctrl line E) 
normalized to ratio of 
GCAP2 spectra  (EF-
GCAP2 / ctrl line E) 
    peptides spectra peptides spectra peptides spectra   
Guanylate cyclase activating protein 2 GUC1B-BOVIN P51177 GUCA1B 9 44 6 32 0 0 x1 
14-3-3 protein epsilon 1433E-MOUSE P62259 Ywhae 5 7 10 29 5 5 x5.6 
14-3-3 protein gamma 1433G-MOUSE P61982 Ywhag 4 5 8 16 3 3 x4.4 
14-3-3 protein zeta/delta 1433Z-MOUSE P63101 Ywhaz 6 8 9 24 6 6 x4.1 
14-3-3 protein beta/alpha 1433B-MOUSE Q9CQV8 Ywhab 0 0 8 17 0 0 ND 
14-3-3 protein theta 1433T-MOUSE P68254 Ywhaq 3 4 7 15 3 3 x5.1 
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Figure R.8.  The protein 14-3-3 binds to recombinant GCAP2 in a phosphorylation-dependent 
manner.  A.  In vitro, Ca2+-free bGCAP2 is phosphorylated more efficiently than Ca2+-bound bGCAP2. 
Upper panel shows an autoradiograph of 33P phosphorylation products from an in vitro phosphorylation 
reaction of recombinant wildtype bGCAP2 or bEF-GCAP2 with protein kinase G (PKG), in the presence or 
absence of free Ca2+.  The 20μ reaction mixture contained 8.5µg of purified recombinant wildtype 
bGCAP2 or bEF-GCAP2, purified PKGIα (100 units, Calbiochem) and 3μCi of 33P- γATP in 
phosphorylation reaction buffer, containing either CaCl2 or EGTA (see Methods).  After incubation, 
reaction mixtures were resolved by 15% SDS-PAGE and transferred to a nitrocellulose membrane. Lower 
panel shows immunostained GCAP2.  Recombinant bGCAP2 or bEF-GCAP2 proteins were present to 
similar amounts in all reaction tubes.  B.  In vitro phosphorylated or mock-treated bGCAP2 and bEF-
GCAP2 were generated for pull-down assays.  Phosphorylation reactions were performed as above, in the 
presence of EGTA, except that cGMP was added to 500µM (+ lanes) or not added (- lanes).  
Immunostaining of GCAP2 in the same nitrocellulose membrane shows the GCAP2 monomer at 25kDa 
and upper bands corresponding to dimers and multimers of GCAP2, observed to a higher extent in the 
EF-GCAP2 lanes.  Molecular mass (MW) markers (Precision Plus Protein Standards, BioRad) are 20, 25, 
37, 50, 75, 100 and 150 kDa.  Experiment shown in duplicate.  C.  The 14-3-3 protein isoforms bind more 
efficiently to phosphorylated bGCAP2 and bEF-GCAP2 than to unphosphorylated counterparts.    
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Phosphorylated or mock- proteins were cross-liked to magnetic beads and pull-down assays were 
performed with whole bovine retinal extracts obtained in 1% Triton-X100.  Panels show the input and 
bound fractions for the indicated phospho- or mock-proteins, resolved by 15% SDS-PAGE.  Membrane 
was sequentially incubated with a pAb to 14-3-3pan (IBL International, Hamburg, Germany), a mAb to 14-
3-3ε (abcam, Cambridge, UK), an IRDye 800CW Goat Anti-rabbit IgG and an IRDye 680CW Goat Anti-
mouse IgG (Tebu-Bio, Offenbach, Germany).  Image was acquired at the Odyssey Imaging System (LI-
COR).  Therefore 14-3-3pan isoforms (30kDa) are shown in green, while 14-3-3ε (33kDa) is shown in red.  
Experiment shown in duplicate. 
 
Because 14-3-3 proteins typically bind to their targets in response to phosphorylation 
(Smith et al. 2011), and since phosphorylation of GCAP2 has been reported to occur in 
vitro at a conserved Ser at position 201 in bGCAP2 (Peshenko et al. 2004b), we next 
assayed whether the binding of 14-3-3 to GCAP2 was phosphorylation dependent.  
We first reproduced the observation that GCAP2 can be phosphorylated in vitro by 
PKG, with Ca2+-free bGCAP2 being a better substrate for the kinase than Ca2+-loaded 
bGCAP2 (Figure R.8A).  Subsequently, we used recombinant bGCAP2 or bEF-GCAP2 
in in vitro phosphorylation reactions with PKG to generate phosphorylated-bGCAP2 or 
mock-treated bGCAP2 for pull-down assays with bovine whole retinal homogenates 
(Figure R.8B).  As seen in Figure R.8C, 14-3-3 showed preferential binding to the 
phosphorylated form of bGCAP2 or bEF-GCAP2 in two independent experiments. 
The observations that 14-3-3 binds more efficiently to bEF-GCAP2 than to bGCAP2 in 
vivo and that 14-3-3 binds to bGCAP2 in a phosphorylation dependent manner, 
together with the reported higher efficiency of GCAP2 phosphorylation in its Ca2+-free 
rather than its Ca2+-bound conformational state led us to hypothesize that bEF-GCAP2  
might be abnormally phosphorylated in the living cell.  To test this hypothesis we 
performed a 32Pi -metabolic labeling of GCAPs-/- bGCAP2 and GCAPs-/- bEF-GCAP2 
retinas in situ, followed by GCAP2 immunoprecipitation and SDS-PAGE analysis.  
Following the incorporation of 32Pi into the retinas of dark-adapted mice for 2h, retinas 
were either kept in darkness or exposed to 5 min of bright white light and immediately 
subjected to Triton X100-solubilization and GCAP2 immunoprecipitation.  GCAPs-/- 
retinas were carried as a negative control. 
Figure R.9A shows equal fractions of the Triton X100-solubilized retinas after 32Pi-
incorporation and 5min dark- or light-exposure. The overall pattern of bands in this 
panel shows that incorporation of 32Pi into the ATP pool of the retina occurred at 
comparable levels in all samples, allowing the detection of phosphorylated proteins 
and changes in the overall phosphorylation pattern caused by light (e.g. the light- 
dependent phosphorylation of rhodopsin is observed at 35-37 kDa). GCAP2 
phosphorylation could not be detected in whole retinal extracts, so these samples were 
used as inputs for the GCAP2 immunoprecipitation assay shown in Figure R.9B. 
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Figure R.9.  32Pi metabolic labeling reveals phosphorylation of bEF-GCAP2 to a higher extent than 
bGCAP2 in living retinas. A. In situ phosphorylation assay. Retinas from dark-adapted mice from the 
indicated phenotypes were dissected under dim red light, incubated in bicarbonate buffered Locke’s 
solution containing 1 mCi/mL of 32P-H3PO4 for 90min in a 5% CO2 incubator and exposed to white light for 
5min (L) or maintained in darkness (D).  Retinas were homogenized in Triton X100-solubilization buffer 
and pre-cleared by centrifugation.  Aliquots corresponding to one tenth of a retina were resolved by 15% 
SDS-PAGE and blotted to a nitrocellulose membrane.  Phosphorylated proteins were visualized by 
autoradiography upon 4h of exposure. B.  GCAP2 immunoprecipitation in 32P-labeled samples.  
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Solubilized samples corresponding to two retinas per phenotype and condition were used as inputs for 
GCAP2 immunoprecipitation with an anti-GCAP2 mAb.  Elution fractions were resolved by 15% SDS-
PAGE, blotted to a nitrocellulose membrane and visualized by autoradiography after 4 days of exposure.  
C. Western blot of samples in (B) using a polyclonal antibody anti-GCAP2 show that the amount of 
GCAP2 in the control GCAPs-/- bGCAP2 E line was comparable to that in mutant lines GCAPs-/- b EF-
GCAP2 A and B.  D. Immunostaining of 14-3-3 proteins in the same membrane, by using a pAb to 14-3-
3pan (IBL International, Hamburg, Germany). 
 
GCAP2 was phosphorylated to low levels in the GCAPs-/- bGCAP2 sample in the 
dark, and to a slightly higher extent when the retina was exposed to light.  No 24 kDa 
bands were observed in the GCAPs-/- samples.  Strikingly high levels of bEF-GCAP2 
phosphorylation were observed in GCAPs-/- bEF-GCAP2 samples (lines A and B).  A 
GCAP2 immunoblot of the 32P-labeled membrane confirmed that comparable levels of 
GCAP2 were immunoprecipitated in GCAPs-/- bGCAP2 and GCAPs-/- bEF-GCAP2 
samples (Figure R.9C).  Figure R.9D shows the subsequent immunostaining of the 14-
3-3 pan and epsilon isoforms in the same membrane, further confirming the selective 
binding of 14-3-3 to the phosphorylated mutant form of GCAP2 impaired to bind Ca2+. 
GCAP2 phosphorylation was further characterized by isoelectrofocusing gel analysis 
followed by immunoblotting with a GCAP2 antibody (Figure R.10). Under room light 
conditions wildtype C57BL/6 mice showed two bands of roughly equal intensity 
corresponding to the pI of the unphosphorylated (4.92) and singly phosphorylated 
(4.85) mGCAP2. The intensity of the 4.85 band was greatly diminished when NaFl, a 
broad phosphatase inhibitor, was omitted from the samples, thus confirming the 
identity of this band as phosphorylated GCAP2 (Figure R.10A). We conclude that 
about half of the total GCAP2 protein is phosphorylated in wildtype mice under 
standard room light conditions.  The extent to which endogenous mGCAP2 was 
phosphorylated in wildtype mice under room light conditions was higher than that of 
bGCAP2 in GCAPs-/- bGCAP2  transgenic mice. 
To address whether GCAP2 phosphorylation takes place differentially in dark/light 
conditions, wildtype mice that were adapted to room light for 1h were dark-adapted for 
up to 14h, and GCAP2 phosphorylation was analyzed at 1,2,3,5 and 14h.Figure R.10B 
shows that the ratio of unphosphorylated to phosphorylated GCAP2 did not vary 
substantially during the 14h dark-adaptation period.  If we presume that GCAP2 is 
preferentially phosphorylated during periods of light exposure when in its Ca2+-free 
conformation, results may indicate that a few hours of dark- or light-adaptation are not 
enough to have a noticeable effect on the overall GCAP2 population.  This would not 
be surprising if only newly synthesized GCAP2 was subjected to the 
kinase/phosphatase regulation (see Discussion). 
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Figure R.10. Analysis of GCAP2 phosphorylation by isoelectrofocusing. A. Isoelectrofocusing (IEF) 
gel of light-adapted wildtype mouse retinal homogenates. Mice were light-adapted to room light.  Retinas 
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were obtained, solubilized in a saline buffer with 1% dodecyl maltoside, in the presence or absence of 
50mM NaF (phosphatase inhibitor).  Samples were clarified, loaded onto an electrofocusing gel (pH range 
3-8) and focused for 2h at 23W.  Proteins were transferred to a nitrocellulose membrane and incubated 
with an anti-GCAP2 Ab.  Two prominent bands are observed at 4.92 and 4.85 isoelectric point, that 
correspond to unphosphorylated and monophosphorylated mGCAP2, respectively. B. The overall 
phosphorylation status of GCAP2 does not change significantly during a 12h period of dark-adaptation.  
Mice were light-adapted to room light for 1h, and subjected to dark-adaptation for a period of up to 14h.  
Retinas were analyzed as above. C. Analysis of GCAP2 phosphorylation status in the indicated mouse 
lines.  Transgenic bGCAP2 is phosphorylated to a lesser extent than the endogenous mGCAP2, whereas 
bEF-GCAP2 is phosphorylated to a much higher extent.  Note that the isoelectric point of bGCAP2 differs 
from that of mGCAP2, and that the isoelectric point of bEF-GCAP2 (E80Q,E116Q,D158N GCAP2) is 
shifted versus that of bGCAP2.  Results from the isoelectrofocusing gels confirm that transgenic bEF-
GCAP2 is phosphorylated to a much higher extent than the control transgenic bGCAP2. 
 
Isoelectrofocusing of retinal samples from GCAPs-/- bEF-GCAP2 and GCAPs-/- 
bGCAP2 were performed to assay the steady-state relative levels of non-
phosphorylated and phosphorylated GCAP2 (Figure R.10C).  Whereas endogenous 
GCAP2 in wildtype C57BL/6 mice showed similar proportions of non-phosphorylated 
and phosphorylated GCAP2, the GCAPs-/- bEF-GCAP2 sample showed a larger 
fraction of phosphorylated GCAP2 and the GCAPs-/- bGCAP2 sample showed the 
reverse: a larger fraction of non-phosphorylated GCAP2. These results are consistent 
with the metabolic labeling results, namely, low levels of phosphorylation in the 
GCAPs-/- bGCAP2 control line, and much higher phosphorylation levels in the 
GCAPs-/- bEF-GCAP2 line (Figure R.10C and Figure R.9B). 
We next tested whether GCAP2 and 14-3-3 association could be inferred by analysis 
of solubilized retinal extracts by size-exclusion chromatography, and whether this 
association was stronger in the mutant than in the control line. Sixteen retinas from 
GCAPs-/- bEF-GCAP2 or GCAPs-/- bGCAP2 mice were solubilized in 1% Triton X-100 
buffer, clarified and separated by size exclusion chromatography in a column with a 
separation range of 10,000 to 400,000 kDa.  Results are shown in Figure R.11.  The 
upper panels show that the peak of GCAP2 appears in the same fraction as the peak 
of 14-3-3 in retinal extracts from both the mutant and the control lines, indicating an 
association between both proteins.  This association appears stronger in the mutant 
line, for which the percentage of GCAP2 (from the total) that is present in the same 
fraction as 14-3-3 is higher than in the control line. 
To test whether bEF-GCAP2 might have a higher tendency than bGCAP2 to aggregate 
and compromise its solubility in vivo, the Triton-X100 resistant fraction at the 
clarification step was solubilized in buffer containing 1% SDS and also subjected to gel 
filtration. Figure R.11 lower panels show that GCAP2 is more enriched at higher 
molecular weight fractions in SDS-solubilized samples than in Triton-X100 samples,  
 
                                                                                                                      CHAPTER 1 
 
111 
 
 
Figure R.11.  Size-exclusion chromatography analysis of GCAP2 and 14-3-3 in solubilized retinas 
from bGCAP2 and bEF-GCAP mice.  Sixteen retinas from GCAPs-/- bEF-GCAP2 or GCAPs-/- bGCAP2 
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mice were obtained at p20-25, and solubilized in buffer containing 1% Triton-X100 (10mM Hepes, 135mM 
NaCl, 5mM KCl, 1.5mM MgCl2, 2mM EDTA, 1mM PMSF, 1% Triton X100).  The Triton-X100-soluble 
fraction was kept, and the Triton X100-resistant fraction was solubilized in 1% SDS buffer (10mM Hepes, 
135mM NaCl, 5mM KCl, 1.5mM MgCl2, 2mM EDTA, 1mM PMSF, 1% SDS).  Triton X100-soluble and 
SDS-soluble fractions were separated in a ultrahydrogel 500 column with a molecular weight range of 
10,000-400,000 kDa.  Fractions were collected each 2 min, concentrated with 3,000 MWCO Amicons and 
loaded into a 12% SDS-PAGE.  Proteins were transferred to nitrocellulose membranes and incubated with 
a pAb to GCAP2 (green signal) and a mAb to 14-3-3ε (abcam, Cambridge, UK, red signal) for the two 
upper panels.  For the lower panels, membranes were sequentially incubated with a mAb to GCAP2 
(Affinity Bioreagents, Golden, Colorado, USA) and a mAb to 14-3-3ε (abcam, Cambridge, UK), both 
signals in red.  Image was acquired at the Odyssey Imaging System (LI-COR).  The integrated intensities 
of all bands were obtained using the Odyssey software, and the added values for each lane (in arbitrary 
units) were plotted in the graphs underneath each panel.  An association between GCAP2 and 14-3-3 
epsilon was observed at the GCAP2 peak fraction in Triton X100-soluble fractions. The percentage of total 
GCAP2 that maps at the peak fraction with 14-3-3 was higher in the EF-GCAP2 than in the GCAP2 
sample.  SDS-soluble samples revealed a tendency for GCAP2 to be enriched at higher molecular weight 
fractions, more clearly manifested at the bEF-GCAP2 than at the bGCAP2 sample.   
 
and this enrichment happens to a higher extent in bEF-GCAP2 samples than in control 
samples. 
To address whether 14-3-3 binding to phosphorylated GCAP2 might be the cause of 
its retention at inner segments, we analyzed the localization of the 14-3-3 proteins in 
retinal sections from GCAPs-/- bGCAP2 and GCAPs-/- bEF-GCAP2 samples.  Figure 
R.12 shows that 14-3-3 epsilon localizes to all cell layers of the retina; the ganglion cell 
layer, the inner cell layer and the photoreceptor cell layer of the retina.  In 
photoreceptor cells it appears to distribute to the inner segment, the perinuclear region 
and the synaptic terminal, but it is excluded from the outer segment.  This isoform of 
14-3-3 colocalized with GCAP2 mainly at the inner segment of GCAPs-/- bGCAP2 
samples, but also to the perinuclear region and synaptic terminals in the GCAPs-/- 
bEF-GCAP2 samples.  From these results we infer that the localization pattern of     
14-3-3ε in photoreceptor cells would be consistent with a role of GCAP2 
phosphorylation and 14-3-3 binding at retaining the mutant form of GCAP2 impaired to 
bind Ca2+ at the proximal compartments of the cell. 
 
4.3.5. Phosphorylation at Ser201 is required for the retention of bEF-GCAP2 at 
the proximal compartments of the photoreceptor cell in vivo 
To address whether phosphorylation of GCAP2 is what causes the retention of bEF-
GCAP2 at the inner segment and proximal compartments of the cell, we expressed a 
mutant form of bEF-GCAP2 in which Ser201 was mutated to Gly as a transient 
transgene in rod cells, given that Ser201 is the only residue that was found to be 
phosphorylated in GCAP2 (Peshenko et al. 2004b). 
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The bS201G/EF-GCAP2 cDNA was expressed under the rod opsin promoter by 
subretinal injection and in vivo electroporation of the DNA in neonatal GCAPs-/- mice 
as described (Matsuda and Cepko 2004).  Both bGCAP2 and bEF-GCAP2 cDNAs 
were carried out in parallel in order to compare the localization of the mutants under 
equivalent experimental conditions.  A plasmid expressing the green fluorescent 
protein (GFP) under the Ubiquitin C promoter was coinjected to identify the region 
arround the injection site in which DNA transfection was efficient, and electroporated 
retinas were analyzed at p28. 
 
Figure R.12.  Coimmunolocalization of 14-3-3ε with GCAP2 in retinas from GCAPs-/-GCAP2 E and 
GCAPs-/- EF-GCAP2 B mice.  Cryosections of central retina from the indicated lines at 20 days of age 
were immunostained with an anti-GCAP2 mAb (Affinity Bioreagents, Golden, Colorado, USA) and an anti-
14-3-3ε rabbit monoclonal (abcam, Cambridge, UK), by indirect immunofluorescence staining with the 
Alexa 488 goat anti-rabbit IgG and Alexa 555 goat anti-mouse IgG (Molecular Probes, Eugene, Oregon).  
GCAP2 signal in red, 14-3-3ε signal in green.  GCAP2 and 14-3-3 proteins colocalize at the inner segment 
and proximal compartments of photoreceptor cells.    
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Figure R.13.  Mutation of Ser201 in bEF-GCAP2 precludes protein retention at the inner segment.  
Wildtype bGCAP2, bEF-GCAP2, bS201G/EF-GCAP2 or bG161R/GCAP2 were transiently expressed in 
the rod photoreceptor cells of GCAPs-/- mice by in vivo DNA electroporation of neonates following 
subretinal injection.  A plasmid expressing GFP driven by the Ubiquitin C promoter was coinjected in order 
to identify transfected areas in the eye at postnatal day 28 (p28).  Cryosections were immunostained for 
GCAP2 with a polyclonal GCAP2 Ab and an Alexa Fluor 555 anti-rabbit IgG (signal converted to green); 
and for rhodopsin with monoclonal Ab 1D4 and an Alexa Fluor 647 anti-mouse IgG (red signal).  Transient 
expression of wildtype bGCAP2 by electroporation reproduced the reported localization pattern in the 
stable transgenic line, namely, its almost equal distribution between the inner and outer segments (panels 
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B, C).  bEF-GCAP2 was mostly retained at the inner segments, being excluded from outer segments 
(panels E, F, and profile for cell N.6), which also reproduced the observation from the stable bEF-GCAP2 
transgenic lines. In contrast, b201G/EF-GCAP2  localized to some extent at the inner segment but mostly 
distributed to  rod outer segments, showing a clear colocalization with rhodopsin (panels H, I, and profile 
from cell N.10).  bG161R/GCAP2 showed, on average, a higher retention at inner segments than the 
wildtype protein, but an statistical analysis showed no significative difference with wildtype GCAP2 
distribution.  Panel M shows a histogram of the mean percentage of GCAP2 distribution to ROS for each 
phenotype and the standard error of the mean, as determined by calculating: (the intensity of GCAP2 that 
colocalizes with rhodopsin) / (intensity of GCAP2 that colocalizes with rhodopsin + intensity of GCAP2 at 
the inner segment), see Methods.  (Five cells were analyzed for the WT, twelve cells for bEF-GCAP2, 
thirteen cells for bS201G/GCAP2 and four cells for bG161R/GCAP2).   
 
Figure R.13 shows that the localization of bGCAP2 and bEF-GCAP2 in the transient 
transgenic mice obtained by electroporation reproduced the localization observed in 
stable transgenics: specifically, bEF-GCAP2 was retained at the inner segment and 
proximal compartments of transfected photoreceptors. bEF-GCAP2 was excluded from 
the outer segment, which is demarcated by rhodopsin immunofluorescence (red) 
(Figure R.13 panels E, F and profile from cell N.6, Figure R.14 for additional images 
and profiles).  In contrast, the mutant bS201G/EF-GCAP2 distributed to the proximal 
compartments of the cell but also to rod outer segments.  As shown in panels H -I of 
Figure R.13 and in the profile from cell N. 10, the GCAP2 signal -in green- co-labeled 
with rhodopsin (red) in all transfected cells (thirteen cells analyzed, 57% of GCAP2 
signal co-labeled with rhodopsin on average, see Figure R.14), indicating its 
redistribution to rod outer segments.  On average, 50% of the protein distributed to rod 
outer segments when bGCAP2 was expressed, whereas virtually all bEF-GCAP2 was 
retained at the inner segment and proximal compartments.  Mutating S201 to Gly in 
bEF-GCAP2 reverted this retention, resulting in 57% of the protein distributing to rod 
outer segment (histogram in Figure R.13M).  
These results indicate that phosphorylation at Ser201 in the mutant form of GCAP2 
impaired to bind Ca2+ is what causes its accumulation at the inner segment and 
proximal compartments of the cell, ultimately leading to toxicity. 
 
4.3.6. Toxicity resulting from the retention and accumulation of GCAP2 at the 
inner segment may contribute to the pathology of the human mutation G157R in 
GCAP2 associated to retinitis pigmentosa. 
The G157R mutation in GCAP2 has been reported to cause autosomal dominant RP 
and macular degeneration in Japanese patients (Sato et al. 2005).  To address 
whether this mutation would cause GCAP2 accumulation at the proximal compartments 
in vivo, we expressed the corresponding mutation in bovine GCAP2 (bG161R/GCAP2) 
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in rod cells by transient transgenesis.  Results are shown in Figure R.13 panels K-L 
and M, and Figure R.14. bG161R/GCAP2 was,on average, retained at inner segments 
to a higher extent than the wildtype protein, since the percentage of the protein 
distributing to ROS was less (38.7 + 5.9 %, n=4 of bG161R/GCAP2 localized to ROS 
versus 50.1 + 4.2% of bGCAP2, n=5).  However the difference was subtle, and was 
not statistically significant based on the number of cells analyzed (histogram in Figure 
R.13M). This result was in line with results obtained from the analysis of 
bG161R/GCAP2 susceptibility to in vitro phosphorylation in Ca2+ versus EGTA 
conditions (Figure R.15), that showed phosphorylation levels at the Ca2+ condition that 
 
 
Figure R.14.  Additional images and GCAP2 staining profiles of cells from electroporated mice. 
Photoreceptor cells from electroporated mice with bGCAP2 (1 cell), bEF-GCAP2 (6 cells), bS201G/EF-
GCAP2 (9 cells) and bG161R/GCAP2 (6 cells).  GCAP2 stained in green, rhodopsin in red. 
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Figure R.15.  In vitro phosphorylation of bG161R/GCAP2 in conditions of Ca2+ or EGTA. Upper 
panel shows an autoradiograph of 33P phosphorylation products from an in vitro phosphorylation reaction 
of recombinant wildtype bGCAP2, bEF-GCAP2 or bG161R/GCAP2 with protein kinase G (PKG), in the 
presence or absence of free Ca2+.  The 20μl reaction mixture contained 8.5µg of the corresponding 
purified recombinant protein, purified PKGIα (100 units, Calbiochem) and 3μCi of 33P- γATP in 
phosphorylation reaction buffer, containing either CaCl2 or EGTA (see Methods).  After incubation, 
reaction mixtures were resolved by 15% SDS-PAGE and transferred to a nitrocellulose membrane. Lower 
panel shows immunostained GCAP2.  GCAP2 mutants were present to similar amounts in all reaction 
tubes.   
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were on average intermediate between the levels of wildtype and bEF-GCAP2 
proteins.  This difference was also subtle, so that the standard deviation between 
assays precludes us from concluding whether it might be physiologically relevant. 
 
4.4. DISCUSSION 
4.4.1. The in vivo effect of mutations that preclude Ca2+ binding in GCAP2 is 
different from mutations that impair Ca2+ binding in GCAP1 
We here report that a form of GCAP2 with mutations that impair Ca2+ coordination at 
the three functional EF-loops (bEF-GCAP2) led to retinal degeneration when 
expressed in rods in transgenic mice. In vitro the bEF-GCAP2 mutant shows a similar 
shift in Ca2+ sensitivity of guanylate cyclase regulation as the Y99C, E155G and other 
GCAP1 mutants that directly or indirectly affect Ca2+ coordination (Dizhoor and Hurley. 
1996) (Dizhoor et al. 1998) (Sokal et al. 1998). These GCAP1 mutants have been 
demonstrated to cause retinal degeneration in vivo by leading to persistent activation 
of the cyclase, causing elevated levels of cGMP and Ca2+  (Olshevskaya et al. 2004) 
(Woodruff et al. 2007) (Buch et al. 2011). Intriguingly, we found that the retinal 
degeneration caused by bEF-GCAP2 expression in rods was independent of cGMP 
metabolism. When guanylate cyclase activity was measured in retinal homogenates 
from bEF-GCAP2 transgenic mice, instead of constitutive activation of the cyclase we 
found very diminished cyclase activity independently of the [Ca2+] conditions, which 
contrasts with the normal cyclase activity observed in homogenates of wildtype and 
bGCAP2 control-transgenic mice (Figure R.5).  Furthermore, retinal degeneration in 
bEF-GCAP2 transgenic mice could not be prevented or delayed by raising the mice 
under constant light exposure (Figure R.7).   These results show for the first time that 
mutations that affect the conformation of GCAP2 can cause cell death in vivo by a 
mechanism independent of guanylate cyclase regulation. 
 
4.4.2. Phosphorylation of GCAP2 and 14-3-3 binding as a new in vivo mechanism 
controling GCAP2 subcellular distribution that causes toxicity when overly 
deregulated 
In contrast to the bGCAP2 control-transgenic protein that reproduced the endogenous 
mGCAP2 subcellular localization, bEF-GCAP2 largely accumulated at inner segment 
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and proximal compartments of the rod when it was expressed in the GCAPs-/- 
background (Figure R.6).  At this compartment, bEF-GCAP2 was phosphorylated to a 
much higher extent than the control transgenic protein in in situ phosphorylation 
assays as well as under steady state level in the intact rod as shown by IEF, and it 
was found to bind 14-3-3 proteins (Table R.1, Figures R.8-R.10).   This constitutes the 
first report that GCAP2 is phosphorylated in vivo, at much higher levels when locked in 
its Ca2+-free conformation, and that phosphorylation of GCAP2 triggers 14-3-3 binding.  
We show that 14-3-3 localization in rod photoreceptors is restricted to proximal 
compartments and excluded from the outer segments (Figure R.12).  Furthermore, we 
demonstrate that phosphorylation is required for bEF-GCAP2 retention at proximal 
compartments by showing that replacing Ser201 by Gly in bEF-GCAP2 substantially 
reverts this retention (Figure R.13).  On average 57% of bSer201/EF-GCAP2 localized 
to rod outer segments (Figure R.13 histogram, n=13 cells). We believe that the reason 
that a 100% reversion was not observed is that 14-3-3 shows some affinity for 
unphosphorylated bEF-GCAP2 as well (Figure R.8).  We therefore infer that 14-3-3 
binding to phosphorylated GCAP2 retains the protein at proximal compartments, in 
what clearly represents an important step in the regulation of GCAP2 subcellular 
distribution in vivo (Figure R.13), somewhat analogous to 14-3-3 regulation of 
phosducin availability during dark and light adaptation. 
14-3-3 proteins are a family of phosphobinding proteins of about 30 kDa that 
comprises seven homologs in mammals.  They exist as homo- or hetero-dimers that 
are rigid in structure, with each 14-3-3 dimer binding to two different phospho-binding 
sites either in the same or in two independent target proteins.  By masking an epitope, 
clasping epitopes or promoting the scaffolding of their clients, 14-3-3 proteins exert a 
diverse range of regulatory roles in metabolism, trafficking or integration of cell survival 
versus cell death pathways (Smith et al. 2011).  In the retina, 14-3-3 proteins interact 
with phosducin at rod inner segments, regulating the amount of free phosducin during 
dark- and light-adaptation (Nakano et al. 2001), (Thulin et al. 2001).  Phosducin 
modulates the amount of Tr
αβγ
 heterotrimer through competition with Gt
α
 subunit for 
binding to the Gt
βγ
 complex.  When light exposure activates Gt, releasing Gt
βγ
 from Gt
α
 
at rod outer segments, phosducin association to Gt
βγ
 facilitates Gt
βγ and Pd-Gtβγ 
independent translocation to the inner segment compartment (Sokolov et al. 2004).  At 
the inner segment during dark-adaptation phosducin is simultaneously phosphorylated 
at Ser-54 and Ser-73 residues by PKA and CaMK, which causes a competing 
interaction with the 14-3-3 protein that dramatically reduces phosducin binding to Gt
βγ 
(Lee et al. 2004).  This allows the redistribution of Gt
α
 and Gt
βγ
 to rod outer segments, 
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the former assisted by UNC119 and the latter by PrBP (Zhang et al. 2011), (Zhang et 
al. 2012).  At rod outer segments Tr subunits are discharged to membranes and a 
heterotrimer forms again. 
How 14-3-3 binding to phosphorylated GCAP2 fits with GCAP2 overall role in 
photoreceptor cell physiology and inherited retinal dystrophies is only emerging.  It is 
clear from this work that GCAP2 is phosphorylated preferentially in its Ca2+-free form in 
vivo. Because it is well established that GCAP2 in its Ca2+-free form forms dimers 
(Olshevskaya et al. 1999b), and that 14-3-3 exists as dimers that bind to two 
consensus binding sites in client proteins (Smith et al. 2011), it seems straightforward 
to propose that a dimer of 14-3-3 would bind to a dimer of GCAP2, presumably to 
stabilize it (Figure R.16). Because GCAP1 and GCAP2, unlike recoverin or phosducin, 
were shown not to redistribute between subcellular compartments during dark- or light-
adaptation (Strissel et al. 2005), we deduce that this mechanism would mainly affect 
the cytosolic distribution of newly synthesized protein. 
We propose a model in which the GCAP2 molecules synthesized during the dark 
period (predominantly in the Ca2+-loaded state) would bind to RetGC and be 
transported to rod outer segments, whereas the GCAP2 molecules synthesized in the 
light period (GCAP2 in its Ca2+-free state) would be phosphorylated and retained at 
proximal compartments by 14-3-3 binding (Figure R.16).  Such a scenario would result 
in the phosphorylation and retention to proximal compartments of about 50% of 
GCAP2 molecules in a physiological situation (wildtype mice raised in standard cyclic 
light).  This is what we observe by IEF (Figure R.10) and by immunolocalization 
analysis (Figure R.6).  This model would also explain why 12h of dark-adaptation did 
not have a noticeable effect on the steady-state phosphorylation levels of GCAP2 
(Figure R.10).  
We propose that GCAP2 phosphorylation and 14-3-3 binding constitute a major 
molecular determinant of GCAP2 subcellular localization upon its synthesis.  What is 
its physiological relevance?  A possibility is that 14-3-3 binding to GCAP2, by trapping 
GCAP2 to proximal compartments, might work to secure a reservoir of GCAP2 at 
these compartments, where GCAP2 may be exerting other roles at the synaptic 
terminal (López-del Hoyo et al. 2012), (Venkatesan et al. 2010).  Alternatively, the 14-
3-3 trapping of Ca2+-free GCAP2 upon its phosphorylation might serve as a protein 
quality control mechanism, to avoid that an excess of Ca2+-free, aggregation-prone 
GCAP2 molecules would reach the rod outer segment.  Irrespective of its physiological 
significance, this regulatory enzymatic step is specific of GCAP2, given that GCAP1 is 
not phosphorylated, and might have evolved because it is more relevant for rods than 
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cones. Conditions that substantially alter this regulatory mechanism increasing the 
protein retention at the inner segment would have toxic consequences for the cell.  We 
propose that toxicity in this scenario would arise from GCAP2 natural tendency to 
aggregate (see below). 
 
Figure R.16.  Model depicting a mechanism regulating GCAP2 distribution in rods involving 
GCAP2 phosphorylation and 14-3-3 binding.  Under high Ca2+ conditions typical of the dark-steady 
state, the Ca2+-loaded form of GCAP2 would bind to Ret-GC and be transported to rod outer segments 
(A); whereas under low Ca2+ conditions (e.g. light periods), the Ca2+-free form of GCAP2 would be 
retained by 14-3-3 at proximal compartments (B).  These alternating scenarios would result in 
approximately half of GCAP2 distributing to the inner segment and proximal compartments of the cell, and 
half to the outer segment compartment in a physiological situation (e.g. in wildtype mice raised in standard 
cyclic light).  However, a prolonged light exposure or genetic conditions that  would result in an abnormal 
accumulation of GCAP2 in its Ca2+-free form (e.g. mutations in GCAP2 that impair Ca2+ binding, or 
mutations in components of the phototransduction cascade causing unabated signaling and a prolonged 
reduction in [Ca2+]i) would lead to neurodegeneration likely by inducing GCAP2 aggregation, or by 
GCAP2-mediated toxicity some other way (C).  
 
4.4.3. Physiological implications of GCAP2 phosphorylation and 14-3-3 binding 
for inherited retinal dystrophies 
GCAP2 phosphorylation and 14-3-3 binding are observed to a more moderate extent 
in the bGCAP2 control transgenic line (IEF gel in Figure R.10) than in wildtype mice, 
presumably because bovine GCAP2 is not such a good substrate for the murine 
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kinase as the endogenous murine GCAP2. In wildtype mice phosphorylated GCAP2 at 
steady state constitutes about 50% of the total protein, consistent with about 50% of 
the protein retention at rod proximal compartments. This indicates that GCAP2 
phosphorylation and 14-3-3 binding are not in itself toxic for the cell.  It is therefore the 
deregulation of this mechanism– when all GCAP2 molecules are impaired to 
coordinate Ca2+ and GCAP2 phosphorylation and 14-3-3 binding are happening to a 
much larger extent- that correlates with severe retinal degeneration in the bEF-GCAP2 
line.  
How does the accumulation of GCAP2-14-3-3 complexes at the rod inner segment 
lead to cell death? We hypothesize that accumulation of these complexes might result 
in pathology due to the formation of misfolded GCAP2 oligomers, in much a similar 
way to which synuclein, APP, Tau, Huntingtin or ataxin lead to neuronal cell death in 
Parkinson’s (PD), Alzheimer (AD), Huntington’s (HD) or spinocerebellar ataxia (SCA) 
diseases. GCAP2 shows a natural tendency to aggregate.  Structural studies have 
shown that the Ca2+-free form of GCAP proteins, and particularly of GCAP2, are 
difficult to maintain in solution and are prone to aggregation (Ames et al. 1999).  When 
expressed in bacteria, recombinant GCAP2 accumulates in inclusion bodies, is only 
solubilized at high concentrations of guanidinium or urea, and is difficult to maintain in 
solution after refolding (Dizhoor et al. 1995).  Dimers and high molecular weight 
aggregates can typically be distinguished by SDS-PAGE, more prominently for EF-
GCAP2 than for the wildtype form of the protein (e.g. this study, Figure R.8B).  On the 
other hand, previous studies have found a close association between 14-3-3 and 
progressive neurodegenerative diseases. 14-3-3 proteins have been shown to 
colocalize with AD neurofibrillary tangles that are composed primarily of 
hyperphosphorylated tau proteins (Layfield et al. 1996), (Lee et al. 2001).  In PD, 14-3-
3 is detectable in Lewy bodies which accumulate α-synuclein (Kawamoto et al. 2002); 
and 14-3-3 colocalization was also reported for mutant ataxin in SCA (Chen et al. 
2003).  Furthermore, 14-3-3 zeta and epsilon binding to phosphorylated ataxin-1 at 
S776 was shown to aggravate neurodegeneration by stabilizing mutant ataxin, 
retarding its degradation and enhancing its aggregation in transfected cells and 
transgenic flies (Chen et al. 2003).  The requirement of 14-3-3 zeta for Htt86Q 
aggregate formation has also been established in cells (Omi et al. 2008).  
We propose that the mutant form of GCAP2 locked in its Ca2+-free conformation 
results in toxicity in vivo by the progressive formation of soluble high molecular weight 
oligomers of GCAP2-14-3-3 that are toxic for the cell.  Consistent with this, we observe 
a much higher fraction of bEF-GCAP2 than of control bGCAP2 associated to 14-3-3 in 
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the fractionation of mouse retinal extracts by size exclusion chromatography (Figure 
R.11).  Fractions showing GCAP2 and 14-3-3 association show also GCAP2 higher 
molecular species including dimers.  The compromised solubility of accumulating bEF-
GCAP2-14-3-3 complexes is manifested in the fraction of bEF-GCAP2 associated to 
14-3-3 found in the Triton-X100 resistant, SDS-soluble fraction (Figure R.11).  
Inclusion bodies were not detected in our immunofluorescence assays with the 
polyclonal or monoclonal anti-GCAP2 antibodies used, or the anti-14-3-3ε monoclonal 
antibody.  It may happen that these antibodies do not recognize inclusion bodies or 
that their absence would result from a relatively efficient clearance of the mutant 
protein and therefore slow formation of putative deposits.  In this sense we have 
observed that inhibition of the proteasome results in an increase of EF-GCAP2 levels 
(López-del Hoyo and Méndez, unpublished observation).   
We investigated whether phosphorylation at Ser201 and 14-3-3 binding may underlie 
the toxicity of G161R-GCAP2, the bovine equivalent to the human G157R-GCAP2 
mutation linked to adRP (Figure R.13).  We found that, while G161R-GCAP2 showed 
on average a higher susceptibility to in vitro phosphorylation in the presence of free 
Ca2+ than the wildtype protein (Figure R.15) and a higher retention at the inner 
segment (Figure R.13), these changes were subtle. The nature of these assays 
precluded us from undertaking the number of assays that would be required to achieve 
statistical significance, and we foresee the requirement of a stable transgenic line to 
determine to what extent the mechanism here described contributes to retinal 
dystrophies associated to the human G157R-GCAP2 mutation. 
This mechanism of toxicity caused by GCAP2 misfolding may contribute to the 
pathology of genetic mutations causing “equivalent-light” damage that result in a 
sustained reduction in the level of intracellular Ca2+: mutations impairing termination of 
the light response or mutations in the visual cycle or the visual pigment resulting in 
opsin basal constitutive activity (e.g. null mutations in RPE65 or G90D opsin (Dizhoor 
et al. 2008) (Singhal et al. 2013), (Woodruff et al. 2003).  Furthermore, this mechanism 
of toxicity is likely to contribute to cell death and retinal degeneration in those cases of 
Lebers Congenital Amaurosis (LCA) in which two conditions converge: GCAPs 
accumulation at the inner segment and a sustained reduction in the level of 
intracellular Ca2+. Those conditions are met, for instance, in LCA1 caused by null 
mutations in RetGC-E (GUCY1E) or LCA12 caused by mutations in RD3, two severe 
and prevalent inherited retinal dystrophies. 
In conclusion, we propose that GCAP2 may be a mediator of “equivalent-light” genetic 
damage, by its natural tendency to aggregate when in its Ca2+-free form, in a process 
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regulated by phosphorylation and 14-3-3 binding.  Future studies will be addressed at 
further characterizing the stoichiometry, solubility and turn-over of GCAP2-14-3-3 
complexes, as well as their effects on the normal functions of the cell. 
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RESUMEN EN ESPAÑOL 
 
Realizamos un minucioso estudio de la ultraestrutura de las terminales sinápticas de 
bastones en modelos de ratón de pérdida de función de GCAP1 y GCAP2 
(GCAP1/GCAP2 doble “knockout”), y modelos de ratón de ganancia de función de  
GCAP2, por la sobreexpresión de este transgén. 
Las cintillas sinápticas de los ratones GCAPs-/- no difieren de las del fenotipo salvaje, 
cuando los ratones son crecidos en oscuridad constante. Esto indicaría que las 
proteínas GCAPs no son requeridas para el ensamblaje y maduración inicial de las 
cintillas. Por lo que vemos a continuación, es el mantenimiento de los niveles entre 
ambas isoformas, GCAP1 y GCAP2, lo que es relevante para la preservación de la 
integridad de la terminal sináptica. 
En cambio, la sobreexpresión de GCAP2 en el fenotipo salvaje (GCAP2 +/+) en 
bastones lleva a un acortamiento de las cintillas sinápticas y a un aumento de los 
intermediarios de ensamblaje de éstas, como son las cintillas esféricas y las que 
adoptan la forma de “palo de golf”.  Sin embargo, cuando la sobreexpresión de GCAP2 
es en el fenotipo knockout para GCAPs (GCAP-/- GCAP2+), porque se restaura la 
expresión de GCAP2, esto es, la expresión de GCAP2 en ausencia de GCAP1 
endógeno, esta sobreexpresión tiene el sorprendente efecto de acortar la longitud de 
las cintillas mucho más que la sobreexpresión de GCAP2 en el fenotipo salvaje, así 
como también acentúa la reducción del grosor de la capa plexiforme externa (OPL) sin 
verse afectado el numero de fotorreceptores bastón. Además, esta sobreexpresión en 
ausencia de GCAP1 exacerba el desensamblaje de las cintillas sinápticas. Por otra 
parte, comprobamos por IHC que GCAP1 y RIBEYE colocalizan parcialmente. 
Creemos pues, que ambas proteínas, y más específicamente, sus niveles relativos 
contribuyen a los cambios morfológicos dependientes de luz que tienen lugar en las 
cintillas sinápticas. Estos cambios pueden deberse a un efecto indirecto de la 
desregulación de niveles de cGMP en el segmento externo, o a un efecto directo de 
las GCAPs sobre las cintillas.  
Cuando realizamos la immunolocalización con oro coloidal a nivel de microscopia 
electrónica, observamos que GCAP2 y RIBEYE estarían colocalizando formando lo 
que parecen focos de desensamblaje. Con esta técnica, confirmamos la presencia de 
GCAP2 en las cintillas sinápticas, avalando un papel directo para las GCAPs como 
mediadoras del efecto de la luz en los cambios morfológicos que tienen lugar en estas 
estructuras. 
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Además, también poseemos estudios funcionales del efecto de variar los niveles de 
GCAP1:GCAP2 en la terminal sináptica, mediante registros de ERG para las distintas 
líneas de ratón. Al comparar la respuesta de ratones GCAPs-/- GCAP2+, cuyas 
cintillas son las más reducidas, que han sido crecidos en oscuridad, con ratones de la 
misma línea que se han crecido 12 horas oscuridad: 12 horas luz. En el caso de los 
primeros, los cambios en la cintilla podrían ser un efecto secundario debido a los 
niveles alterados de cGMP que se acumulan en el segmento externo, por la 
descompensación de GCAP1:GCAP2, y que en última instancia, provoca una 
variación en los niveles de Ca2+ en la sinapsis. En el caso de los segundos, el ERG 
muestra que la respuesta en los bastones es como la de los ratones salvajes, por lo 
que los cambios en el tamaño de las cintillas no se explica por el efecto secundario de 
los anteriores. Pero mostraría que las cintillas pueden verse sometidas a cambios 
agudos en sus dimensiones ( de ~ 40% ) sin verse afectada su funcionalidad. Como ya 
postuló Venkatesan en “Nicotinamide adenine dinucleotide-dependent binding of the 
neuronal Ca2+ sensor protein GCAP2 to photoreceptor synaptic ribbons” (Venkatesan 
et al. 2010), cambios en los niveles de Ca2+ serían los desencadenantes de que 
GCAPs promuevan cambios en las cintillas sinápticas. 
Finalmente, nuestra demostración de la immunolocalización de GCAP2 en las cintillas 
sinápticas a nivel ultrastructural avalaría un papel in situ para las GCAPs como 
mediadoras del efecto de la luz en los cambios morfológicos que tienen lugar en estas 
cintas sinápticas.  
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5.1. CONTRIBUCIONES 
Las líneas transgénicas descritas en este trabajo fueron generadas originalmente por 
A. Méndez en el laboratorio de la Dra. Jeannie Chen en la University of Southern 
California, Los Angeles, y trasladadas a Barcelona para su caracterización.  Los 
ensayos de coinmunolocalizacion de GCAP2 y RIBEYE a nivel de microscopia 
confocal y microscopia electrónica fueron realizados por Lucrezia Fazioli y A. Mendez, 
con la inestimable ayuda técnica de Almudena Garcia y Nuria Cortadellas, en la 
plataforma cientificotécnica de microscopia electronica del Hospital Clinic, CCiT-UB, y 
del Dr. Benjamín Torrejon en CCiT-UB Bellvitge.  Las figuras de análisis de la 
conectividad sináptica de los distintos tipos neuronales con marcadores especificos 
por IHC fueron realizadas por Lucrezia Fazioli en colaboración con Laura Fernandez-
Sanchez del laboratorio del Dr. Nicolas Cuenca en la Universidad de Alicante.  Los 
ensayos de ERG fueron realizados en el laboratorio del Dr. Pedro de la Villa en la 
Universidad de Alicante, con la valiosa ayuda técnica de Laura Ramírez. 
La contribución experimental de N. López del Hoyo a este capítulo ha sido⁞ 1) el 
mantenimiento y genotipaje de rutina de las cepas de ratón descritas, 2) la preparación 
de colecciones de ojos en bloques de resina Epoxi o Spur para el análisis 
ultraestructural, 3) la observación y captacion de imágenes al microscopio electrónico 
de cientos de terminales sinápticas por fenotipo 4) las mediciones de las cintillas 
sinápticas en las imágenes captadas, y el análisis estadístico. 
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5.2. BRIEF INTRODUCTION 
A fundamental ability of photoreceptor cells in the retina is to sense light stimuli over a 
broad dynamic range of ambient light intensities in the natural world, by reliably 
transmiting fine gradations in membrane potential that set the rate of neurotransmitter 
release to bipolar and horizontal cells  (Parsons et al. 2003) (Thoreson 2007) (Werblin 
2011). 
To accomplish this, they rely on specialized synapses that support the continuous 
neurotransmitter release at high rates: synaptic ribbons (von Gersdorff 2001) (Prescott 
and Zenisek. 2005).  It is known that intracellular Ca2+ levels cause illumination-
dependent remodeling of ribbons.  A recent study has proposed Guanylate Cyclase 
Activating Protein 2 (GCAP2) as a prime candidate for mediating the Ca2+-dependent 
structural changes of ribbons, based on the following observations: 1) GCAP2 interacts 
with RIBEYE, the main protein component of synaptic ribbons; 2) GCAP2 colocalizes 
with RIBEYE at ribbon synapses; and 3) GCAP2 overexpression in photoreceptor cells 
achieved by viral infection of retinal explants led to the disassembly of the synaptic 
ribbon in a high percentage of synaptic terminals (Venkatesan et al. 2010). 
In order to gain insight into the roles that GCAP1 and GCAP2 may play at the synaptic 
terminal, and whether they might mediate the light-triggered morphological changes of 
photoreceptor ribbons, we performed a detailed morphological analysis of the outer 
plexiform layer (OPL) and rod synaptic terminals in retinas from mouse models of gain-
of-function of GCAP2 and loss-of-function of GCAP1 and GCAP2. 
                                                                                                                      CHAPTER 2 
 
131 
 
5.3. RESULTS 
5.3.1. Mouse Models of Gain-of-function and Loss-of-function of GCAP2 Show 
Morphological Alterations at the Outer Plexiform Layer 
The mouse lines used in this study are summarized in Figure R.17 and Table R.3. To 
study the effect of GCAP2 overexpression on the morphology and function of rod 
synaptic terminals in vivo, we used a previously characterized transgenic line that 
expresses GCAP2 in rods under the mouse opsin promoter (Figure R.17A). This line 
expresses heterologous GCAP2 (bovine GCAP2, bigger than the murine isoform in 
three amino acids) at 1.5-fold the endogenous GCAP2 levels (Figure R.17B), and is 
referred to as GCAP2+ in Table R.3. By breeding this original transgenic line to 
transgene homozygosis we obtained a line in which transgenic GCAP2 was expressed 
to 3-fold the endogenous level of GCAP2 (GCAP2+/+, Figure R.17D, Table R.3). 
These mice showed virtually normal retinas for up to six months of age when raised in 
standard cyclic light conditions. No noticeable signs of retinal degeneration were 
observed by light microscopy in mice raised in constant darkness at postnatal day 40 
(Figure R.17C). 
As a mouse model of loss-of-function we used the double knock-out in GCAP1 and 
GCAP2, referred to as GCAPs−/− (Mendez et al. 2001). These mice were originally 
obtained by homologous recombination in embryonic stem cells with a single 
replacement vector, because the GUCA1A and GUCA1B genes encoding GCAP1 and 
GCAP2 are contiguous in the genome. Mice deficient in GCAP1 and GCAP2 lack the 
rapid and robust Ca2+ feedback signal to cGMP synthesis set in place by light, and 
show slower light response kinetics, enhanced sensitivity to light and impaired light 
adaptation. Despite this marked functional phenotype, retinas from GCAPs−/− mice 
show normal appearance for up to 5 months of age when mice are raised in standard 
cyclic light (Mendez et al. 2001) (Figure R.17E). A transgenic line that expresses 
GCAP2 in the absence of GCAP1 was obtained by breeding the GCAP2+ line to the 
GCAPs−/− line. GCAP2 expression in this line restores the endogenous GCAP2 
localization and function (Mendez et al. 2001). Retinas from these mice show a normal 
outer nuclear layer thickness for at least 5 months of age (Figure R.17E). 
To study whether the loss of expression of both GCAP1 and GCAP2 in the GCAPs−/− 
mice or the selective restoration of GCAP2 expression in this line has an effect on the 
synaptic terminals of rods and cones, the OPL in retinal sections from p40 mice was 
immunolabeled with an antibody anti-RIBEYE, the major protein component of synaptic 
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Figure R.17. Mouse models of overexpression of GCAP2 and loss-of-function of GCAP1 and 
GCAP2 used in the study A. GCAP2 transgene construct. MOP, 4.4 kb-version of the mouse opsin 
promoter; bGCAP2, cDNA of bovine GUCA1B gene encoding guanylate cyclase activator protein 2 
(GCAP2); MP1pA, polyadenylation signal of mouse protamine gene 1. B. Western blot of total retinal 
homogenates illustrating GCAP2 level of expression in the GCAP2+ line. Equivalent fractions of a retina 
(1/10) of WT and GCAP2+ mice were resolved in a 12% SDS-PAGE, transferred to a nitrocellulose 
membrane and incubated with a polyclonal Ab anti-GCAP2. The bovine (transgenic) and murine 
(endogenous) isoforms of GCAP2 can be resolved on the basis of their 3-aa difference in size. In the 
GCAP2+ transgenic line bGCAP2 is expressed to 1.5-fold the endogenous GCAP2 expression (Mendez et 
al. 2001). C. Light micrographs of vertical sections of the retina of dark-reared WT, GCAP2+ and 
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GCAP2+/+ (transgenic line bred to homozygosity, that expresses transgenic GCAP2 to 3-fold the 
endogenous GCAP2 level) at postnatal day 40. Mice overexpressing GCAP2 show at this age a normal 
retinal morphology. D. Expression of bGCAP2 transgene in the GCAP1/GCAP2 double knockout 
background (GCAPs−/− background). Western blot shows expression of transgenic bGCAP2 in the 
absence of endogenous GCAP2 in the GCAPs−/−GCAP2+ mice. E. Light micrographs of vertical sections 
of the retina from GCAPs−/− and GCAPs−/−GCAP2+ at 1, 3 or 5 months of age, when reared in standard 
cyclic light. Mice lacking GCAP1 and GCAP2 retain the normal thickness of outer nuclear layer, that is, the 
normal number of photoreceptor cells for up to 8 months of age. Mice in which GCAP2 expression is 
restored in the GCAPs−/− background do not show obvious signs of retinal degeneration at the light 
microscopy level. 
 
ribbons. Sections were co-stained with an antibody anti-GCAP2. Measurements of 
OPL thickness were taken at the confocal microscope at four points along the retinal 
vertical meridian (A, B, C and D shown in Figure R.18B inset, see Methods). The 
retinas analyzed in this study were obtained from mice raised in complete darkness to 
avoid secondary changes at the synaptic terminal that could derive from differences in 
the gain of the light response at the rod outer segment among different mouse models. 
The absence of both GCAP1 and GCAP2 in the GCAPs−/− mice had a minor effect on 
OPL thickness, which was significant only in the upper retina. However, expression of 
GCAP2 in the absence of GCAP1 caused a 40% reduction in OPL thickness along the 
entire length of the retina, indicating that the size or the number of synaptic terminals 
was reduced (Figure R.18A). 
 
Mouse strain GCAP1 expression * GCAP2 expression * 
WT (C57Bl) 1 -fold 1 –fold 
GCAPs-/- 0 0 
GCAPs-/-GCAP2+ 0 1.5 –fold 
GCAP2+ 1 -fold 1.5 + 1 = 2.5 –fold 
GCAP2+/+ 1 -fold 3 + 1 =  4 –fold 
* expressed respect to the endogenous protein level (1 -fold) 
 
Table R.3. Transgene expression levels in the different mouse lines. 
 
This reduction of OPL thickness was not preceded by photoreceptor cell death. GCAP2 
expression in the absence of GCAP1 did not cause noticeable morphological changes 
at the outer segment, inner segment or outer nuclear layers of the retina (Figure 
R.18A). GCAPs−/−GCAP2+ mice showed an outer nuclear layer undistinguishable in 
thickness from that of GCAPs−/− littermate control mice along the entire length of the 
retina (Figure R.18C), indicating that the thinning of the OPL was not a secondary 
consequence of ongoing photoreceptor cell death. 
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Figure R.18. Mice that express GCAP2 in the GCAPs−/− background show a reduction of outer 
plexiform layer (OPL) thickness compared to wildtype mice. A. Immunolabeling of vertical retinal 
sections from WT, GCAPs−/− and GCAPs−/−GCAP2+ mice with rabbit polyclonal antibodies anti-GCAP2 
and a monoclonal antibody against RIBEYE(B)/CtBP2. GCAP2 antibodies give a strong immunolabeling 
signal at the outer segment (os), inner segment (is) and outer plexiform layer (opl) of the retina. This signal 
is absent in GCAPs−/− mice, and is restored in GCAPs−/−GCAP2+ mice, in which the GCAP2 transgenic 
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protein reproduces the endogenous GCAP2 intracellular localization. GCAP2 partially colocalizes with 
RIBEYE at ribbon synapses, as pointed by white arrows in WT magnified OPL panel, as previously 
reported (Venkatesan, Natarajan et al. 2010). This figure shows that the expression of GCAP2 in the 
GCAPs−/− background, that is, GCAP2 expression in the absence of GCAP1, leads to a substantial 
shortening of the OPL: compare immunolabeling intensity and thickness of the OPL in WT and 
GCAPs−/−GCAP2+ panels. B. Statistical analysis of the outer plexiform layer thickness in the WT, 
GCAPs−/− and GCAPs−/−GCAP2+ phenotypes. Measurements of OPL thickness were taken at four 
different regions along vertical sections of the central retina (A, B, C and D in inset) for each phenotype. 
WT, GCAPs−/− and GCAPs−/−GCAP2+ mice were raised in constant darkness and processed at p40. 
OPL thickness was determined at each position based on measurements of the anti-GCAP2 Ab 
immunolabeled region (left histogram) or anti-RIBEYE mAb immunolabeled region (right histogram) at the 
laser scanning confocal microscope. In GCAPs−/−GCAP2+ mice the OPL thickness is reduced to 60–65% 
of the wildtype OPL. Values in histograms are the mean ± standard deviation from measurements taken 
from four mice per phenotype. * denotes P<0.01; ** denotes P<0.001 in the Student’s t-test. C. Mice that 
express GCAP2 in the absence of GCAP1 (GCAPs−/−GCAP2+) retain the normal quantity of 
photoreceptor cells at p40 when raised in constant darkness. The retinal morphometry analysis shows that 
outer nuclear layer thickness (in µm) at 200 µm intervals covering the whole length of the vertical central 
retina (left diagram) is undistinguishable in GCAPs−/− and GCAPs−/−GCAP2+ mice at p40 (overlapping 
graphs). Mean values ± standard error were obtained from at least three littermate mice per phenotype. 
 
To study whether the magnitude of the reduction of the OPL thickness in the 
GCAPs−/−GCAP2+ mice depends on whether the mice are raised in constant 
darkness (with constant intracellular Ca2+ levels at rod outer segments and tonic 
neurotransmitter release at the synapse) or exposed to regular 12 h:12 h dark:light 
cycles (with photoreceptor intracellular Ca2+ levels varying daily between its dark and 
daylight values), the OPL from 40 day-old mice raised either in constant darkness or in 
standard 12 h:12 h dark:light cycles was stained with an anti-Bassoon antibody (Figure 
R.19) and measurements of OPL thickness were taken at four points in the retina 
vertical meridian. GCAPs−/−GCAP2+ mice raised in cyclic light also presented an 
statistically significant reduction in OPL thickness when compared to wildtype controls, 
although slightly lower in magnitude than when mice were raised in constant darkness 
(20–30% reduction of OPL thickness depending on the retinal region, versus the 40% 
uniform reduction in dark reared-mice, data not shown). Immunolabeling of cone 
pedicules with an antibody for the Transducin Gγ c subunit did not reveal noticeable 
alterations in the synaptic terminals of cones or the density of their synaptic ribbons 
among the different mouse phenotypes (Figure R.19). 
To determine whether the connections between photoreceptor cells and horizontal and 
bipolar cells were affected, horizontal and bipolar cells were immunolabeled with 
antibodies for Calbindin and PKCα, respectively (Figure R.20). Photoreceptor synaptic 
terminals were highlighted with an antibody for Synaptophysin, SYP. There was a 
reduction in the density and size of horizontal cell processes, both in GCAPs−/− and in 
GCAPs−/−GCAP2+ mice. Remodeling changes were also apparent in the dendrites of 
bipolar cells, which were more dramatic in GCAPs−/−GCAP2+ mice that were raised in 
constant darkness than in mice raised in cyclic light, with shorter bipolar dendrites and 
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loss of dendritic tip terminals. Immunostaining of retinal sections with Bassoon also 
showed a reduction in the density and size of synaptic ribbons in the OPL of 
GCAPs−/−GCAP2+ mice respect to wildtype mice, while no variation in OPL thickness 
is observed in GCAPs−/− mice versus wildtype mice. 
 
 
Figure R.19. Outer plexiform layer reduction in GCAPs−/−GCAP2+ mice takes place regardless of 
whether the mice are raised in constant darkness or in 12h dark : 12h light cyclic light. 
Immunolabeling of synaptic active zones (arciform densities) with a monoclonal antibody anti-Bassoon (in 
red), and cone pedicules with a polyclonal antibody anti-transducin γ (in green) in WT, GCAPs−/− and 
GCAPs−/−GCAP2+ retinas. Mice were either raised in darkness (two upper rows) or were raised in 
standard 12 h dark : 12 h cyclic light (two lower rows) and processed at p40. OPL thickness in 
GCAPs−/−GCAP2+ mice was reduced to about 65% of wildtype thickness independently of the light-
rearing conditions [compare OPL thickness in WT and GCAPs−/− GCAP2+ panels, arrows]. 
 
Together these results show that mice that express GCAP2 in the absence of GCAP1 
have a severe reduction in the thickness of the OPL, with a decrease in the density of 
synaptic ribbons. GCAP2 expression effect on retinal morphology is specific to the 
outer plexiform layer, and is not accompanied by photoreceptor cell loss by postnatal 
day 40. These OPL alterations are more dramatic when mice are raised in constant 
darkness than when they are raised under cyclic light conditions, and are accompanied 
by remodeling changes that reduce the density of connecting horizontal and bipolar cell 
processes. 
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Figure R.20. Reduction in the density of horizontal and bipolar cell dendritic processes in mice that 
express GCAP2 in the GCAPs−/− background. A. Immunolabeling of horizontal cells by indirect 
immunofluorescence with anti-Calbindin polyclonal antibodies [green signal] and rod and cone synaptic 
terminals with a monoclonal antibody anti-Synaptophysin [SYP, red signal] in WT, GCAPs−/− and 
GCAPs−/−GCAP2+ mice raised in constant darkness. Note the reduction in density and complexity of 
horizontal cell processes in GCAPs−/− and GCAPs−/−GCAP2+ retinas compared to WT samples. B. 
Immunolabeling of bipolar cells with a polyclonal antibody against PKCα [blue signal] and detection of 
arciform densities in rod and cone synaptic terminals with a monoclonal antibody anti-Bassoon [red signal]. 
Note the remodeling of bipolar cell dendrites that is taking place at p40 in GCAPs−/−GCAP2+ samples 
associated to a reduction in the number and dimensions of synaptic ribbons and arciform density 
structures at rod and cone synaptic terminals. 
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5.3.2. Overexpression of GCAP2 in Rod Photoreceptors Leads to Shorter 
Synaptic Ribbons and Increases the Abundance of Ribbon Assembly 
Intermediates 
To study whether GCAP2 overexpression in rods leads to the shortening of synaptic 
ribbons at the ultrastructural level, the OPL region of retinal ultrathin sections from 
transgenic mice expressing GCAP2 to 2.5 or 4-fold the endogenous GCAP2 levels 
(GCAP2+ or GCAP2+/+ transgenic mice respectively, see Table R.3) was examined by 
transmission electron microscopy. The lengths of transversal rod synaptic ribbons 
contained in two to eight 16×16-µm frames of OPL per specimen from at least two 
specimens per phenotype were determined and averaged, and compared to those of 
C57Bl control mice (Figure R.21 and Table R.4, see Methods). Mice were reared in 
complete darkness and sacrificed at p40 under dark-adapted conditions or following a 
1–5 h period of light exposure. 
C57Bl mice that were raised in constant darkness to postnatal day 40 and were 
processed in darkness presented ribbons that measured on average 0,2915±0,0066 
µm (n = 103 synaptic ribbons from 5 mice), whereas littermate mice that were 
processed after 1–5 h of light exposure showed ribbons that measured on average 
0,2534±0,0082 (n = 98 synaptic ribbons from 5 mice), Table R.4. This represents a 
13% reduction of ribbon length in C57Bl mice following a 1–5 h period of light exposure 
that was statistically significant (Figure R.21A and R.21C) 
Transgenic expression of GCAP2 led to a shortening of synaptic ribbons that correlated 
with transgene dosage, independently of whether the mice were sacrificed in the dark 
or following light exposure. GCAP2+ mice presented a 9,6% reduction whereas 
GCAP2+/+ mice presented a 13,7% reduction in ribbon length versus the C57Bl control 
when processed under dark-adapted conditions (representative ribbons shown in 
Figure R.21A, statistical analysis shown by black bars in Figure R.21C, see Table R.4). 
Under light-adapted conditions the reduction was of 4% for GCAP2+ and of 17% for 
GCAP2+/+ when compared to the C57Bl light value (Figure R.21A, grey bars in Figure 
R.21C). 
Because illumination-dependent changes of photoreceptor ribbon structure were 
shown to differ between mouse strains (Fuchs et al. 2013) it was important to discard 
that minor variations in the genetic background between GCAP2-transgenic and C57Bl 
mice may account for the phenotype observed, given that the analysis of GCAP2 gene 
dosage effect on ribbon length could not be performed on littermate mice. Although the 
GCAP2- expressing transgenic mice  used in  this study were back-crossed to  C57Bl/6  
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Figure R.21. Overexpression of GCAP2 in transgenic mice leads to shortening of ribbon length and 
to an increase in the fraction of club-shaped and spherical morphologies representing 
disassembling ribbons. A. Electron micrographs of rod synaptic terminals of dark-reared C57Bl, 
GCAP2+ or GCAP2+/+ mice at p40 that were processed in darkness or immediately after 1–5 h of light 
exposure, showing transversal sections of synaptic ribbons. Notice the difference in length in C57Bl [left], 
GCAP2+ [middle] and GCAP2+/+ [right panel] ribbons. In addition to synaptic vesicles, vesicle-like 
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particles that are smaller in diameter than synaptic vesicles were seen forming clusters in the cytosol 
[GCAP2+/+ panel]. These clusters found in the vicinity of the ribbons were more extensive in GCAP2+/+ 
samples than in C57Bl samples. B. Club-shaped ribbons were more abundant in GCAP2+ and GCAP2+/+ 
than in C57Bl samples. Two examples of the density of club-shaped and spherical-ribbons are shown in 
8,000× visual fields of GCAP2+ and GCAP2+/+ retinal sections. Club-shaped and spherical ribbons 
pointed by arrows are shown at higher magnification in the right panels. C. Statistical analysis of ribbon 
length in C57Bl, GCAP2+ and GCAP2+/+ mice that were either raised in constant darkness (D); or raised 
in constant darkness and subsequently exposed to 1–5 h light (L). A minimum of forty synaptic ribbons 
were measured from at least two mice per phenotype. Plotted in the histogram are mean values ± 
standard error. *** denotes P<0.0001 in Student’s t-test. ** denotes P≤0,001 in Student’s t-test. *denotes 
PP≤0,01 in Student’s t-test. D. Statistical analysis of ribbon length in GCAP2+ and WT littermate control 
mice raised in standard cyclic light and processed at p60. GCAP2-expressing mice showed a 10% 
reduction in ribbon length compared to WT littermate controls. Notice the difference in the Y-axis scale. *** 
denotes P≤0,0001 in Student’s t-test. E. Histogram comparing the percentage of club-shaped and 
spherical ribbons [of total synaptic ribbons] in C57Bl, GCAP2+ and GCAP2+/+ at p40 processed in 
darkness [D] or immediately after 1 h or 5 h of light exposure. 
 
for at least four generations, they were originally obtained in a C57Bl × DBA mixed 
genetic background (Mendez et al. 2001) 
To discard the contribution of genetic background effects, synaptic ribbon length was 
compared in GCAP2+ versus transgene-negative control mice (herein called WT) in 
the same litter, raised in the same cage under standard cyclic light and analyzed at 
p60. GCAP2 transgene expression led to a 10% reduction in ribbon length compared to 
WT mice [0,2621±0,0059 µm in transgene-positive mice, n = 131 from four mice; 
versus 0,2902±0,0067 μm in WT mice, n = 135 from three mice; Student’s t = 3,114, 
264d.f., P = 0,002] (Figure R.21D). 
Taken together these results indicate that the overexpression of GCAP2 promotes the 
loss of ribbon material, both in dark-adapted and light-adapted retinas. 
It has been reported that as synaptic ribbons loose material in the light adaptation 
process, different morphologies are observed at the ultrastructural level, such as club-
shaped ribbons (csr) or ribbons with a spherical form (sr) in tangential sections. This is 
probably due to the fact that the ribbons, laminar in nature, assemble and disassemble 
material in preformed spherical blocks at focal points (Vollrath et al. 1996) (Vollrath et 
al. 2001) (Spiwoks-Becker et al.2004). 
To study whether the overexpression of GCAP2 led to a higher abundance of these 
“assembly intermediate” morphologies, the percentage of club-shaped and spherical 
ribbons was determined in GCAP2+ and GCAP2+/+ versus C57Bl mice (Histogram in 
Figure R.21E, Table R.4). While C57Bl mice that were raised in darkness showed less 
than 1% of club-shaped/spherical ribbons, GCAP2+ and GCAP2+/+ mice raised in 
darkness showed a 4.8% and 3.6% of these structures respectively, which represents 
at least a four-fold increase in their relative abundance (Table R.4).   In C57Bl mice that 
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Phenotype; 
dark/light 
condition 
Mouse ID:  [N. of rod synaptic terminals, rod terminals with ribbon, rod 
terminals with measurable tangential ribbon] per 16 x 16 m frame (2-10 
frames per Epon block, separated by semicolons) 
Synaptic ribbon 
length (µm) + 
standard error 
%  of club-shape ribbons (csr) 
and spherical ribbons (sr) 
C57Bl 
40d dark 
 
#1: [19,8,5]; [12,8,6] 
#2: [19,13,9]; [12,9,7]; [10,7,6]; [14,9,7]; [12,11,8] 
#3: [18,6,5]; [14,9,4]; [15,9,7]; [18,8,4] 
#4: [22,9,3]; [22,19,10] 
#5: [7,6,6]; [12,6,4]; [12,7,4]; [11,10,8] 
[Total rod synaptic terminals: 249; Total rod synaptic ribbons: 154; Tangential 
ribbons: 103] 
0,2915 + 0,0066 
(n=103) 
#1:  0; 0 
#2:  1csr; 0; 0; 0; 0 
#3:  0; 0; 0; 0 
#4:  0; 0 
#5:  0; 0; 0; 0 
 
Percentage csr/sr: 0,65% 
C57Bl 
40d dark 
1-5h light 
#6: [16,10,8]; [10,9,5]; [14,9,8]; [15,5,2]; [17,13,8] 
#7: [15,9,5]; [19,14,9]; [13,10,8]; [13,11,8]; [15,11,6] 
#8: [10,3,2] 
#9: [11,3,3]; [17,10,7]; [13,6,3]; [14,8,5]; [15,5,4]; [8,4,2] 
#10: [5,3,3]; [9,3,2] 
[Total rod synaptic terminals: 249; Total rod synaptic ribbons: 146; Tangential 
ribbons: 98] 
0,2534 + 0,0082 
(n=98) 
 
#6: 0; 1; 0; 1; 2 
#7: 2; 1; 0; 0; 1 
#8: 0 
#9: 1; 2; 0; 0; 1; 0 
#10: 0; 0 
 
Percentage csr/sr: 8,2% 
GCAP2+ 
40d dark 
 
#11: [15,14,8]; [18,11,7]; [16,16,13]; [12,10,9]; [13,11,4] 
[Total rod synaptic terminals: 74; Total rod synaptic ribbons: 62; Tangential 
ribbons: 41] 
0,2634 + 0.013 
(n=41) 
#11: 0; 0; 1; 2; 0 
 
Percentage csr/sr: 4,8% 
GCAP2+ 
40d dark 
1-5h light 
#12: [14,14,8]; [16,8,4]; [12,8,3]; [15,7,3]; [21,12,6]; [9,6,4]; [16,11,5];  
[17,12,11] 
#13: [8,8,2]; [18,6,3]; [18,9,3]; [12,10,5]; [10,8,3]; [9,7,5];  [16,8,5]; [18,14,6] 
[Total rod synaptic terminals: 229; Total rod synaptic ribbons: 148; Tangential 
ribbons: 76] 
0,2439 + 0.010 
(n=76) 
#12: 1; 2; 2; 2; 3; 1; 2; 1 
#13: 0; 0; 0; 0; 1; 2; 2; 0 
 
 
Percentage csr/sr: 12,8 % 
 
GCAP2+/+ 
40d dark 
 
#14: [15,7,5]; [13,10,7]; [13,10,6]; [17,13,9]; [13,8,5] 
#15: [12,7,4]; [14,7,5]; [11,7,4]; [13,11,3]; [11,8,6] 
#16: [16,9,8]; [22,11,7]; [14,7,5]; [15,11,7]; [16,11,8] 
[Total rod synaptic terminals: 215; Total rod synaptic ribbons: 137; Tangential 
ribbons: 89] 
0,2516 + 0,0085 
(n=89) 
#14: 0; 1csr; 1csr; 0; 1csr 
#15: 0; 0; 0; 1csr; 1sr 
#16: 0; 0; 0; 0; 0 
 
Percentage csr/sr: 3,6% 
GCAP2+/+ 
40d dark 
1-5h light 
#17: [16,9,5]; [13,7,5]; [8,5,3] 
#18: [17,11,7]; [13,8,8]; [14,13,9]; [11,9,5]; [13,11,7] 
[Total rod synaptic terminals: 105; Total rod synaptic ribbons: 73; Tangential 
ribbons: 49] 
0,2098 + 0,0134 
(n=49) 
#17: 1csr,1sr; 1csr,1sr; 0 
#18: 1csr,1sr; 2csr; 1csr,2sr; 
1csr; 1sr 
Percentage csr/sr: 17,8% 
WT 
60d cyclic light 
#19: [16,12,12]; [11,5,3]; [14,9,8]; [18,8,5]; [15,8,6]; [10,9,9] 
#20: [9,4,3]; [9,5,4]; [13,6,4]; [13,5,5]; [14,10,8]; [10,10,9] 
#21: [11,8,8]; [15,8,7]; [13,7,6]; [15,10,9]; [12,5,5]; [12,6,6]; [8,6,5]; [10,7,6] 
[7,2,2]; [11,5,5] 
[Total rod synaptic terminals: 266; Total rod synaptic ribbons: 155; Tangential 
ribbons: 135] 
0,2902 + 0,0067 
(n=135) 
 
ND 
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Table R.4. Ribbon length and percentage of club-shaped/spherical ribbons at ribbon synapses of the different mouse lines. Two to ten 16×16 µm frames at 
8,000× magnification were delimited in the opl region of each specimen. Each frame typically contained 10 to 22 rod synaptic terminals. Every synaptic terminal in the 
frame was individually scanned at 100,000× magnification, and length measurements were determined in ribbons resulting from tangential cuts (ImageJ software). Values 
are expressed as the Mean ± Standard error. The percentage of club-shaped/spherical ribbons is expressed as the ratio of club-shaped ribbons and spherical ribbons to 
total rod synaptic ribbons (tangential, longitudinal and sagital). Cone synaptic terminals were excluded from the analysis. 
- Color code in Mouse ID indicates that mice are littermates. 
- % of csr/sr is expressed as the ratio of club-shaped ribbons and spherical ribbons to total rod synaptic ribbons (tangential, longitudinal and sagital). 
- 1-5h light indicates that mice were exposed to either a 1h or a 5h light step (no differences found between these light conditions). 
GCAP2+ 
60d cyclic light 
#22: [16,8,6]; [12,6,5]; [9,7,6]; [12,7,4]; [16,10,8]; [7,4,3] 
#23: [14,8,3]; [13,7,6]; [9,7,4]; [11,10,7]; [13,10,5]; [16,12,3] 
#24: [16,10,7]; [13,5,3]; [15,7,6]; [12,7,5] 
#25: [17,11,10]; [13,6,5]; [14,6,5]; [14,10,4]; [18,10,6]; [16,9,8]; [9,4,4]; [9,9,8] 
[Total rod synaptic terminals: 314; Total rod synaptic ribbons: 190; Tangential 
ribbons: 131] 
0,2621 + 0,0059 
(n=131) 
 
ND 
 
 
GCAPs-/- 
40d dark 
 
#26: [21,18,9]; [20,10,7] 
#27: [20,13,11]; [21,12,10]; [15,10,7]; [19,13,7]; [18,13,11] 
#28: [30,18,13]; [29,12,10]; [11,9,7], [22,19,17]; [15,15,13]; [15,14,14] 
#29: [18,13,12]; [15,8,4]; [17,8,5], [18,10,2]; [11,10,3]; [12,9,4]; [17,12,8]¸ 
[16,13,9]; [15,12,12]; [17,9,7]; [13,12,12] 
#30: [16,7,4]; [16,10,8]; [10,5,3], [10,6,6] 
#31: [9,7,6]; [9,5,2]; [13,9,7], [12,7,6] 
[Total rod synaptic terminals: 520; Total rod synaptic ribbons: 332; Tangential 
ribbons: 256] 
 
 
 
0,2791 + 0.0175 
(n=256) 
ND 
GCAPs-/- 
GCAP2+ 
40d dark 
#32: [19,5,3]; [15,8,5]; [18,6,2]; [19,14,8] 
#33: [17,11,9]; [13,11,5]; [23,11,8]; [16,10,6]; [23,8,5] 
#34:[13,7,5]; [10,7,3]; [12,8,4]; [14,7,3] 
#35:[15,6,3]; [10,9,7]; [14,7,5]; [18,8,8] 
#36: [20,13,9]; [16,7,9]; [22,15,11]; [20,10,8]; [13,7,6]; [8,5,5] 
#37: [10,3,3]; [18,5,4]; [16,6,6]; [16,7,5]; [14,10,5]; [23,10,5]; [17,11,6]; 
[18,11,7] 
[Total rod synaptic terminals: 500; Total rod synaptic ribbons: 263; Tangential 
ribbons:178] 
0,1798 + 0,004 
(n=178) 
 
ND 
GCAPs-/- 
GCAP2+ 
40d cyclic light 
#38: [16,7,5]; [17,10,8]; [14,8,8]; [14,8,6]; [10,5,2]; [15,7,5]; [13,8,5] 
[Total rod synaptic terminals: 99; Total rod synaptic ribbons: 53; Tangential 
ribbons:39] 
0,1788 + 0,007 
(n=39) 
 
#16: 0; 0; 1; 1; 1; 1; 1 
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were light-adapted for 1–5 h the percentage of club-shaped/spherical ribbons 
increased to 8%, while in GCAP2+ or GCAP2+/+ mice exposed to these same light 
conditions the increase was even higher (14% and 18% of assembly intermediates 
respectively, Table R.4). 
Figure R.21B shows two representative visual fields from light-adapted GCAP2+ and 
GCAP2+/+ samples, in which two and three club-shaped/spherical ribbons are present 
per visual field, respectively [shown by arrows and magnified in subsequent panels]. 
This density of club-shaped/spherical ribbons is not observed in the C57Bl samples. 
Taken together, the reduction of ribbon length and the increase in the frequency of 
ribbon morphology intermediates indicate that GCAP2 overexpression causes ribbon 
disassembly in vivo. 
Occasionally, accumulations of electrodense particles that seem like clusters of small 
vesicles (smaller in diameter than synaptic vesicles) were observed in the vicinity of the 
ribbon and horizontal cell processes (Figure R.21A, GCAP2+/+ panel, dark condition). 
These clouds of particles of unknown nature, that appear in synaptic terminals 
irrespective of whether a synaptic ribbon is observed or not, were more voluminous 
and appeared more frequently in GCAP2+/+ mice than in wildtype mice. We speculate 
that they might represent debris resulting from bulk membrane retrieval in the process 
of synaptic vesicle recycling. This observation suggests that GCAP2 might somehow 
interfere with their clearance. 
 
5.3.3. GCAP2 and RIBEYE Partially Colocalize at Synaptic Ribbons 
In order to study whether GCAP2 colocalizes with RIBEYE at synaptic ribbons at the 
ultrastructural level and whether it localizes to ribbon assembly intermediates, we 
performed immunohistochemistry at the electron microscopy level. For these studies 
we used an affinity purified polyclonal antibody anti-GCAP2 generated in rabbit against 
recombinant GCAP2 protein. This antibody is highly specific, recognizing a single 
protein band at 24 kDa in Western blots. 
Immunolocalization of GCAP2 was assayed in sections from GCAPs−/−GCAP2+ mice. 
Figure R.22A shows that the anti-GCAP2 antibody decorates the disc membranes at 
the rod outer segment compartment, as expected. At the synaptic terminal, GCAP2 
was observed sparsed in the cytosolic space and occasionally associated to synaptic 
ribbons, to the plasma membrane and to the presynaptic membrane apposing 
horizontal cell processes (5nm-gold particles, arrows in Figure R.22B and R.22C). This  
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Figure R.22. Immunoelectron microscopic localization of GCAP2 and RIBEYE at rod synaptic 
terminals of GCAPs−/−GCAP2+ mice. A. Localization of GCAP2 in ultrathin sections of the retina at the 
outer segment layer region, as an intrinsic control of the immunoelectron microscopic localization protocol. 
GCAP2 [5nm-gold particles, arrows] associates to the disc membranes, as expected. B-C. View of entire 
synaptic terminals, to show GCAP2 immunoreactivity sparsed in the cytosolic space and also associated 
to the plasma membrane, the membrane apposing invaginating horizontal processes and the ribbon. D. 
Gold-particles decorating the border of an invaginating horizontal process. E-G. Selected examples of 
longitudinal ribbons showing GCAP2 [5nm-gold particles in E, F, 15-nm gold particles in G, pointed by 
arrows in all panels] colocalizing with RIBEYE [arrowheads in all panels]. H-J. Selected ribbon transversal 
sections showing GCAP2 localization at the ribbon or its proximity [arrows point to GCAP2 associated 
particles, arrowheads to RIBEYE associated particles]. K, L. Representative examples of club-shaped 
ribbon transversal sections, densely immunolabeled for RIBEYE but not GCAP2. Scale bar corresponds to 
200 nm in all panels. 
 
staining pattern reproduces the GCAP2 immunostaining reported by confocal 
microscopy, although the density of GCAP2 signal is much lower at the ultrastructural 
level. 
In order to assess the specificity of the occasional immunostaining of synaptic ribbons 
and the presynaptic membrane apposing horizontal cell processes, the gold particles 
were counted in more than 70 randomly selected synaptic terminals in the 
GCAPs−/−GCAP2+ sample (e.g. synaptic terminals presented in Figure R.22B and C) 
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and GCAPs−/− control sections. In the GCAPs−/−GCAP2+ sample 16% of the 
analyzed synaptic terminals presented at least one gold particle associated to the 
ribbon, whereas only 6% of the synaptic terminals analyzed in the GCAPs−/− control 
presented gold particle association to the ribbon. About 27% of synaptic terminals in 
GCAPs−/−GCAP2+ sections presented association of the gold particles to the plasma 
membrane surrounding horizontal cell processes, whereas only 16% presented this 
association in the GCAPs−/−. Panels R.22E-G show longitudinal sections of synaptic 
ribbons in which GCAP2 immunostaining is observed in clusters (Figure R.22E-F, 5nm-
gold particles, arrows; Figure R.22G, 15nm-gold particles, arrows] colocalizing with 
RIBEYE, that selectively marks the ribbon (arrowheads in all panels). In tangential 
sections, GCAP2 is occasionally observed in the ribbon (Figure R.22 I, arrow) and/or in 
the proximity of the arciform density (Figure R.22J, arrow). Pictures showing GCAP2 
association to the membrane apposing invaginating dendritic processes of horizontal 
cells are shown in Figure R.22H-J. Club-shaped ribbons that were extensively labeled 
with anti-RIBEYE antibody did not show labeling with the anti-GCAP2 antibody (Figure 
R.22K,L). 
The fact that GCAP2 appears to be occasionally associated with the ribbon in clusters 
rather than showing a more extensive and homogeneous ribbon distribution might 
reflect a transient nature of the interaction of GCAP2 with the ribbon structural 
components. 
 
5.3.4. GCAP1/GCAP2 Double Knockout Mice have Unaltered Ribbons, but the 
Effect of GCAP2 Overexpression at Shortening Synaptic Ribbons is Magnified in 
the Absence of GCAP1 
In order to study how the loss-of-function of both GCAP1 and GCAP2 affected synaptic 
ribbon length, ribbon length measurements were taken in rod terminals from GCAPs−/− 
and compared to those of wildtype mice. For the comparison in Figure R.23 mice were 
reared in constant darkness. GCAP1 and GCAP2 ablation leads to an increase in light 
sensitivity, due to suppression of the Ca2+-feedback loop to cGMP synthesis (Mendez 
et al. 2001). This would have the effect of magnifying the change in cell membrane 
potential and Ca2+ dynamics upon light exposure. However, dark-adapted GCAPs−/− 
mice show a similar dark current value to that of wildtype mice. Therefore, we reasoned 
that by rearing the mice in darkness any difference detected in ribbon length between 
wildtype and GCAPs−/− mice could be assigned to their direct effect on ribbon 
dynamics at the synaptic terminal. However, no significative differences in length were 
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observed between GCAPs−/− ribbons (0,2791±0,0175 μm, n = 256) and WT ribbons 
(0,2915±0,00665 µm, n = 103), Figure R.23A-B, Histogram in Figure R.23F and Table 
R.4, which indicates that GCAP1 and GCAP2 are both dispensable for the normal 
development and basic structural maintenance of synaptic ribbons, at least when 
raised in darkness. 
Surprisingly, GCAPs−/−GCAP2+ mice raised in darkness showed a remarkable 
reduction in ribbon length at p40 (0,1798±0,004 µm, n = 178), Figure R.23F and Table 
R.4. This represents a 36% reduction of ribbon length in GCAPs−/−GCAP2+ compared 
to GCAPs−/− littermate controls. This 36% reduction of ribbon length in 
GCAPs−/−GCAP2+ mice that express GCAP2 to 1,5-fold the endogenous level is 
much higher than the 14% reduction of ribbon length observed in GCAP2+/+ mice, that 
overexpress GCAP2 to 4-fold the endogenous levels in the wildtype genetic 
background. These results suggest that endogenous GCAP1 somehow counteracts 
GCAP2 effect at shortening synaptic ribbons. 
 
Figure R.23. Expression of GCAP2 in the absence of GCAP1 exacerbates the effect of GCAP2 at 
promoting ribbon disassembly. A-C. Electron micrographs from WT (A), GCAPs−/− (B) and 
GCAPs−/−GCAP2+ (C) ultrathin retinal sections obtained from dark-reared mice at postnatal day 40, 
showing a representative rod synaptic ribbon from each phenotype. While GCAPs−/− mice show ribbons 
that are undistinguishable in length from wildtype ribbons, GCAPs−/−GCAP2+ mice show ribbons that are 
on average about 40% shorter than wildtype ribbons. hc: horizontal cell process; bc: bipolar cell process; 
sr: synaptic ribbon. D, E. Examples of GCAPs−/−GCAP2+ synaptic terminals containing accumulations of 
vesicle-like particles in the vicinity of the active zone (arrows). These aggregates, that might appear in 
terminals with or without ribbons, might generate as by-products in the bulk endocytosis for synaptic 
vesicle recycling process. F. Histogram of synaptic ribbon length in WT, GCAPs−/− and 
GCAPs−/−GCAP2+ mice. Plotted are mean values ± standard errors. * denotes P<0.001 in ANOVA 
analysis [F(2, 196532) = 97,37, P = 0.000] using the PASW program package (IBM) 
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We have observed that GCAP1 also localizes at the synaptic terminal, by 
immunolocalizing GCAP1 with an affinity-purified anti-GCAP1 polyclonal antibody 
raised against the whole recombinant protein (Figure R.24). GCAP1 
immunolocalization signal partially overlaps with RIBEYE at the synaptic ribbon, 
indicating that GCAP1 could have a role at the synaptic terminal. 
 
Figure R.24. GCAP1 localizes to the synaptic terminal and partially overlaps with RIBEYE. 
Immunolabeling of vertical retinal sections from WT and GCAPs−/−GCAP2+ mice with rabbit polyclonal 
antibody anti-GCAP1 and a monoclonal antibody against RIBEYE/CtBP2. GCAP1 is found at the outer 
segment (os) inner segment (is) and outer plexiform layer (opl) of the retina, where it colocalizes with 
RIBEYE at synaptic ribbons (white arrows). GCAP1 antibody immunolabeling signal was absent in 
GCAPs−/−GCAP2+ sections when identical laser power and acquisition gain parameters were used at the 
confocal microscope, excluding that the signal originates from cross-reactivity of anti-GCAP1 antibody with 
GCAP2 at this working dilution. 
 
To study whether there are other ultrastructural changes at the synaptic terminal 
between GCAPs−/−GCAP2+ mice and their GCAPs−/− littermate controls, the 
dimensions of individual synaptic terminals were determined in five 16×16 µm2 visual 
fields in the OPL region. The size of the synaptic terminals was determined to be 
smaller in GCAPs−/−GCAP2+ mice than in GCAPs−/− littermate controls, that were in 
turn smaller than the wildtype. A Duncan’s test established the size of the synaptic 
terminals as follows: GCAPs−/−GCAP2+ (2.47±0.09 μm2, X+SE, n = 69) < GCAPs−/− 
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(3.18±0.12 µm2, n = 88) < WT (3,58±0,13 µm2n = 69), with P<0,05 (Figure R.25). The 
percentage of synaptic terminals that contained a synaptic ribbon was also reduced in 
GCAPs−/−GCAP2+ versus the two other groups. Mean values were [WT 70,1±1,8 n = 
69; GCAPs−/−67,3±2,3 n = 88; GCAPs−/−GCAP2+57,6±2,3 n = 69]. An ANOVA 
analysis showed a statistically significant difference between the GCAPs−/−GCAP2+ 
values and the two other groups, F [2], [12] = 9,36, P = 0,004 (Figure R.25C). 
 
Figure R.25.  GCAPs-/-GCAP2+ mice present smaller synaptic terminals than GCAPs-/- and WT 
mice, and fewer synaptic terminals with ribbon. A. Low magnification micrographs of the opl region of 
WT, GCAPs-/- and GCAPs-/-GCAP2+ mice.  Scale bar, 2μm. B. Histogram comparing the percentage of 
synaptic terminals with ribbon in the three phenotypes.  The number of synaptic terminals that contain a 
synaptic ribbon was determined in five representative visual fields per phenotype and expressed as the 
percentage of the total [Mean + Standard Error].  Mean values were [WT 70,1+1,8 μm2 n 69; GCAPs-/- 
67,3+2,3 μm2 n 88; GCAPs-/-GCAP2+  57,6+2,3 μm2 n 69].  The ANOVA analysis showed a statistically 
significant difference between the GCAPs-/-GCAP2+ values and the two other groups of values, F[2,12] = 
9,36, P=0,004.  Asterisc in histogram denotes P< 0,01.  No statistically significant difference was observed 
between WT and GCAPs-/- values [Duncan’s test].  C. Histogram comparing synaptic terminal size in WT, 
GCAPs-/- and GCAPs-/-GCAP2+ mice.  Statistically significant differences were observed among groups 
by ANOVA analysis F[2,223] =20,37, P=0,000.  A Duncan’s test established GCAPs-/-GCAP2+ mice 
synaptic terminals (2.47+0.09 μm2 , X+SE, n=69,) < GCAPs-/- (3.18+0.12 μm2 n=88) < WT (3,58+0,13 μm2 
n=69), with P< 0,05. 
 
That is, synaptic terminals are smaller in GCAPs−/−GCAP2+ mice, and there is a lower 
percentage of synaptic terminals that contain a ribbon. This figure explains our 
observation in Figure R.18 that OPL thickness is substantially reduced in 
GCAPs−/−GCAP2+ mice, and reflects that the integrity of the ribbon synapse is 
compromised to some extent in these mice. However, neurodegeneration in these mice 
appears to be milder than the neurodegeneration described for other mouse models 
with mutations in presynaptic proteins (Dick et al. 2003) (tom Dieck et al. 2005) (Reim 
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et al. 2005) (Schmitz et al. 2006) (Biehlmaier et al. 2007) (Grossman et al. 2009) 
(Sharma et al. 2011), and signs of autophagia like vacuolization or mitochondria 
swelling were not appreciated in GCAPs−/−GCAP2+ mice compared to GCAPs−/− or 
WT controls (Figure R.25). 
When GCAPs−/−GCAP2+ mice were raised in 12 h:12 h dark:light standard cyclic light 
they showed a similar reduction in ribbon length at p40 (0,1788±0,007 µm, n = 43) than 
when raised in darkness, whereas GCAPs−/− littermate control mice raised under the 
same cyclic light conditions showed a more subtle reduction in ribbon length 
(0,2412±0,01 µm, n = 29). 
Taken together, these results indicate that abolishing the expression of both GCAP1 
and GCAP2 does not alter the length or morphology of synaptic ribbons in dark-reared 
mice, or substantially affect the thickness and connectivity of the OPL. However, 
expressing GCAP2 in the absence of GCAP1 (GCAPs−/−GCAP2+ mice) had a severe 
effect at shortening the ribbons, lowering the number of synaptic ribbons, reducing the 
dimensions of synaptic terminals and ultimately causing a thinning of the OPL. We 
conclude that altering the ratio of GCAP1 to GCAP2 in rod photoreceptor cells in 
vivo leads to morphological alterations at the synaptic terminal including a substantial 
shortening of the synaptic ribbon. Because alteration of GCAP1 to GCAP2 relative 
levels has a bigger effect than the overexpression of GCAP2, we infer that it is the 
balanced action of these proteins in rods that is required to maintain the integrity of 
synaptic terminals. 
 
5.3.5. Mice that Express GCAP2 in the Absence of GCAP1 and are Raised in 
Darkness have Severely Impaired Light Responses in the Scotopic Range 
To study whether the phenotype observed at the ultrastructural level in these mouse 
lines correlates with a functional phenotype, electroretinogram responses to a family of 
flashes of increasing intensities were recorded in the scotopic and the photopic range. 
Rod b-wave amplitudes in the scotopic range (I = −4 to l = −2 Log cd.s/m2), as well as 
a-wave and b-wave amplitudes from rod and cone mixed responses (l = 1,5 Log 
cd.s/m2) and pure cone responses (I = 2,0 Log cd.s/m2) were averaged for the different 
mouse lines, and are presented in Table R.5. Representative recordings are shown in 
Figure R.26. While dark-reared GCAPs−/− mice presented minor reductions in the 
amplitude of the rod b-wave and the a-wave from mixed responses (compare blue 
traces to red traces), dark-reared GCAPs−/−GCAP2+ mice showed very diminished 
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responses in the scotopic range as well as diminished a-wave amplitudes in the rod-
cone mixed responses (compare black traces to red traces). In contrast, pure-cone 
responses in the photopic range were unaffected (Table R.5, Figure R.26 bottom 
traces). Photopic responses in GCAPs−/−GCAP2+ mice are not expected to differ from 
GCAPs−/− responses because the transgene is not expressed in cones. 
 
ERG wave amplitude  b – rod a – mixed b - mixed b - cone 
Intensity (cd·s·m-2)  -2,0 1,5 1,5 2,0 
WT  [D-D] n = 4 304,08 ± 15,39 277,90 ± 34,30 529,48 ± 34,29 188,75 ± 8,84 
              
GCAPs -/-  [D-D] n = 4 230,98 ± 22,62 177,01 ± 18,07 380,65 ± 32,78 140,81 ± 19,78 
              
GCAPs -/- GCAP 2+ [D-D] n = 10 69,91 ± 16,57*** 54,44 ± 19,18*** 228,38 ± 24,65*** 180,69 ± 13,77 
              
WT  [L-D] n = 4 255,84 ± 11,53 203,62 ± 7,83 474,29 ± 14,46 188,75 ± 8,84 
              
GCAPs -/-  [L-D] n = 4 158,81 ± 7,04 183,59 ± 9,28 446,52 ± 53,77 237,84 ± 28,33 
              
GCAPs -/- GCAP 2+ [L-D] n = 6 178,76 ± 37,57 185,89 ± 31,38 455,33 ± 68,24 256,87 ± 31,43 
              
GCAP 2+  [L-D] n = 3 224,31 ± 25,01 175,22 ± 12,54# 420,08 ± 33,97 234,25 ± 8,04 
 
Table R.5 ERG response parameters in the different mouse lines. Statistical analysis of ERG data was 
performed using GraphPad InStat software; each experimental group was considered independent. A 
general linear model procedure with analysis of the variance (ANOVA) was carried out.  Post hoc multiple 
comparisons Tukey test was used.  Data are expressed as mean ± SEM. The results were considered 
significant at p<0.05. 
WT  [D-D] vs. 
- GCAPs -/-  [D-D]:  n.s.  
- GCAPs -/-   GCAP 2+ [D-D]:
 *** p<0.001 
 
 
WT  [L-D] vs. 
- GCAPs-/-  [L-D] :  n.s.  
- GCAP 2+ [L-D] :  n.s.  
-         GCAPs -/-  GCAP 2+ [L-D]: n.s
The reduction in the magnitude of the rod component of the ERG response was more 
severe in GCAPs−/−GCAP2+ rods when mice were raised in constant darkness than 
when mice were raised in standard 12 h:12 h dark:light cycles (Figure R.26, compare 
superimposed traces in left and middle panels). 
Because both the a-wave and b-wave are reduced in dark-reared GCAPs−/−GCAP2+ 
ERG responses, this visual impairment cannot be solely attributed to ribbon shortening.  
                                                                                                                      CHAPTER 2 
 
151 
 
 
Figure R.26. Comparison of electroretinogram responses from WT, GCAP2+, GCAPs−/− and 
GCAPs−/−GCAP2+ mice that were either raised in constant darkness or in 12h:12h dark:light 
standard cyclic light. Left panel, superimposed representative responses of WT (red), GCAPs−/− (blue) 
and GCAPs−/−GCAP2+ (black) mice at p40 that were reared in constant darkness, in the scotopic and 
photopic range. The a-wave amplitude is severely reduced in GCAPs−/−GCAP2+ mice (black trace) 
compared to wildtype and GCAPs−/− traces in the scotopic range. This difference is absent in the photopic 
range, since the transgene is only expressed in rods. Central panel, superimposed representative 
responses of the same phenotypes, but raised in 12h:12h dark:light standard cyclic light and dark-adapted 
previous to the experiment. ERG responses from GCAPs−/−GCAP2+ mice were similar to GCAPs−/− and 
wildtype responses. Right panel, superimposed traces of cyclic light reared wildtype and GCAP2+ mice at 
p40. There were no statistically significant differences in the a-wave and b-wave amplitudes of these 
responses, whether the mice were raised in constant darkness or in 12h:12h dark:light standard cyclic light 
(cyclic reared mice results shown). 
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Furthermore, the same shortening of the ribbons takes place when GCAPs−/−GCAP2+ 
mice are raised in cyclic light, but ERG responses are indistinguishable from 
GCAPs−/− responses. These results indicate that the rod component of the ERG 
response is very diminished in dark-reared GCAPs−/−GCAP2+ mice; and, on the other 
side, that a shortening of 40% of ribbon length in cyclic-light reared GCAPs−/−GCAP2+ 
mice has little effect on the amplitude of the B-wave of ERG responses in the scotopic 
range. That is, ribbon shortening has a limited effect on synaptic strength. 
The decreased contribution of the rod component of the ERG response to dark-reared 
GCAPs−/−GCAP2+ responses is not due to the loss of rod photoreceptor cells. 
GCAPs−/−GCAP2+ mice that have been raised in constant darkness show at p40 the 
same number of photoreceptor nuclei rows that wildtype mice, as shown by 
morphometric analysis of outer nuclear layer thickness at different regions covering the 
whole length of the retina in these mice (Figure R.18C). Therefore, we infer that the 
rods in GCAPs−/−GCAP2+ mice raised in darkness have a diminished contribution to 
ERG responses because they are unable to respond to light, likely due to electrical 
saturation (see Discussion). 
 
5.4. DISCUSSION 
Guanylate Cyclase Activating Proteins (GCAPs) are neuronal Ca2+ sensors from the 
calmodulin superfamily. They play a fundamental role in the recovery of the light 
response by conferring Ca2+ modulation to retinal guanylate cyclase at the membrane 
discs of rod and cone outer segments where phototransduction takes place (Arshavsky 
et al. 2012). The main isoforms GCAP1 and GCAP2 also localize to the inner segment 
and synaptic terminal of photoreceptor cells, where their function is unknown (Cuenca 
et al. 1998). A recent study has demonstrated that GCAP2 interacts with RIBEYE, a 
unique and major protein component of synaptic ribbons, and partially colocalizes with 
RIBEYE at these structures, and pointed to GCAP2 as a candidate that might mediate 
the Ca2+-dependent disassembly of synaptic ribbons (Venkatesan et al. 2010). 
In this study we set to test this hypothesis in vivo, by analyzing alterations in the 
density and morphology of synaptic ribbons in GCAP2 models of gain-of-function 
(GCAP2 overexpression) and loss-of-function (GCAP1/GCAP2 double knockout, 
GCAPs−/−) and their correlation with a functional phenotype. We here report that mice 
that lack GCAP1 and GCAP2 develop synaptic ribbons that are similar in length and 
morphology to wildtype ribbons, indicating that the GCAP2-RIBEYE interaction is not 
required for the initial assembly or anchoring of the ribbon to the active zone. By 
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characterizing transgenic mice that overexpress GCAP2 in rods (GCAP2+ and 
GCAP2+/+ mice) or mice in which GCAP2 expression was restored in the GCAPs−/− 
genetic background (GCAPs−/−GCAP2+ mice) we have confirmed that GCAP2 
overexpression leads to the shortening of synaptic ribbons. This phenotype is 
manifested when mice are reared either in standard cyclic light or in constant darkness, 
and it worsens when GCAP2 is expressed in the absence of GCAP1, in which case it 
severely impairs visual function when mice are dark-reared. We also demonstrate 
GCAP2 colocalization with RIBEYE at the ultrastructural level. Based on our results we 
suggest that both GCAP1 and GCAP2 isoforms, and particularly the relative levels of 
GCAP1 to GCAP2, might contribute to mediate the ribbon morphological changes 
triggered by light through a combination of effects: a secondary effect on the ribbon 
due to their role at regulating cGMP synthesis at rod outer segments; and a more direct 
effect on the ribbons exerted at the synaptic terminal. We here analyze our findings 
and their physiological significance in the context of the current knowledge of GCAP1 
and GCAP2 function and biochemical properties. 
 
5.4.1. GCAP1 and GCAP2 are not Required for the Early Assembly of 
Photoreceptor Ribbon Synapses 
The group of Frank Schmitz has identified GCAP2 as an interacting partner of RIBEYE. 
In their localization assays, Venkatesan and collaborators showed that the GCAP2 
immunofluorescence signal filled the cytosolic space of the synaptic terminal, partially 
overlapping with RIBEYE at the ribbons (Venkatesan et al. 2010). 
Synaptogenesis in rod photoreceptors of the mouse retina is initiated at P6–P8, and is 
completed by the time mice open their eyes at P13–P14. The assembly of 
photoreceptor ribbons during synaptogenesis involves the formation of sphere-like 
structures from protein aggregates of ribbon cytomatrix proteins: Bassoon, RIBEYE, 
Piccolo and RIM1. These non-membranous electrodense “precursor spheres” were 
proposed to be the transport units of the ribbon cytomatrix active zone (CAZ) proteins 
that assemble into immature floating ribbons and subsequently give rise to mature 
anchored ribbons (Regus-Leidig et al. 2009). Mice that lack Bassoon show impaired 
aggregation of ribbon cytomatrix proteins at early stages, delayed formation of 
precursor spheres (Regus-Leidig et al. 2010b) and a failure to form anchored ribbons 
(Dick et al. 2003). The fact that GCAP2 interacts with RIBEYE raises the question of 
whether GCAP2 might be required for the developmental assembly of synaptic ribbons. 
In this study we have observed that the GCAP1/GCAP2 double knockout mice 
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(GCAPs−/−) present a largely normal OPL at p40 with the typical pattern of RIBEYE 
staining (Figures R.18, R.19, and R.20); and the usual number of synaptic ribbons, with 
standard size and morphology by transmission electron microscopy (Figure R.23 and 
Figure R.25). 
Measurements of synaptic ribbon length in GCAPs−/− mice were initially taken from 
mice that were reared in constant darkness (Figure R.23). The reason for this is that 
GCAPs−/− rod photoreceptors show a higher sensitivity to light than wildtype rods, and 
the same prolonged light stimuli could have different effects on WT and GCAPs−/− 
mice (Mendez et al. 2001). Nevertheless, we have subsequently observed that either 
dark-reared or cyclic-light reared GCAPs−/− mice yielded similar to wildtype ERG 
responses in a range of light intensities that covered the scotopic and photopic ranges 
(Figure R.26). These results indicate that GCAP1 and GCAP2 are not required for the 
developmental assembly of synaptic ribbons in rod photoreceptors. However, they do 
not exclude that these proteins play more subtle roles: e.g. at regulating ribbon 
dynamic turn-over (see below). 
 
5.4.2. Ultrastructural Localization of GCAP2 at the Synaptic Terminal 
Original immunolocalization studies of GCAP1 and GCAP2 reported that GCAP1 
localized more abundantly to cone outer segments whereas GCAP2 appeared to be 
present in the outer segment, the inner segment and the synaptic terminals of both 
rods and cones in different species (Cuenca et al. 1998) (Kachi et al. 1999). 
Venkatesan’s study has shown that the GCAP2 immunofluorescence signal filled the 
synaptic terminal and to some extent overlapped with synaptic ribbons (Venkatesan et 
al. 2010). Our localization data at the confocal microscopy level confirms this 
observation (Figure R.18), which is relevant because our assays overcome two 
previously identified limitations in GCAP localization studies. First, the fact that 
antibodies raised against one specific isoform might cross-react with the other (e.g. 
Antibodies raised against GCAP2 typically crossreact with GCAP1, and vice versa). 
Second, the fact that antibodies raised against a particular species isoform yield 
different results in retinal tissue from different species (Howes et al. 1998) (Otto-Bruc et 
al. 1997). Our antibodies were raised against the bovine isoform of GCAP2, and they 
were used to immunolocalize the bovine isoform of GCAP2 expressed in transgenic 
mice. The bovine GCAP2 isoform has been shown to restore endogenous GCAP2 
localization and function in GCAPs−/− mice (Mendez et al. 2001). 
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Our immunoelectron localization study revealed for the first time at the ultrastructural 
level that GCAP2 co-localizes with RIBEYE in about 16% of the synaptic ribbons 
analyzed in the GCAPs−/−GCAP2+ mice (Figure R.22). Instead of a homogeneous 
distribution along the ribbon, we found that GCAP2 was present in clusters, easier to 
detect in longitudinal sections [with up to two or three clusters per ribbon, Figure 
R.22E-G) than in tangential sections. That GCAP2 appears associated to the ribbon in 
only 16% of the ribbons analyzed might be indicative of a transient interaction. It has 
been described that, following the in vitro EGTA treatment of retinas, ribbon 
disassembly begins with the formation of protrusions and the pinching off of spherical 
ribbon material (Spiwoks-Becker et al. 2004), (Regus-Leidig et al. 2009), that are seen 
as club-shaped ribbons and as floating spheres in tangential sections. Therefore, in our 
immunolabeled ultrathin sections we thoroughly looked for clusters of RIBEYE and 
GCAP2 outside the ribbon that might reflect modules of disassembly containing both 
proteins, but could not detect them. Taken together, our results confirm GCAP2 
localization at the ribbons at the ultrastructural level, and would sustain GCAP2 
involvement in the regulation of ribbon morphological changes triggered by changes in 
Ca2+. 
In addition to the synaptic ribbon, GCAP2 was also associated to the plasma 
membrane and particularly to the presynaptic membrane apposing the invaginating 
processes of horizontal cells (Figure R.22D,H-J). The whole delimiting membrane was 
decorated, and not just the active zone. This result points to GCAP2 having additional 
functions at the synaptic terminal, where it could be imparting Ca2+ sensitivity to new 
molecular targets. Future experiments will attempt to identify GCAP2 molecular targets 
in this compartment. 
 
5.4.3. GCAPs Effect on Ribbon Length 
Synaptic ribbons in photoreceptor cells of the mouse retina in the albino strain Balb/c 
tend to disassemble in response to illumination by releasing ribbon material in spherical 
modules; and elongate by regaining ribbon material during dark-adaptation (Vollrath et 
al. 1996) (Adly et al. 1999) (Vollrath et al. 2001) (Spiwoks-Becker et al. 2004) (Regus-
Leidig et al. 2009) (Regus-Leidig et al. 2010a). Although the physiological significance 
of this ribbon remodeling with light is not yet clear and strong variations in the extent of 
these changes have been reported between different mouse strains (Fuchs, 
Sendelbeck et al. 2013), we have observed in this study that 1 h of light exposure can 
cause a 13% reduction of ribbon length in pigmented C57Bl/6 mice (Figure R.21 and 
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Table R.4). While we doubt that this might be a relevant mechanism to regulate 
synaptic strength or serve to extend the operational range of rods, it might represent a 
turn-over mechanism of the ribbon set in place by light, e.g. following photic damage. 
It has been shown in albino mice that ribbon disassembly depends on the drop in 
intracellular Ca2+ at the synapse caused by the light-triggered hyperpolarization of the 
cell (Spiwoks-Becker et al. 2004) (Regus-Leidig et al. 2010a). Because GCAP2 has 
been shown to interact with RIBEYE and localize to the ribbon (Venkatesan et al. 
2010), we here wanted to test whether GCAP2 might mediate the Ca2+ -dependent 
structural changes of ribbons as proposed (Venkatesan et al. 2010). 
Our findings indicate that, although both GCAP1 and GCAP2 isoforms are dispensable 
for developmental ribbon formation and basic structural maintenance, altering the 
GCAP1 to GCAP2 ratio does have an effect on the morphology of synaptic terminals 
and does alter ribbon length. 
Mice that express GCAP2 to 2,5-fold the endogenous levels (GCAP2+ line, Table R.3) 
presented a 10%reduction in ribbon length compared to wildtype mice when both 
transgenic and wildtype mice were raised in constant darkness, or in standard cyclic 
light (Figure R.21, Table R.4). Mice that express GCAP2 to 4,5-fold the endogenous 
level [GCAP2+/+] showed a 14% reduction in ribbon length when mice were raised in 
constant darkness and a 24% reduction when they were raised in constant darkness 
and subsequently exposed to light for 1–5 h. In addition, the percentage of ribbon 
shapes that identify a disassembling ribbon (club-shaped and spherical ribbons versus 
bar-shaped ribbons in transversal sections) was higher in transgenic mice than in 
wildtype mice. These ultrastructural effects on the synaptic ribbons show that GCAP2 
overexpression causes ribbon disassembly. This noticeable change in ribbon 
dimensions, however, had only minor effects on the functional response to light, as 
measured by electroretinogram (ERG). GCAP2+ mice elicited light responses by ERG 
that were similar to wildtype responses in a-wave and b-wave amplitude and kinetics, 
when they were raised either in constant darkness or in standard cyclic light (traces 
from cyclic light-reared mice shown in Figure R.26; traces from dark-reared mice not 
shown). This indicates that a 10% reduction in ribbon length is not enough to produce a 
significative change in the b-wave of the ERG response, and that more extensive 
remodeling of the ribbon might be necessary to affect synaptic strength. 
As discussed above, GCAPs−/− synaptic ribbon length did not differ from wildtype 
synaptic ribbons at p40, and ERG responses of GCAPs−/− mice at p40 were similar to 
wildtype. 
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Intriguingly, mice in which GCAP2 expression was selectively restored in the 
GCAPs−/− background (GCAPs−/−GCAP2+) showed synaptic ribbons that were 40% 
shorter than wildtype ribbons at p40 when raised in constant darkness (Figure R.23). 
GCAPs−/−GCAP2+ mice, when raised in constant darkness, had severely impaired rod 
visual function at p40. Both the a-wave and b-wave amplitudes of ERG responses were 
severely reduced in the scotopic range. Because the a-wave amplitude of the ERG 
reflects the change in membrane potential elicited by the phototransduction cascade 
and the inverted-sign b-wave reflects postreceptoral activation of rod on-bipolar cells, 
genetic defects affecting synaptic transmission typically affect predominantly the b-
wave (Ball et al. 2002) (Haeseleer et al. 2004) (Van Epps et al. 2004) (Mansergh et al. 
2005). Therefore the GCAPs−/−GCAP2+ visual impairment could not be solely 
attributed to the shortening of rod ribbons. Instead, the ERG phenotype of dark-reared 
GCAPs−/−GCAP2+ mice revealed a diminished capacity to respond to light at the rod 
outer segment (ROS) level. 
The ratio of the Ca2+-bound inhibitory state to the Mg2+-bound stimulatory state of each 
GCAP isoform is what determines the rate of cGMP synthesis by retinal guanylate 
cyclase in rod outer segments at any given [Ca2+]i. Given the well characterized 
difference in the Ca2+sensitivities of GCAP1 and GCAP2, there is a narrow range of 
[Ca2+]i -around the [Ca2+]itypical of the dark-adapted steady state- for which GCAP1 
molecules would be in the stimulatory state while most GCAP2 molecules would be 
inhibitory state of the cyclase, and these antagonistic effects would cancel each other 
(Mendez et al. 2001). It is therefore not surprising that chronic darkness might result in 
an alteration in the free cGMP levels at ROS in GCAPs−/−GCAP2+ mice in which 
GCAP2 is expressed in the absence of GCAP1, reducing cGMP levels gradually over 
time. Abnormally low levels of free cGMP would cause the closure of cGMP-gated 
channels and the electrical saturation of rods, and could explain the diminished rod 
component of the ERG despite retention of a normal number of rods in these retinas 
(Figure R.26 and Figure R.18C). Therefore it cannot be excluded that shortening of the 
ribbons might result from a chronic alteration of [Ca2+]I at the synapse due to 
abnormally low levels of cGMP. That is, when GCAPs−/−GCAP2+ mice are raised in 
constant darkness, alterations in ribbon morphology could be a secondary 
consequence of GCAP2 effect on cGMP metabolism. The involvement of the 
phototransduction cascade and cGMP metabolism on the light-triggered morphological 
changes of ribbons has been established (Spiwoks-Becker et al. 2004) . 
In contrast to mice raised in constant darkness, GCAPs−/−GCAP2+ mice reared in 12 
h:12 h dark:light cycles preserved scotopic ERG traces at p40 similar to wildtype in 
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magnitude and kinetics (Figure R.26, Table R.5). Noteworthy, synaptic ribbons in 
GCAPs−/−GCAP2+ mice raised in cyclic light at p40 are shortened to the same extent 
as GCAPs−/−GCAP2+ mice raised in darkness (Table R.4). These mice have been 
reported to have dark current values similar to wildtype, in association with normal free 
cGMP levels (Mendez et al. 2001). This makes it unlikely that changes in ribbon length 
observed in these animals are secondary to altered cGMP metabolism at ROS. 
Strikingly, the absence of GCAP1 exacerbates the effect of GCAP2 at shortening 
ribbon length, even when mice are raised in cyclic light. We infer that altering the 
balance between GCAP1 and GCAP2 leads to the shortening of the ribbons. 
Altering the balanced action of GCAP1 and GCAP2 also compromises the ribbon 
synapse integrity, as shown by the reduction in the size of the synaptic terminals in 
GCAPs−/−GCAP2+ mice (Figure R.25). Therefore, we cannot completely rule out that 
ribbon disassembly might be a secondary consequence of a presynaptic defect caused 
at some other level. There are numerous examples in the literature of mutations in 
presynaptic proteins that cause presynaptic defects that are accompanied by changes 
in ribbon structure. Mutations in Cav1.4, bassoon, complexin, synaptojanin and laminin 
produce floating ribbons  (Dick et al. 2003) (Reim et al. 2005) (tom Dieck et al. 2005) 
(Chang et al. 2006) (Biehlmaier et al. 2007). Mutations in tubby-like protein 1 (TULP1), 
which impairs rhodopsin trafficking to the outer segment, also affect synaptic ribbon 
morphology (Grossman et al. 2009). Mutations in cysteine string protein alpha, a 
chaperone required for SNAP25 and SNARE complex assembly cause photoreceptor 
degeneration and the appearance of floating ribbons (Schmitz et al. 2006), (Sharma et 
al. 2011). Myosin Va mutant mice have both anatomical and physiological 
abnormalities at rod synapses (Libby et al. 2004). However some of these mouse 
models [e.g. Tulp1 KO, CSPα KO] manifest a rapid retinal degeneration with a 
substantial loss of photoreceptor cells that is accompanied by severe functional defects 
before one month of age (Hagstrom et al. 1999) (Schmitz et al. 2006). 
GCAPs−/−GCAP2+ transgenic mice, in contrast, preserve the normal number of 
photoreceptor cells for months (Figure R.18) and do not present obvious signs of 
neurodegeneration like vacuolization or mitochondria swelling at the synapse (Figure 
R.25). The fact that the absence of GCAP1 exacerbates the effect of GCAP2 at 
shortening ribbons argues against a non-specific toxic effect of overexpressed GCAP2 
at the synaptic terminal. Rather, it seems that the balanced action of GCAP1 and 
GCAP2 might be needed to preserve the integrity of the synapse and the ribbon. 
Together with Venkatesan’s report that GCAP2 interacts with RIBEYE, our observation 
that GCAP2 can appear associated to the ribbon at the ultrastructural level and the 
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marked reduction in ribbon length that is observed in GCAPs−/−GCAP2+ mice leads 
us to suggest that GCAPs might be involved in mediating the morphological changes at 
the ribbons triggered by changes in Ca2+. 
Further genetic and biochemical experiments will be needed to confirm the direct 
implication of GCAP2 and GCAP1 in this process, and to study whether GCAP1 and 
GCAP2 might have new molecular targets and new functions at the synapse. 
 
5.5. CONCLUSION 
The central observation of this study is that the overexpression of GCAP2 in rods in 
vivo has an impact at shortening synaptic ribbons that is exacerbated in the absence of 
GCAP1. These results, together with the lack of phenotype when both GCAP1 and 
GCAP2 isoforms are absent in the double knockout, point to the balanced action of 
GCAP1 and GCAP2 having an effect on the ultrastructure of the synaptic terminals and 
on synaptic ribbon length, likely through a combination of mechanisms: i) an indirect or 
secondary effect on the ribbon would be caused by their primary effect on cGMP 
metabolism at rod outer segments, manifested in this study when GCAP2 is expressed 
in the absence of GCAP1 and mice are reared in constant darkness; and ii) an effect 
on the ribbon through a mechanism independent of cGMP metabolism, manifested 
when GCAP2 is overexpressed or expressed in the absence of GCAP1 and mice are 
reared in cyclic light. We have observed that a 40% reduction of ribbon length in vivo in 
GCAPs−/−GCAP2+ mice raised in cyclic light had only subtle effects on ERG 
responses in the scotopic range, indicating that ribbons can withstand dimensional 
restrictions without a severe functional effect. 
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RESUMEN EN ESPAÑOL 
Las guanilato ciclasas de retina (RetGCs) y las proteínas activadoras de las guanilato 
ciclasas (GCAPs) están ensambladas en un complejo (RetGC/GCAPs) que tiene un 
papel fundamental en el compartimento sensorial de células fotorreceptor para la 
terminación de la señal a la luz y para la adaptación a la luz, y un nodo clave en la 
señal de retrorregulación recíproca entre el cGMP y el Ca2+. 
A pesar de la extensa caracterización bioquímica de estas proteínas, otros aspectos 
relacionados con su función en la célula se desconocen todavía, como: a) – Qué 
determina su distribución subcelular?; b) - Qué otras funciones desempeñan en los 
otros compartimentos celulares, fuera del segmento externo?; c) – Cómo 
desencadenan la muerte celular las formas mutadas de las proteínas GCAP1 y 
GCAP2 asociadas a ceguera hereditaria? 
En este estudio hemos abordado estas cuestiones mediante la caracterización de un 
modelo de ratón  que expresa una forma mutada de GCAP2 en que todos los dominios 
de unión a Ca2+ han sido inactivados.  La expresión de esta forma mutada de la 
proteína en fotorreceptores bastón conduce a una degeneración retinal rápida.  
Primero demostramos que este mutante causaba toxicidad por un mecanismo 
independiente del metabolismo de cGMP, un resultado inesperado dado que las 
mutaciones en GCAP1 que reducen su afinidad de unión a Ca2+ conducen a la 
activación constitutiva de cGMP, tanto in vitro como in vivo.  Sin embargo, la forma 
mutada EF-GCAP2 es retenida en los compartimentos proximales de la célula y no se 
transporta al segmento externo.  Además, en el segmento interno y compartimentos 
proximales de la célula, se acumula en una forma incompetente para la activación de 
la actividad guanilato ciclasa en ensayos de reconstitución.  
Para estudiar cómo la acumulación de la forma mutada EF-GCAP2 en el segmento 
interno conduce al daño celular, investigamos  qué interacciones establece la forma 
mutada EF-GCAP2 de forma selectiva respecto a la forma wildtype de GCAP2.  El 
análisis proteómico identificó a las proteínas 14-3-3 como interactores de mayor 
afinidad a la forma mutada que a la wildtype.  La identificación de las distintas 
isoformas de 14-3-3 como interactores de GCAP2 nos llevó a desvelar un mecanismo 
molecular clave en el control de la distribución intracelular de GCAP2, con 
implicaciones importantes en enfermedad.  GCAP2 se fosforila in vivo principalmente 
cuando se encuentra en su forma libre de Ca2+.  La fosforilación es lo que incita la 
unión de 14-3-3, y su retención en el segmento interno.  En ratones wildtype, un 50% 
del total de la forma endógena de GCAP2 se fosforila; y esto se correlaciona con el 
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porcentaje de GCAP2 que se localiza en los compartimentos proximales de la célula 
(50%).  En ratones que expresan EF-GCAP2, casi la totalidad de la proteína se 
encuentra fosforilada, y casi la totalidad de la proteína es retenida en los 
compartimentos proximales.  La asociación de GCAP2 y 14-3-3 in vivo se manifiesta 
claramente también en separaciones de extractos de retina por cromatografía de 
exclusión en tamaño.  
De nuestros resultados emerge el siguiente modelo: GCAP2 se sintetiza en el 
segmento interno.  Si une Ca2+ tras su síntesis (cuando la [Ca2+]i es alta, en períodos 
de oscuridad), entonces se une a RetGC y es transportada al segmento externo.  Si no 
une Ca2+ tras su síntesis (a baja [Ca2+]i, en períodos de exposición a luz), entonces 
une Mg2+ y adquiere una conformación  tridimensional que es menos estable.  La 
forma libre de Ca2+ de GCAP2 forma dímeros, es fosforilada y une dímeros de 14-3-3.  
Esta unión podría explicar la retención de GCAP2-P en el segmento interno y 
compartimentos proximales, ya que las isoformas de 14-3-3 están excluídas del 
segmento externo.  De hecho, en este estudio presentamos la comprobación genética 
de que la fosforilación de GCAP2 es la responsable de su retención.  Al mutar la 
Ser201 en EF-GCAP2 revertimos su retención, y la proteína se transporta al segmento 
externo.  De acuerdo con nuestro modelo, la distribución subcelular de GCAP2 (una 
proteína citosólica) es un proceso altamente regulado, dictado por interacciones 
proteína-proteína que ocurren de forma diferente en los períodos de luz que en los 
períodos de oscuridad, y no como resultado de la equilibración de su concentración en 
el espacio citosólico.  Las mutaciones en GCAP2 que disminuyen o impiden su unión a 
Ca2+ alteran este mecanismo de distribución de la proteína, creando un desequilibrio –
por acumulación de GCAP2 en el segmento interno en una forma conformacional 
inestable- que en último término conduce a la muerte celular. 
Esto es, aquí describimos un nuevo mecanismo de toxicidad de mutaciones en las 
proteínas GCAP que es independiente del metabolismo de cGMP. La expresión 
transgénica de bEF-GCAP2 condujo a una degeneración retinal rápida.  Por tanto, la 
acumulación en exceso en el segmento interno de GCAP2 en su conformación “libre 
de Ca2+” resulta en toxicidad para la célula.  Nuestros resultados sugieren que la 
toxicidad deriva de la inestabilidad térmica de la proteína. Está bien establecido que 
GCAP2 en su conformación libre de Ca2+ es térmicamente inestable y muestra 
tendencia a la agregación.  La propensión de GCAP2 en su forma “libre de Ca2+” a 
precipitar es lo que ha impedido hasta ahora la determinación de su estructura 
tridimensional por NMR, mientras que la estructura de GCAP2 en su forma “unida a 
Ca2+”  sí ha podido ser determinada.  Hay muchos estudios que han descrito una 
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asociación entre 14-3-3 y enfermedades neurodegenerativas progresivas. Las 
proteínas 14-3-3 se han detectado en depósitos amiloides de la proteína Tau 
hiperfosforilada de las placas seniles (ovillos neurofibrilares) en la enfermedad de 
Alzheimer.  En la enfermedad de Parkinson, 14-3-3 es detectada en cuerpos de Lewy 
formados por depósitos de sinucleina, y también se ha descrito la colocalizacion de 14-
3-3 con formas mutadas de ataxin en la ataxia cerebelar espinosa.  
Como resultado de este estudio proponemos que la forma mutada de GCAP2 
bloqueada en su forma libre de Ca2+ causa toxicidad in vivo por la formación 
progresiva de oligomeros solubles de alto peso molecular GCAP2-14-3-3 que son 
toxicos para la celula.  De acuerdo con esta hipótesis, observamos una fracción mucho 
mayor de EF-GCAP2 que de GCAP2 control asociada a 14-3-3 en experimentos de 
fraccionamiento por tamaño de extractos de retina de ratones transgénicos.  Las 
fracciones que muestran asociación entre GCAP2 y 14-3-3 muestran también especies 
de GCAP2 de alto peso molecular (dimeros y multimeros).  La acumulación de 
complejos EF-GCAP2-14-3-3  muestra cierta tendencia a formar agregados insolubles, 
como se muestra en la fracción de EF-GCAP2-14-3-3 que aparece en la fracción 
resistente a Triton X-100, soluble en SDS. 
Proponemos que el efecto deletéreo de la forma de GCAP2 libre de Ca2+ 
conformacionalmente inestable es un factor que contribuye a la patología de un 
numero considerable de distrofias hereditarias de la retina⁞  a) las causadas por 
mutaciones en GUCA1B(GCAP2) que afecten a su afinidad de unión a Ca2+, b) 
distrofias causadas por mutaciones en diferentes genes que en ultimo termino causen 
una reducción en la concentración intracelular de Ca2+ de forma sostenida, que son 
aquellas distrofias conocidas como ‟escenarios equivalentes a luz”. 
Ejemplos de defectos genéticos que resultan en un fenotipo ‟escenario  equivalente a 
luz” son  a) mutaciones nulas en GUCY2E (RetGC) asociadas a Amaurosis Congénita 
de Leber, en que falla el transporte de las proteínas GCAP debido a la ausencia de 
RetGC, a la vez que hay una reducción sostenida de los niveles de Ca2+ debido al 
cierre de los canales en ausencia de síntesis de cGMP;  b) mutaciones en RD3,  al 
afectar el transporte de los complejos RetGC/GCAPs al segmento externo crean las 
condiciones anteriormente citadas; c) mutaciones nulas en RPE65, que al afectar al 
ciclo visual –impidiendo el reciclaje del cromóforo- crean un escenario en que el 
pigmento visual se encuentra como opsina (apoproteína en ausencia de cromóforo), 
generando una actividad constitutiva basal y creando, por tanto, una reducción en los 
niveles de Ca2+ intracelular de forma sostenida. 
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En el futuro próximo diseñaremos experimentos para determinar en cuales de estos 
desórdenes hereditarios la acumulación de GCAP2 térmicamente inestable esta 
contribuyendo a la patología.  Ademas, trataremos de identificar la quinasa 
responsable de la fosforilación de GCAP2, y las vías implicadas en la degradación de 
los agregados de GCAP2-14-3-3, asi como su reciclaje (“turnover”). 
 
Además de localizarse en el segmento externo de los fotorreceptores, las proteínas 
GCAP también se localizan en el segmento interno y en la terminal sináptica de 
fotorreceptores, donde hasta ahora se desconoce su función. Este trabajo demuestra 
que tanto GCAP1 como GCAP2 se localizan en la terminal sináptica colocalizando con 
RIBEYE, el componente estructural mayoritario de las cintillas sinápticas, y que tanto 
la sobreexpresión de GCAP2 como la reducción de GCAP1 in vivo (la alteración de la 
relación molar GCAP1:GCAP2) provoca el desensamblaje de las cintillas sinápticas y 
reduce la sensibilidad a la luz de los fotorreceptores. Este dato es importante porque 
aporta nueva información acerca de la organización/regulación de las cintillas 
sinápticas, un orgánulo presumiblemente fundamental en fotorreceptores para 
coordinar los cambios de calcio en la terminal presináptica con la maquinaria de 
exocitosis/ endocitosis de vesículas sinápticas, y sin embargo aún poco caracterizado. 
Futuros experimentos trataran de continuar la caracterización de las funciones de 
GCAP1 y GCAP2 en terminal sináptica, mediante la caracterización funcional de 
nuevas interacciones de las GCAP en este compartimento. 
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DISCUSSION 
The guanylate cyclase/guanylate cyclase activating proteins (RetGC/GCAP proteins) 
are assembled in a complex that has a key role at the light-sensitive compartment of 
photoreceptor cells. This complex is responsible for the synthesis of cGMP, the second 
messenger in phototransduction. It synthesizes cGMP at basal levels in darkness that 
counter-balances the basal activity of cGMP-phosphodiesterase, keeping a constant 
level of free cGMP that sets the fraction of open cGMP-channels at the plasma 
membrane and the inward current of Ca2+ that keeps photoreceptors partially 
depolarized (Figure I.4, upper diagram). Light activates an enzymatic cascade that 
ultimately causes the hydrolysis of cGMP. As cGMP drops, some cGMP-gated 
channels are closed and the inward current –including Ca2+ influx– is reduced, so that 
photoreceptors hyperpolarize and emit a signal (Figure I.4, middle diagram). As the 
light is dimmed or extinguished, the darkness equilibrium must be restored by 
reinstating the dark levels of cGMP. This is achieved as the GCAP proteins sense the 
drop in Ca2+ during the light response and exert a robust stimulation of RetGC activity 
(Figure I.4, lower diagram). Therefore, the RetGC/GCAPs complexes are essential for 
termination of the light response and light adaptation, and a key node in the cGMP and 
Ca2+ reciprocal feedback loop in photoreceptors (Burns and Arshavsky 2005). 
Extensive biochemical analysis of the two major isoforms of guanylate cyclase 
activating proteins in mammals, GCAP1 and GCAP2 , has led to the proposal of the 
Ca2+-relay model of action of GCAP proteins in the light response of rods and cones.   
Intracellular free [Ca2+] declines from ~ 250nM in darkness to 23nM in saturating light in 
mouse rod outer segments.  The models proposes that this Ca2+ decrease is first 
sensed at GC/GCAP complexes comprising GCAP1 and successively at those 
comprising GCAP2 [Ca2+ EC50 for GCAP1 ~130nM; for GCAP2 ~50nM], in a sequential 
mode of action -referred to as a Ca2+-relay model-.  Altogether, the rate of cGMP 
synthesis upon light exposure is stimulated up to ~12-fold over its basal levels, serving 
to restore the cGMP levels and to reopen the channels during the recovery of the light 
response and light adaptation (Kock and Dell’Orco 2013). 
However, despite their extensive biochemical characterization, there are still important 
questions regarding GCAP1 and GCAP2 :  a) – What determines their subcellular 
distribution?, b) – What other functions do GCAP1 and GCAP2 exert at other cellular 
compartments, other than the light-sensitive compartment? , c) – How do they result in 
photoreceptor cell death when mutated? 
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In this study we have addressed these questions by combining mouse genetic 
techniques with biochemical, physiological and histological analysis.  We undertook an 
extensive characterization of a transgenic line expressing a mutant form of GCAP2 
impaired to bind Ca2+, in which all functional EF-hands were mutated, the EF-GCAP2 
(Figure R.2.). This mutant resulted in severe retinal degeneration, reproducing the 
phenotype caused by human mutations that impair Ca2+-binding. We first demonstrated 
that this mutant was causing toxicity by a mechanism independent of cGMP 
metabolism, which was unexpected (Figure R.5.). Its toxicity was not caused by 
unabated cGMP synthesis, the mechanism underlying the pathology of mutations in 
GCAP1 that have been associated to autosomal dominant cone/rod dystrophies 
(adCORD).  In the case of GCAP1 mutations, most of the mutations that have been 
identified cause protein conformational distorsions that affect the Ca2+-coordination 
capacity of EF-hand 3 or EF-hand 4. It has been demonstrated both in vitro and in vivo 
that the effect of impairing Ca2+-binding to GCAP1 is the constitutive activation of the 
cyclase, leading to elevated levels of cGMP, a higher-than-normal fraction of open 
cGMP-gated channels and therefore an abnormally elevated entry of Ca2+, with 
ensuing apoptosis (Dizhoor et al. 1998) (Dizhoor 2000) (Jiang and Baehr 2010). In 
contrast, in our transgenic line, the mutant form of GCAP2 impaired at binding Ca2+, 
EF-GCAP2, failed to be transported to rod outer segments and accumulated at the 
photoreceptor inner segment and proximal compartments (Figure R.6.). In order to 
study how the mutant protein was causing damage to the cell by accumulating at the 
inner segment, we undertook the characterization of protein interactions established by 
the mutant protein, by designing a differential proteomic analysis using the mutant 
transgenic line, a transgenic control line and the GCAPs knockout strain. As a result of 
the proteomic analysis, we identified the 14-3-3 phosphobinding proteins as the major 
EF-GCAP2 interactors (Table R.1. and Table R.2.). 
The identification of 14-3-3 protein isoforms as binding proteins of GCAP2 led us to 
unveil an important mechanism governing GCAP2 subcellular distribution in vivo, with 
important implications for disease. We here demonstrate that GCAP2 is 
phosphorylated in vivo, to a much higher extent in its Ca2+-free form than in its Ca2+-
loaded form (Figure R.9). Phosphorylation of GCAP2 is what triggers 14-3-3 binding 
(Figure R.8), and the retention of the protein at the inner segment and proximal 
compartments (Figure R.12).. In wildtype mice, we have seen that about 50% of the 
total protein is phosphorylated at steady state (Figure R.10), and that about 50% of the 
protein localizes to proximal compartments, whereas about 50% of the protein is 
distributed to the rod outer segment (Figure R.13. and R.14.).  We have also shown 
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that GCAP2 and 14-3-3 co-fractionate during separation of murine retinal homogenates 
by size exclusion chromatography, which indicates that these proteins might be 
associated in vivo (Figure R.11).   
Our results, taken together, suggest the following model (Figure R.16): GCAP2  is 
synthesized at the inner segment.  If it binds Ca2+ immediately upon synthesis (at the 
high [Ca2+]i typical of dark periods), then it would bind to Ret-GCs and be transported to 
rod outer segments.  If it does not bind Ca2+ upon synthesis (at the low [Ca2+]i typical of 
prolonged light exposures), then it would bind Mg2+ and the protein would acquire a 
tridimensional conformation that would be less stable.  It would form dimers.  It would 
be phosphorylated, and it would bind a dimer of 14-3-3.  Because 14-3-3 isoforms 
distribute to proximal compartments of photoreceptors and are excluded from the outer 
segments (Figure R.12) (Nakano et al. 2001), the binding of 14-3-3 to phosphorylated 
GCAP2 could account for GCAP2 retention at proximal compartments.  In fact, we 
revert GCAP2 retention at the inner segment in the bEF-GCAP2 transgenic line when 
we mutate Ser201, precluding the phosphorylation of the protein.  When 
phosphorylated and bound to 14-3-3, GCAP2 would be retained and precluded from 
binding RetGC for its transport to rod outer segments. 
Therefore, our model envisages the subcellular localization of GCAP2 (a cytosolic 
protein) as a highly regulated process, dictated by protein-protein interactions that 
occur differently in dark or light conditions, rather than the result of equalizing its 
concentrations in the cytosolic space.  Mutations in GCAP2 that disrupt or preclude 
Ca2+-binding would alter this mechanism of protein distribution, creating an imbalance 
that would ultimately lead to cell death (see below). 
We here uncover a mechanism by which mutations in GCAP2 may lead to cell death 
which is independent of cGMP metabolism.  Transgenic expression of bEF-GCAP2 led 
to a rapid retinal degeneration.  Therefore, GCAP2,  when building up in excess at the 
inner segment in its conformationally unstable Ca2+-free conformation results in severe 
toxicity.  Data suggests that toxicity comes from Ca2+-free GCAP2 thermal instability. 
It is well established that the Ca2+-free conformation of GCAP2 is conformationally 
unstable  and has a natural tendency to aggregate (Olshevskaya et al. 1999b) 
(Pettelkau et al. 2013).   The propensity of Ca2+-free GCAP2 to precipitate in vitro has 
precluded so far the determination of its NMR structure, whereas the structure of the 
Ca2+-bound form of GCAP2 has been resolved (Ames et al. 1999).  By homology to the 
reported Ca2+-dependent structural changes in GCAP1, the release of Ca2+ from the 
EF-hand domains in the GCAP2 molecule would likely result in the swiveling of the 
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interdomain region, separating the N-terminus and C-terminus domains of the protein 
(Stephen et al. 2007).  This would result in the release of the C-terminus from a three-
element network of intramolecular interactions involving the N-terminus, the buried 
myristoyl group and the C-terminus, so that the C-terminus becomes more exposed, 
and more susceptible to phosphorylation at Ser201.  Phosphorylation at this residue 
triggers 14-3-3 binding (Peshenko et al. 2004b). 
Several investigations in the last decade have linked 14-3-3 proteins with progressive 
neurodegenerative diseases: 14-3-3s colocalize with hyperphosphorylated tau in 
Alzheimer disease neurofibrillary tangles (Layfield et al. 1996) (Lee et al. 2001), with α-
synuclein in Lewy bodies typical of PD (Kawamoto et al. 2002), with ataxin in 
spinocerebellar ataxia (SCA, Chen et al. 2003). Moreover, phosphorylation of ataxin-1 
at S776 stabilizes the protein by inducing 14-3-3 binding (zeta and epsilon isoforms), 
delaying its degradation and reinforcing its aggregation in Drosophila (Chen et al 
2003). 
We propose that it is the gradual formation of GCAP2-14-3-3 soluble oligomers that 
results in toxicity for the photoreceptor cell. We have observed in size exclusion 
chromatography experiments that those fractions that present the highest 
colocalization of GCAP2 and 14-3-3 are enriched in high molecular weight species of 
GCAP2 (Figure R.11). These GCAP2-14-3-3 complexes are shifted towards “higher 
molecular weight” fractions in these assays when retinal extracts are solubilized in 1% 
SDS rather than in TritonX100, which is to say that higher molecular weight complexes 
have a tendency to precipitate (Figure R.11). 
We propose that the deletereous effects of the conformationally unstable Ca2+-free 
GCAP2 will be contributing to the pathology of a number of inherited retinal 
dystrophies:  a) those caused by mutations in the GUCA1B gene (GCAP2 protein) that 
preclude Ca2+-binding;  and b) dystrophies caused by mutations in different genes that 
ultimately result in a sustained reduction in the intracellular concentration of Ca2+ [e.g, 
mutations impairing termination of the light response or mutations in the visual pigment 
resulting in opsin basal constitutive activity (Singhal et al. 2013), (Woodruff et al. 
2003)], the so-called “equivalent-light” genetic scenario (Fain and Lisman 1999) (Figure 
D.1.). 
An example of mutations leading to “equivalent-light” conditions, for which this 
mechanism could be of relevance, follows: 
- Null mutations in RetGC1 (GUCY2E), associated to Lebers Congenital 
Amaurosis, LCA1. GUCY2E was the first gene identified that was involved in 
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LCA and accounts for ~20% LCA cases (Perrault et al.2000). In the absence of 
functional RetGC in photoreceptors:  a) there is no transport of GCAP1 or 
GCAP2 to rod outer segments, and GCAP1 and GCAP2 accumulate at 
proximal compartments; and b) synthesis of cGMP is reduced, cGMP levels are 
lower than normal, consequently the fraction of open cGMP channels is lower 
than normal, mimicking the effect of light, and Ca2+ entry is therefore lower than 
normal (Baehr et al. 2007). In the “equivalent-light” situation, the conditions 
converge that: a) GCAPs accumulate at the inner segment; and b) intracellular 
Ca2+ is abnormally low.  
- Null mutations in RD3, associated to Lebers Congenital Amaurosis, 
LCA12.  RD3 is an accesory protein required for the transport of RetGC/GCAP 
complexes to the outer segments.  Therefore the consequences of lacking a 
functional RD3 are the same of lacking functional RetGC1 (Azadi et al. 2010). 
- Null mutations in RPE65, associated to Lebers Congenital Amaurosis , 
LCA12.  Mutations in RPE65 disrupt synthesis of the opsin chromophore ligand 
11-cis-retinal, leading to light-independent constitutive signaling by unliganded 
opsin, therefore resulting in a sustained decrease in intracellular Ca2+ (Marlhens 
et al. 1997) (Gu et al. 1997). 
 
 
 
 
 
 
 
 
 
 
 
Figure D1. Retinal dystrophies in which mutations result in a sustained reduction in intracellular 
Ca2+, shown in bold in the broader context of mutations leadingto different forms of inherited 
blindness. arRP; adRP, XlRP: autosomal recessive/dominant/ X-linked retinitis pigmentosa.  
Mutations impair rod function, leading initially to “night blindness” and loss of peripheral vision.  As the 
disease progresses, at a certain threshold of rod cell death cones are also compromised, and there is loss 
of central visual acuity (tunnel vision) and eventually total blindness. LCA: Leber congenital amaurosis. 
Severe retinal dystrophy, evident in the first year of life.  Near complete impairment of visual function (both 
rods and cones typically affected).adCORD: autosomal dominant cone-rod dystrophy.  Gene defects 
affect initially cone and subsequently rod function; leading to loss of visual acuity and central vision. 
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- G90D-rhodopsin.  Mutations in rhodopsin that abolish chromophore binding 
would have the same functional consequences that null mutations in RPE65 
(that not having chromophore) (Woodruff et al. 2007) (Dizhoor et al. 2008). 
- Null mutations in proteins involved in termination of the light response: 
such as rhodopsin kinase (Yamamoto et al. 1997) or arrestin (Fuchs et al. 
1995), associated to Congenital Stationary Night Blindness or Oguchi 
disease. Abnormally prolonged signaling initiated by rhodopsin in response to 
light, by not being terminated when the light is extinguished , would lead to 
sustained reduced intracellular Ca2+ (Chen et al. 1999) (Lamb and Pugh 2004) 
(Metayé et al. 2006) 
 
Future experiments will test whether the mechanism here outlined contributes to the 
pathology of these inherited retinal dystrophies by using mouse models of these 
diseases.  Also, experiments will be addressed at characterizing the kinase involved 
and its regulation, the stoichiometry and turn-over of GCAP2-14-3-3 complexes, as well 
as at characterizing the deletereous effects that GCAP2 and GCAP2-14-3-3 
aggregates have in the cell (the link with cell death). 
 
Besides its localization at the photoreceptor sensory compartment and at the metabolic 
compartment, GCAP proteins also localize to the synaptic terminal, where its function 
is unknown (Howes et al. 1998). This study confirms that both GCAP1 and GCAP2 are 
localized at the synaptic terminal, and further demonstrates GCAP2 colocalization with 
RIBEYE, the major structural component of synaptic ribbons (Venkatesan et al. 2010) 
both at the confocal level (Figures R.18, R.19 and R.20) and at the ultrastructural level 
(Figure R.22). We here demonstrate the colocalization of GCAP1 with RIBEYE at 
synaptic ribbons as well (Figure R.24). 
GCAP2 overexpression in vivo (altering the GCAP1:GCAP2 molar ratio) causes 
synaptic ribbon disassembly (Figure R.21 and R.23) and reduces photoreceptors light 
sensitivity (Figures R.26). This study is relevant because it points to a role of GCAP2 
(and GCAP1) at the synaptic terminal, at regulating the dynamic reorganization of 
ribbons during light exposure.  
Because RetGC and RD3 are also present at the synaptic terminal, it cannot be 
discarded that GCAPs could be regulating cGMP synthesis at this compartment as well 
(Liu et al. 1994) (Cooper et al. 1995) (Duda et al. 2002) (Venkataram et al. 2003) 
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(Azadi et al. 2010) (Peshenko et al. 2011b), although this seems unlikely given that the 
[Ca2+]i is much higher at the synaptic terminal than at rod outer segments.  
Future experiments will also aim at further investigating the role of GCAP2 and GCAP1 
at the synaptic terminal, by continuing the characterization of protein-protein 
interactions that GCAP2 and GCAP1 establish in this compartment, besides RIBEYE  
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RESUMEN EN ESPAÑOL 
1. Demostramos la presencia de GCAP1 y GCAP2 en las cintillas sinápticas de la 
terminal sináptica de los bastones mediante microscopia electrónica y confocal. 
2. GCAP1 y GCAP2 son prescindibles en el ensamblaje y mantenimiento básico de las 
cintillas sinápticas. 
3. La sobreexpresión de GCAP2 en el fenotipo salvaje, que incrementa el ratio 
GCAP2:GCAP1, promueve el desensamblaje de las cintillas. 
4. Proponemos que GCAP2 podría jugar un papel mediando cambios morfológicos en las 
cintillas sinápticas promovidas por cambios en los niveles de Ca2+. 
5. La expresión in vivo de la proteína bEF-GCAP2, que no une Ca2+, provoca 
degeneración retinal a un ritmo que se correlaciona con la pérdida de función visual, y 
esto es debido a la mutación en sí y no a la sobreexpresión del transgén.  
6. bEF-GCAP2 se localiza en los compartimentos proximales de los fotoreceptores y no 
transloca al segmento externo, por lo que no activa GC. 
7. bEF-GCAP2 está anormalmente fosforilada in vivo. 
8. La fosforilación de GCAP2 promueve la unión de 14-3-3. 
9. La fosforilación de GCAP2 en la serina 201 retiene a GCAP2 en el segmento interno y 
evita su translocación al segmento externo. In vivo, esta retención es revertida cuando 
la serina 201 se muta a una glicina. 
10.  Proponemos que la fosforilación de GCAP2 y su unión a 14-3-3 determina la 
localización de GCAP2 en la celula.  
11. Proponemos que mutaciones en GCAP2 o condiciones de luz que promuevan la 
acumulación de GCAP2 en su forma libre de Ca2+en el segmento interno de la célula, 
conducen a la muerte celular por la inestabilidad conformacional de GCAP2. Y más 
importante, proponemos que esto aplicaría también a condiciones genéticas que 
mimetizan los efectos de exposición a luz prolongada, los escenarios recogidos bajo la 
hipótesis de “equivalente a luz”. 
 
 
 
 
CONCLUSIONS                                                                                                              _  
 
178 
 
                                                                                                                CONCLUSIONS 
 
179 
 
CONCLUSIONS 
1. GCAP1 and GCAP2, in addition to their role at confering Ca2+ sensitivity to cGMP 
synthesis at rod outer segments, are also present at the synaptic terminal.  At confocal 
and electron microscopy level, we have shown that GCAP1 and GCAP2 localize to 
ribbon synapses in rod synaptic terminals. 
2. The absence of GCAP1 and GCAP2 does not alter synaptic ribbon length.  If both 
GCAP1 and GCAP2 isoforms are ablated, there is no overall effect on synaptic ribbon 
length at the ultrastructural level.  GCAP1 and GCAP2 proteins are not required for the 
early assembly or basic maintenance of synaptic ribbons. 
3. The overexpression of GCAP2 in the wildtype background (increasing GCAP2 to 
GCAP1 ratio) promotes ribbon disassembly, as observed by the shortened ribbons in 
GCAP2+/+ mice compared to WT and by the higher abundance of club-shaped and 
spherical ribbons, representative of assembly intermediates.  This effect is exacerbated 
in the absence of GCAP1. 
4. We propose that GCAP2 is involved in mediating the morphological changes at the 
synaptic ribbons triggered by changes in Ca2+ levels. 
5. Expression of a mutant form of GCAP2 impaired to bind Ca2+, bEF-GCAP2, in the rods 
of transgenic mice leads to a retinal degeneration that correlates with the loss of visual 
function that can be specifically assigned to the mutation and not to overexpression of 
the transgene. 
6. Transgenic bEF-GCAP2 in photoreceptors is excluded from rod outer segments where 
Ca2+-dependent GC modulation takes place, and accumulates at the inner segment 
and proximal compartments of the cell in a form incompetent to activate the cyclase. 
7. bEF-GCAP2 shows an abnormally enhanced phosphorylation in vivo as seen by in situ 
phosphorylation assays as well as by isoelectrofocusing gels. 
8. GCAP2 phosphorylation triggers 14-3-3 binding, as assessed by immunoprecipitation 
assays, and as indicated by retinal homogenate separation by size-exclusion 
chromatography. 
9. GCAP2 phosphorylation at Ser201 retains GCAP2 at the inner segment and proximal 
compartments, precluding its distribution to rod outer segments.  Ser201 mutation to 
Gly reverts this retention in vivo. 
10. We propose that GCAP2 phosphorylation and 14-3-3 binding determine GCAP2 
subcellular localization. 
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11. We propose that mutations in GCAP2 or light conditions that result in accumulation of 
GCAP2 in its Ca2+-free form at the inner segment of the cell lead to cell death due to 
GCAP2 conformational instability.  Importantly,  we propose that this would also apply 
to genetic conditions mimicking the effects of prolonged light exposure, the so-called 
“equivalent-light” scenarios. 
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A.1. LIST OF ABBREVIATIONS 
 
A   Å   Armstrong 
   aa   amino acid 
   Ab   antibody 
   ad   arciform density 
   AD   Alzheimer disease 
   adCD   autosomal dominant cone dystrophy 
   adCORD  autosomal dominant cone-rod dystrophy 
   adRP   autosomal dominant retinitis pigmentosa 
   AMPA   α-amino-3-hydroxy-5-methyl-4-isoxazole 
propionic acid 
   APP   amyloid precursor protein 
B   bc   bipolar cell 
   b or bov GCAP bovine GCAP 
   bp   base pairs 
   BSA   bovine serum albumin 
C   Ca2+   calcium 
   [Ca2+]free  calcium free concentration 
   [Ca2+]I    calcium initial concentration 
   CaCl2   calcium chloride 
   CaM   calmodulin 
   cAMP   cyclic adenosine monophosphate 
   cGMP   cyclic guanosine monophosphate 
   CO2   carbon dioxide 
   csr   club-shaped ribbons 
   CV   column volume 
D   DNA   deoxyribonucleic acid 
   dNTPs   nucleotides 
   DTT   dithiothreitol 
E   EC50   half maximal effective concentration 
   ECL   enhanced chemiluminescence 
EDTA   ethylene diamine tetraacetic acid 
e.g.   for example 
EGTA   ethylene glycol tetraacetic acid 
ER   endoplasmic reticulum 
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ERG   electroretinogram 
etc.   et cetera 
G   G
α
, G
β
, G
γ
  Subunits of transducin protein 
   GAP   GTPase- activating protein 
   GC   guanylate cyclase 
GCAP   guanylate cyclase activating protein 
GCIP   guanylate cyclase inhibiting protein 
GDNF   glial cell-derived neurotrophic factor 
GDP   guanosine diphosphate 
GFP   green fluorescent protein 
GMP   guanosine monophosphate 
GRK1   G protein-coupled receptor kinase 1 
GTP   guanosine triphosphate 
H   hc   horizontal cell 
   HCl   hydrochloric acid 
   HD   Huntington disease 
HEPES  2-[4-(2-hydroxyethyl)piperazin-1-yl] 
ethanesulfonic acid 
HPLC   high-performance liquid chromatography 
I   IBMX   1-methyl-3-(2-methylpropyl)-7H-purine- 
2,6-dione 
IEF   isoelectric focusing 
   IgG   immunoglobulin G 
K   K+   potassium 
KChIP   K+ channel-interacting protein 
KCl   potassium chloride 
kDa   kilodalton 
KO   knockout 
KOH   potassium hydroxide 
Kv channel  voltage-gated K+ channel 
L   LTD   long-term depression 
   LCA   Leber’s Congenital Amaurosis 
M   MAPK   mitogen-activated protein kinases 
Mg2+   magnesium 
MgCl2   magnesium chloride 
   mM   millimolar 
   MOPS   3-(N-morpholino)propanesulfonic acid 
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   ms   millisecond 
   myr   myristoylated 
N   Na+   sodium 
   NaCl   sodium chloride 
   NAD(H)  nicotinamide adenine dinucleotide 
   NaFl   sodium fluoride 
   NaH2PO4  sodium phosphate 
   Na2CO3  sodium carbonate 
NCS   neuronal calcium sensor 
   nM   nanomolar 
   NMR   nuclear magnetic resonance 
O   OCT   optimal cutting temperature compound 
ONL   outer nuclear layer 
   OPL   outer plexiform layer 
P   32Pi   radioactively labeled inorganic phosphate 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
PD   Parkinson disease 
PDE   phosphodiesterase 
PKC   protein kinase C 
PKG   protein kinase G 
PMA   plant plasma membrane H+-ATPase 
PMSF   phenylmethanesulfonylfluoride 
R   R9AP   RGS9 anchoring protein 
RD3   retinal degeneration 3 protein 
RetGC   retinal guanylate cyclase 
   RGS9   regulator of G-protein signalling 9 
   RIS   rod inner segment 
   ROS   rod outer segment 
   RP   retinitis pigmentosa 
RRP   readily releasable pool 
S   s   second 
   SCA   spinocerebellar ataxin 
   SDS   sodium dodecyl sulfate 
   SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel 
SNARE complex SNAP (Soluble NSF Attachment Protein) 
REceptor complex 
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sr synaptic ribbon 
ss synaptic sphere 
U   μM   micromolar 
   µCi   microcurie 
V   VSNL   visinin-like protein 
W   wt   wildtype 
Z   zGCAP  GCAP from zebrafish 
   Zn(OAc)2  zinc acetate 
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A.2. STANDARD AMINOACIDS 
Amino Acid 3-Letter 1-Letter Side-chain 
polarity 
Side-chain charge 
(pH 7.4)  
Hydropathy 
Alanine Ala A Nonpolar neutral 1.8 
Arginine Arg R Basic polar positive −4.5 
Asparagine Asn N Polar neutral −3.5 
Aspartic acid Asp D acidic polar negative −3.5 
Cysteine Cys C Nonpolar neutral 2.5 
Glutamic acid Glu E acidic polar negative −3.5 
Glutamine Gln Q Polar neutral −3.5 
Glycine Gly G Nonpolar neutral −0.4 
Histidine His H Basic polar positive(10%)/ 
neutral(90%) 
 
−3.2 
Isoleucine Ile I Nonpolar neutral 4.5 
Leucine Leu L Nonpolar neutral 3.8 
Lysine Lys K Basic polar positive −3.9 
Methionine Met M Nonpolar neutral 1.9 
Phenylalanine Phe F Nonpolar neutral 2.8 
Proline Pro P Nonpolar neutral −1.6 
Serine Ser S Polar neutral −0.8 
Threonine Thr T Polar neutral −0.7 
Tryptophan Trp W Nonpolar neutral −0.9 
Tyrosine Tyr Y Polar neutral −1.3 
Valine Val V Nonpolar neutral 4.2 
Table A.1. Standard amino acid abbreviations and properties 
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A.3. GCAPs AND DISEASE 
Until now, GCAPs mutant proteins have been described to be involved in the following 
retinal diseases (all of them with a dominant phenotype) (Table A.2): on one hand, 
GCAP1 mutants lead to autosomal dominant cone dystrophy (adCD) and autosomal 
dominant cone-rod dystrophy (adCORD) (see INTRODUCTION: Molecular basis of 
inherited retinal dystrophies: GCAPs mutations and disease). On the other hand, in 
three independent Asian families was found G157R mutation in GCAP2 that leads to 
retinitis pigmentosa (RP) and in some cases to dominant macular dystrophy (Sato et al. 
2005). 
 
Symbols; 
OMIM 
Numbers 
Location Diseases; Protein How Identified; 
Comments 
References 
GUCA1A, 
COD3, 
CORD14, 
GCAP1; 
120970, 
602093, 
600364 
6p21.1 Dominant cone 
dystrophy; dominant 
cone-rod dystrophy; 
protein: guanylate 
cyclase activating 
protein 1A [Gene] 
linkage mapping, 
candidate gene; British 
family with constitutively 
active mutant; variable 
phenotype within families 
Downes 01; 
Payne 97; 
Payne 98, 
Sokal 98 
GUCA1B, 
GCAP2, 
RP48; 
268000, 
602275, 
613827 
6p21.1 Dominant retinitis 
pigmentosa; 
dominant macular 
dystrophy; protein: 
guaylate cyclase 
activating protein 1B 
[Gene] 
Candidate gene ; 
Gly157Arg mutation in 
Japanese families with 
variable phenotype ; no 
pathologic changes found 
in 400 Bristish patients 
with dominant 
retinopathies 
Payne 99a; 
Sato 04 
 
Table A.2. GUCA1A and GUCA1B data extracted from “Genes and map loci causing general disease” in 
webpage: https://sph.uth.edu/Retnet/home.htm.  
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Overexpression of Guanylate Cyclase Activating Protein
2 in Rod Photoreceptors In Vivo Leads to Morphological
Changes at the Synaptic Ribbon
Natalia Lo´pez-del Hoyo1., Lucrezia Fazioli1., Santiago Lo´pez-Begines1, Laura Ferna´ndez-Sa´nchez2,
Nicola´s Cuenca2, Jordi Llorens1,3, Pedro de la Villa4, Ana Me´ndez1,5*
1 Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain, 2Department of Physiology, Genetics and Microbiology, Universidad de Alicante, Alicante, Spain,
3Department of Physiological Sciences II, University of Barcelona-Bellvitge Health Science Campus, Barcelona, Spain, 4Department of Physiology, University of Alcala´ de
Henares, Madrid, Spain, 5Department of Pathology and Experimental Therapeutics, University of Barcelona-Bellvitge Health Science Campus, Barcelona, Spain
Abstract
Guanylate cyclase activating proteins are EF-hand containing proteins that confer calcium sensitivity to retinal guanylate
cyclase at the outer segment discs of photoreceptor cells. By making the rate of cGMP synthesis dependent on the free
intracellular calcium levels set by illumination, GCAPs play a fundamental role in the recovery of the light response and light
adaptation. The main isoforms GCAP1 and GCAP2 also localize to the synaptic terminal, where their function is not known.
Based on the reported interaction of GCAP2 with Ribeye, the major component of synaptic ribbons, it was proposed that
GCAP2 could mediate the synaptic ribbon dynamic changes that happen in response to light. We here present a thorough
ultrastructural analysis of rod synaptic terminals in loss-of-function (GCAP1/GCAP2 double knockout) and gain-of-function
(transgenic overexpression) mouse models of GCAP2. Rod synaptic ribbons in GCAPs2/2 mice did not differ from wildtype
ribbons when mice were raised in constant darkness, indicating that GCAPs are not required for ribbon early assembly or
maturation. Transgenic overexpression of GCAP2 in rods led to a shortening of synaptic ribbons, and to a higher than
normal percentage of club-shaped and spherical ribbon morphologies. Restoration of GCAP2 expression in the GCAPs2/2
background (GCAP2 expression in the absence of endogenous GCAP1) had the striking result of shortening ribbon length to
a much higher degree than overexpression of GCAP2 in the wildtype background, as well as reducing the thickness of the
outer plexiform layer without affecting the number of rod photoreceptor cells. These results indicate that preservation of
the GCAP1 to GCAP2 relative levels is relevant for maintaining the integrity of the synaptic terminal. Our demonstration of
GCAP2 immunolocalization at synaptic ribbons at the ultrastructural level would support a role of GCAPs at mediating the
effect of light on morphological remodeling changes of synaptic ribbons.
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Introduction
Photoreceptor cells in the retina sense the light intensity at
different points in the visual field. They transduce absorbed
photons into graded changes in membrane potential that set the
rate of neurotransmitter release to bipolar and horizontal cells. A
neural signal is thereby relayed from photoreceptor to bipolar cells
that is in turn conveyed to ganglion cells. The neural circuitry
involved in the convergence of this signal is what emphasizes the
spatial differences in light intensity that are processed by ganglion
cells to evoke the distinct visual functions [1].
Because light intensities in the natural world can vary over ten
orders of magnitude, one fundamental ability of rod and cone
photoreceptor cells is to sense and reliably transmit fine gradations
in light intensity covering a broad dynamic range. To accomplish
this, photoreceptor cells avoid spikes and finely grade the
quantized synaptic output with graded changes in membrane
potential [2,3]. Like sensory receptors in the auditory and
vestibular systems, they rely on specialized synapses that support
the continuous neurotransmitter release at high rates [4,5]. A
hallmark of these synapses is a specialized structure, the ‘‘ribbon’’
or ‘‘dense body’’, a plate-like proteinaceous scaffold that anchors
to the active zone just adjacent to the clustered voltage-gated
calcium channels[6–9]. Ribbons presumably facilitate focal
exocytosis at high throughput by targeting vesicular fusion and
the molecular components that trigger this fusion to the proximity
of sites of Ca2+ influx[10–12].
Synaptic ribbons are heterogeneous organelles present in
various forms in different cell types, such as spherical, ellipsoid,
or bar-shaped structures, with different shapes in hair cells being
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associated with different functional properties [5,6]. In rod
synapses of the mouse retina of the albino Balb/c strain synaptic
ribbons undergo dynamic turn-over changes depending on
illumination. Ribbons tend to disassemble in response to
illumination by releasing ribbon material in spherical modules;
and elongate by regaining ribbon material during dark-adapta-
tion[13–16]. This illumination-dependent ribbon remodeling was
reported to affect visual function in Balb/c mice [13]. Whether
these light-dependent ribbon turn-over changes can be regarded as
a general mechanism for light adaptation is questionable based on
the variability observed between mouse strains. Illumination-
dependent ribbon remodeling changes are minor in pigmented
C57Bl/6 mice compared to Balb/c [17]. Therefore the physio-
logical significance of the light-dependent ribbon turn-over
changes is not yet clear.
Mechanistically, the illumination-dependent disassembly of
ribbons is known to depend on the drop in intracellular Ca2+ at
the synapse caused by the light-triggered hyperpolarization of the
cell. Disassembly has been experimentally induced in in situ retinas
by chelating extracellular Ca2+ with EGTA/BAPTA[14–16,18]. A
member of the neuronal calcium sensor (NCS) family of EF-hand
containing proteins, Guanylate Cyclase Activating Protein 2
(GCAP2), has been recently proposed as a prime candidate for
mediating the Ca2+-dependent structural changes of ribbons [19].
Guanylate Cyclase Activating Proteins (GCAPs) are EF-hand
containing Ca2+ binding proteins that were characterized as the
proteins that confer Ca2+ sensitivity to retinal guanylate cyclase at
the outer segment discs of rods and cones[20–23]. The two main
isoforms, GCAP1 and GCAP2, are thought to be associated to the
cyclase and regulate its catalytic activity in response to small
fluctuations in Ca2+. GCAPs shift between a ‘‘Ca2+-bound state’’
that inhibits the cyclase catalytic activity, and a ‘‘Mg2+-bound
state’’ that stimulates cyclase activity. Both GCAPs display high
Ca2+ sensitivity, with GCAP2 Ca2+ sensitivity being slightly higher
than GCAP1 (EC50Ca for GCAP1 , 132–139 nM and EC50Ca for
GCAP2 , 50–59 nM, [24]). At the high intracellular Ca2+
concentration typical of rod outer segments in the dark steady-
state GCAPs inhibit guanylate cyclase activity. When the
intracellular free Ca2+ is reduced in response to light, GCAP1
and GCAP2 sequentially respond to this Ca2+ decline by shifting
from their ‘‘inhibitory’’ to their ‘‘stimulatory’’ state of the cyclase,
to promote the restoration of cGMP to the levels of the darkness
equilibrium [25]. By counteracting the effect of light this way,
GCAPs play a fundamental role in termination of the light
response and in the process of light adaptation [26,27].
In addition to the outer segment, GCAP1 and GCAP2 also
localize to the inner segment compartment and to the synaptic
terminal of photoreceptor cells, where their function is unclear
[28,29]. GCAP2 has been proposed to mediate the Ca2+ -
dependent structural changes of ribbons based on the following
observations: i) GCAP2 interacts with Ribeye, the main protein
component of synaptic ribbons; ii) GCAP2 colocalizes with Ribeye
at ribbon synapses; and iii) GCAP2 overexpression in photore-
ceptor cells achieved by viral infection of retinal explants led to the
disassembly of the synaptic ribbon in a high percentage of synaptic
terminals [19].
To study the function of GCAPs at rod synaptic terminals, and
to test whether GCAP2 (and/or GCAP1) might mediate the Ca2+-
dependent ribbon morphological changes that take place during
dark/light adaptation, we analyzed structural alterations in
ribbons from GCAP1/GCAP2 double knockout or GCAP2-
overexpressing mice. We here demonstrate that GCAP2 overex-
pression in rods leads to the shortening of synaptic ribbons in vivo.
Interestingly, we have seen that mice that lack GCAP1 and
GCAP2 (GCAPs2/2mice) develop and maintain normal ribbons
whereas mice that lack GCAP1 but express GCAP2 (GCAPs2/
2GCAP2+ mice) display severely shortened ribbons at 40 days of
age. That is, the lack of GCAP1 exacerbates GCAP2 effect at
shortening synaptic ribbons. These histological observations,
together with the functional phenotype of these mice, indicate
that GCAP1 and GCAP2 can have opposing effects on ribbon
length, likely through a combination of indirect (through their
effect on cGMP metabolism and membrane potential) and more
direct (at the synapse) effects. A direct function of GCAP2 at
promoting the disassembly of ribbon material from the ribbon
would be supported by GCAP2 ultrastructural localization in
clusters at the ribbon.
Materials and Methods
Ethics Statement
The care and use of animals was done in compliance with Acts
5/1995 and 214/1997 for the welfare of experimental animals of
the Autonomous Community (Generalitat) of Catalonia, and
approved by the Ethics Committee on Animal Experiments of the
University of Barcelona.
Mouse Genetic Models
The GCAP1/GCAP2 double knockout line (GCAPs2/2 mice)
was produced by simultaneous disruption of the GUCA1A and
GUCA1B genes that are organized in a head-to-head gene array
in the genome [27]. The generation of transgenic mice that
express bovGCAP2 in rods under the control of the mouse opsin
promoter and the determination of GCAP2 transgene expression
levels have been described [27].
Antibodies and Fluorescent Dyes
The GCAP2 antibody used in Western blots, indirect immu-
nofluorescence assays and electron microscopic immunolocaliza-
tion is a polyclonal antibody raised in rabbit against a His-tagged
recombinant form of bovGCAP2 expressed in bacteria. Antibodies
were affinity-purified with a recombinant GCAP2 affinity column.
For indirect immunofluorescence assays GCAP2 Ab was used at a
1:400 working dilution from a 1 mg/ml stock. Ribeye immuno-
labeling of synaptic ribbons was performed with a monoclonal
antibody anti-CtBP2 (BD biosciences 612044, 1:250). The GCAP1
antibody is a polyclonal antibody raised in rabbit against a His-
tagged recombinant form of human GCAP1, and was affinity-
purified.
To label retinal cell types we used primary antibodies directed
against the following molecules: Transducin Gc c subunit
(Cytosignal PAB-00801-G Ab, 1:200, for cone pedicules);
Calbindin D (Swant CB-38a Ab, 1:500, for horizontal cells);
Protein Kinase C a isoform, PKCa (Santa Cruz Biotechnology sc-
10800 Ab, 1:100, for rod-on bipolar cells); Bassoon (Stressgen
VAM-PS003 mAb, 1:1000, for arciform densities in rods and
cones); and Synaptophysin, SYP (Chemicon MAB5258 mAb,
1:1000, for rod spherules and cone pedicules). Secondary
antibodies for immunofluorescence were Alexa 488 goat anti-
rabbit IgG [Molecular Probes A-21206]; Alexa 555 goat anti-
mouse IgG [Molecular Probes A-31570] and Alexa 633 goat anti-
guinea pig IgG [Molecular Probes A-21105], used at a 1:100
dilution.
Immunofluorescence Microscopy
For immunofluorescence microscopy, mice were sacrificed and
eyes were marked at the superior center for orientation purposes.
Immediately after enucleation the eyes were punctured with a
GCAPs Effect on the Ribbon at Rod Synapses
PLOS ONE | www.plosone.org 2 August 2012 | Volume 7 | Issue 8 | e42994
needle and submerged in fixative: 4% paraformaldehyde; 0,02%
glutaraldehyde in phosphate buffer saline at pH7.4. At 5 min into
the fixation step the cornea was excised, at 20 min the lens was
removed and eye cups were further fixed for a total of 2 h at room
temperature. Eye cups were infiltrated in acrylamide (8,4%
acrylamide, 0,014% bisacrylamide in PBS pH7.4 for 14 h before
acrylamide polymerization was induced) or in sucrose (30% w/v in
PBS pH7.4 for 14 h), and included in OCT compound.
Cryosections along the vertical axis of the eyecup were obtained
at 20 mm-thickness using a CM1510S Leica cryostat (Leica
Microsystems). Sections were incubated with blocking solution
(3% normal goat serum, 1% BSA, 0,3% Triton X100 in PBS
pH7.4, 1 h at room temperature); first antibody (14 h at 4uC),
secondary antibody (1 h at room temperature), and fixed for
15 min in 4% paraformaldehyde prior to being mounted with
Mowiol [Calbiochem 475904]. An antigen retrieval treatment of
retinal sections (incubation in 0,05 mg/ml proteinase K in PBS
pH7.4 for 2 min at room temperature followed by a heat shock at
70uC for 10 sec) was needed for GCAP2 immunostaining. Images
were acquired at a laser scanning confocal microscope (Leica
TCS-SL and TCS-SP2). For measurements of outer plexiform
layer (OPL) thickness, pictures were taken at four different
positions in the retinal vertical meridian (A, B, C and D). These
regions, at 800 mm from the superior edge (A), equidistant from
point A and the optic nerve (B), at 750 mm from the optic nerve in
the inferior retina (C) and equidistant from C and the inferior edge
(D) were marked at 106 magnification by photobleaching the
fluorescent signal next to the point of interest. By using the
photobleached areas as a reference, pictures at A, B, C and D
positions were taken at 636magnification. Measurements of OPL
thickness were taken at each point in the different phenotypes by
determining the width of the GCAP2 (or Ribeye) immunolabeled
bands with the Leica LAS AF Lite image acquisition software.
Three different measurements were taken per point to calculate
the average for each retina specimen, and at least four mice per
phenotype were analyzed to calculate the mean.
Retinal Preparation for Light Microscopy and Electron
Microscopy
For the ultrastructural analysis of rod synaptic terminals the
different mouse lines were raised in constant darkness by
maintaining cages in aerated dark cabinets. They were sacrificed
under dim red light at postnatal day 40 (dark conditions); or
exposed to 1500 lux white fluorescent light for 1 or 5 h after pupil
dilation with a mixture of 0.75% tropicamide and 2.5%
phenylephrine hydrochloride (light conditions) and immediately
sacrificed. For orientation purposes, a mark was imprinted at the
superior center of the eye before enucleation. Immediately after
enucleation the eye was punctured with a 30-G needle and fixed in
2% paraformaldehyde, 2.5% glutaraldehyde in 0.1 M cacodylate
buffer for 5 min. An incision was made around the ora serrata and
fixation was allowed to proceed for 1 h. The cornea and lens were
removed and the eye cup was further fixed for 12 h at 4uC. After
this fixation step, eye cups were washed with 0.1 M cacodylate
buffer and fixed with 1% osmium tetroxide (OsO4) in 0.1 M
cacodylate buffer for 2 h at room temperature. Specimens were
dehydrated in ethanol (30–100%) or acetone, infiltrated with
propylene oxide and embedded in Epoxi embedding medium
(Fluka Analytical).
To measure synaptic ribbons in GCAP2+ and WT littermate
control mice, 4 GCAP2+ and 3 WT littermate controls were raised
in 12 h:12 h dark-light standard cyclic light and were processed at
p60 at the end of the dark period. Processing of the eyes for
conventional electron microscopy was done as described.
Ultrathin Sectioning, Image Acquisition and Analysis at
the Transmission Electron Microscope
Ultrathin sections (70–90 nm) in the vertical meridian of the eye
cup were made using a Reichert Ultracut S ultramicrotome
(Leica), collected on 200 mesh copper grids, counterstained with
heavy metal staining (2% uranyl acetate in 50% ethanol for
30 min) and contrasted with 2% lead citrate for 10 min. Ultrathin
sections were analyzed in a JEOL 1010 or a Tecnai Spirit Twin
[FEI] 120 Kv LaB6 transmission electron microscope. Images
were obtained with a Bioscan Gatan wide angle slow scan CCD
camera. In order to determine the ribbon length in the different
mouse lines, at least two different specimens were analyzed per
phenotype. Two to ten 16616 mm frames at 8,0006magnification
were delimited per Epon block, that typically contained 10 to 22
rod synaptic terminals. At a given plane of sectioning along the
vertical axis in the center of the eye cup, the synaptic ribbon was
visible in about 60–70% of the synaptic terminals, and about 40%
of all terminals presented ribbons discernible as resulting from
transversal cuts (Table S1). Contrary to ribbons from longitudinal
or oblique cuts that result in variable shapes and sizes, transversal
cuts are easily recognized as defined lines anchored at the arciform
density between the two invaginating processes of horizontal cells,
and their length should represent the length of the ribbon plate at
any point. Therefore, once the 8,0006magnification frames were
delimited, all synaptic terminals contained in the frame were
individually scanned at 100,0006 magnification, and length
measurements were taken from ribbons resulting from tangential
cuts by using the ImageJ software. Cone synaptic terminals were
excluded from the analysis.
For determination of synaptic terminal size [mm2], micrographs
of the OPL area were obtained at the electron microscope at low
magnification [x8000], and ImageJ was used to obtain the
dimensions of delimited regions of interest with the form of the
synaptic terminals.
To determine the percentage of synaptic terminals containing a
synaptic ribbon, the number of total synaptic terminals was
determined in five 16616 -mm2 frames per fenotype, and the
number of terminals containing a longitudinal, transversal or
sagittal ribbon were counted. A percentage was calculated per
frame, and the five results obtained per phenotype were averaged.
Immunoelectron Microscopy
For immunoelectron labeling of GCAP2 and Ribeye in
GCAPs2/2GCAP2+ mice and GCAPs2/2 negative control
mice, dark-reared mice at p40 were sacrificed in dim light. The
eyes were marked, enucleated and immediately fixed in 2%
paraformaldehyde in phosphate buffer saline at pH7.4 for 2 h at
room temperature, following the puncture and dissection steps
described above. In order to preserve antigenicity while main-
taining ultrastructure, immediately after fixation eye cups were
processed by a progressive lowering temperature (PLT) protocol of
dehydration and embedding in Lowicryl resin. Dehydration
protocol was: [0uC, 30 min 30% ethanol; 220uC, 60 min 50%
ethanol; 235uC, 60 min 70% ethanol; 235uC, 60 min 95%
ethanol; 235uC, 60 min 100% ethanol; 235uC, 60 min 100%
ethanol]. Infiltration was performed with Lowicryl embedding
media K4M: [235uC, 60 min resin:ethanol 1:3; 235uC, 60 min
pure resin; 235uC, 16 h pure resin]. The resin was polymerized
by long wavelength UV irradiation for at least 24 h. Ultrathin
sections were incubated at room temperature in blocking solution
(1% BSA, 20 mM glycine in PBS pH7.4, for 30 min), first
antibody (anti-Ribeye Ab, for 2 h) and secondary antibody (5 nm
or 15 nm gold-conjugated goat anti-mouse IgG, BBInternational,
for 1 h); and the process was subsequently repeated for GCAP2
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immunolabeling, by repeating the blocking step and incubating
with antibody (anti-GCAP2 Ab, for 2 h) and secondary antibody
(5 nm or 15 nm gold-conjugated goat anti-rabbit IgG, BBInterna-
tional, for 1 h). After washes, sections in the gold grids were
counterstained with heavy metal staining (2% uranyl acetate in
50% ethanol for 10 min) and contrasted with 2% lead citrate for
5 min.
Sections were observed at a JEOL JEM1010 transmission
electron microscope at 80 Kv and images were obtained with a
Bioscan Gatan wide angle slow scan CCD camera.
To assess specificity of the association of gold-particles to
GCAP2 antigenicity in the GCAPs2/2GCAP2+ specimens, the
number of gold particles associated to synaptic ribbons were
counted in 74 synaptic terminals randomly selected from two
specimens, and compared to that of GCAPs2/2 negative control
samples. Out of 74 randomly selected synaptic terminals in the
GCAPs2/2GCAP2+ sample, 12 out of 74 (about 16%) had at
least one gold particle associated to the synaptic ribbon, and 20 out
of 74 (about 27%) showed association of gold particles to the
presynaptic plasma membrane in apposition to the invaginated
processes of horizontal cells; whereas in the GCAPs2/2 only 6%
of the ribbons analyzed showed associated gold particles and only
16% showed association of gold particles to the membrane
delineating the invaginating horizontal dendritic processes.
Therefore, we consider the micrographs presented in this study
to be an accurate illustration of GCAP2 intracellular localization
at the synaptic terminal.
Electroretinogram Analysis
Electroretinogram (ERG) recordings were performed in 12 h
dark-adapted deeply anesthetized mice. Recordings were acquired
with a Burian-Allen mouse electrode set on a corneal lens
specifically designed to fit the mouse eye (Hansen Ophthalmic
Development Lab), with the reference electrode positioned at the
mouth and the ground grasped on the tail. Pupil from the right eye
was dilated, and flash-induced ERG responses were recorded in
response to light stimuli produced with a Gansfeld stimulator. The
intensity of light stimuli ranged from 24 to 2 log cd.s.m22. For
each light intensity, responses from four consecutive light
presentations were averaged. The range of light intensities from
24 to 21,52 log cd.s.m22 elicited rod-mediated responses. In the
range from 21,52 to 0,48 log cd.s.m22 ERG recordings reflected
mixed responses from rods and cones. Pure cone responses were
recorded after inducing rod saturation by exposing the mouse to a
30 cd/m2 background light for 10 min, and then applying light
stimuli in the range of 20,52 to 2 log cd.s.m22 superimposed to
the background. ERG signals were amplified and band filtered
between 0.3 and 1000 Hz (Grass CP511 AC amplifier), digitized
at 10 kHz with a Power Lab data acquisition board (ADI
instruments) and analyzed off-line by measuring the amplitudes
of the a-wave (from the baseline to the peak of the a-wave) and of
the b-wave (from the peak of the a-wave to the peak of the b-
wave). ERG measurements were done on a blind basis with
respect to the mouse phenotype.
Retinal Morphometry
For retinal morphometry analysis of GCAPs2/2 and
GCAPs2/2GCAP2+ retinas, a high magnification picture of
the whole retina under study was obtained by fusion (HUGIN
software) of three 206overlapping frames covering the length of a
vertical section from central retina. Pictures were taken with the
ProgResCapturePro 2.6 software in a Stereo Lumar V12
stereoscopic microscope (Zeiss) coupled to a Jenoptik camera.
On whole retina-pictures, lines were traced from an imaginary
point at the center of the retina semicircumference to the optic
nerve and to the superior and inferior borders, dividing the retina
in its superior and inferior quadrants; and then to marks traced at
200 mm intervals starting from the optic nerve that divided the
superior retina into 12 equal divisions and the inferior retina into
11 divisions. Marks were numbered 1 to 10 starting at the second
mark from the optic nerve towards the superior edge, and from
21 to 210 at equivalent positions in the inferior retina. At each
marked position the onl thickness was determined by taking three
measurements with the ProgResCapturePro 2.6 software and
averaging them. To obtain the graph comparing the morphomet-
ric analysis in GCAPs2/2GCAP2+ versus GCAPs2/2, at least
three animals per phenotype were used.
Results
Mouse Models of Gain-of-function and Loss-of-function
of GCAP2 Show Morphological Alterations at the Outer
Plexiform Layer, Pointing to a Role of GCAP2 at the
Synaptic Terminal of Photoreceptors
In order to gain insight into the roles that GCAP1 and GCAP2
may play at the synaptic terminal, and whether they might
mediate the light-triggered morphological changes of photorecep-
tor ribbons, we performed a detailed morphological analysis of the
outer plexiform layer (OPL) in retinas from mouse models of gain-
of-function of GCAP2 and loss-of-function of GCAP1 and
GCAP2.
The mouse lines used in this study are summarized in Fig. 1 and
Table 1. To study the effect of GCAP2 overexpression on the
morphology and function of rod synaptic terminals in vivo, we used
a previously characterized transgenic line that expresses GCAP2 in
rods under the mouse opsin promoter [Fig. 1A]. This line
expresses heterologous GCAP2 (bovine GCAP2, bigger than the
murine isoform in three amino acids) at 1,5-fold the endogenous
GCAP2 levels [Fig. 1B], and is referred to as GCAP2+ in Table 1.
By breeding this original transgenic line to transgene homozygosis
we obtained a line in which transgenic GCAP2 was expressed to 3-
fold the endogenous level of GCAP2 (GCAP2+/+, Fig. 1D,
Table 1). These mice showed virtually normal retinas for up to six
months of age when raised in standard cyclic light conditions. No
noticeable signs of retinal degeneration were observed by light
microscopy in mice raised in constant darkness at postnatal day 40
[Fig. 1C].
As a mouse model of loss-of-function we used the double knock-
out in GCAP1 and GCAP2 (referred to as GCAPs2/2 [27]).
These mice were originally obtained by homologous recombina-
tion in embryonic stem cells with a single replacement vector,
because the GUCA1A and GUCA1B genes encoding GCAP1 and
GCAP2 are contiguous in the genome. Mice deficient in GCAP1
and GCAP2 lack the rapid and robust Ca2+ feedback signal to
cGMP synthesis set in place by light, and show slower light
response kinetics, enhanced sensitivity to light and impaired light
adaptation. Despite this marked functional phenotype, retinas
from GCAPs2/2 mice show normal appearance for up to 5
months of age when mice are raised in standard cyclic light [27]
[Fig. 1E]. A transgenic line that expresses GCAP2 in the absence
of GCAP1 was obtained by breeding the GCAP2+ line to the
GCAPs2/2 line. GCAP2 expression in this line restores the
endogenous GCAP2 localization and function [27]. Retinas from
these mice show a normal outer nuclear layer thickness for at least
5 months of age [Fig. 1E].
To study whether the loss of expression of both GCAP1 and
GCAP2 in the GCAPs2/2 mice or the selective restoration of
GCAP2 expression in this line has an effect on the synaptic
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Figure 1. Mouse models of overexpression of GCAP2 and loss-of-function of GCAP1 and GCAP2 used in the study. A. GCAP2
transgene construct. MOP, 4.4 kb-version of the mouse opsin promoter; bGCAP2, cDNA of bovine GUCA1B gene encoding guanylate cyclase
activator protein 2 (GCAP2); MP1pA, polyadenylation signal of mouse protamine gene 1. B. Western blot of total retinal homogenates illustrating
GCAP2 level of expression in the GCAP2+ line. Equivalent fractions of a retina (1/10) of WT and GCAP2+ mice were resolved in a 12% SDS-PAGE,
transferred to a nitrocellulose membrane and incubated with a polyclonal Ab anti-GCAP2. The bovine (transgenic) and murine (endogenous) isoforms
of GCAP2 can be resolved on the basis of their 3-aa difference in size. In the GCAP2+ transgenic line bGCAP2 is expressed to 1.5-fold the endogenous
GCAP2 expression [27]. C. Light micrographs of vertical sections of the retina of dark-reared WT, GCAP2+ and GCAP2+/+ (transgenic line bred to
homozygosity, that expresses transgenic GCAP2 to 3-fold the endogenous GCAP2 level) at postnatal day 40. Mice overexpressing GCAP2 show at this
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terminals of rods and cones, the OPL in retinal sections from p40
mice was immunolabeled with an antibody anti-Ribeye, the major
protein component of synaptic ribbons. Sections were co-stained
with an antibody anti-GCAP2. Measurements of OPL thickness
were taken at the confocal microscope at four points along the
retinal vertical meridian (A, B, C and D shown in Fig. 2B inset, see
Methods). The retinas analyzed in this study were obtained from
mice raised in complete darkness to avoid secondary changes at
the synaptic terminal that could derive from differences in the gain
of the light response at the rod outer segment among different
mouse models. The absence of both GCAP1 and GCAP2 in the
GCAPs2/2 mice had a minor effect on OPL thickness, which
was significant only in the upper retina. However, expression of
GCAP2 in the absence of GCAP1 caused a 40% reduction in OPL
thickness along the entire length of the retina, indicating that the
size or the number of synaptic terminals was reduced [Fig. 2A].
This reduction of OPL thickness was not preceded by
photoreceptor cell death. GCAP2 expression in the absence of
GCAP1 did not cause noticeable morphological changes at the
outer segment, inner segment or outer nuclear layers of the retina
[Fig. 2A]. GCAPs2/2GCAP2+ mice showed an outer nuclear
layer undistinguishable in thickness from that of GCAPs2/2
littermate control mice along the entire length of the retina
[Fig. 2C], indicating that the thinning of the OPL was not a
secondary consequence of ongoing photoreceptor cell death.
To study whether the magnitude of the reduction of the OPL
thickness in the GCAPs2/2GCAP2+ mice depends on whether
the mice are raised in constant darkness (with constant intracel-
lular Ca2+ levels at rod outer segments and tonic neurotransmitter
release at the synapse) or exposed to regular 12 h:12 h dark:light
cycles (with photoreceptor intracellular Ca2+ levels varying daily
between its dark and daylight values), the OPL from 40 day-old
mice raised either in constant darkness or in standard 12 h:12 h
dark:light cycles was stained with an anti-Bassoon antibody [Fig. 3]
and measurements of OPL thickness were taken at four points in
the retina vertical meridian. GCAPs2/2GCAP2+ mice raised in
cyclic light also presented an statistically significant reduction in
OPL thickness when compared to wildtype controls, although
slightly lower in magnitude than when mice were raised in
constant darkness (20–30% reduction of OPL thickness depending
on the retinal region, versus the 40% uniform reduction in dark
reared-mice, data not shown). Immunolabeling of cone pedicules
with an antibody for the Transducin Gc c subunit did not reveal
noticeable alterations in the synaptic terminals of cones or the
density of their synaptic ribbons among the different mouse
phenotypes [Fig. 3].
To determine whether the connections between photoreceptor
cells and horizontal and bipolar cells were affected, horizontal and
bipolar cells were immunolabeled with antibodies for Calbindin
and PKCa, respectively [Fig. 4]. Photoreceptor synaptic terminals
were highlighted with an antibody for Synaptophysin, SYP. There
was a reduction in the density and size of horizontal cell processes,
both in GCAPs2/2 and in GCAPs2/2GCAP2+ mice.
Remodeling changes were also apparent in the dendrites of
bipolar cells, which were more dramatic in GCAPs2/2GCAP2+
mice that were raised in constant darkness than in mice raised in
cyclic light, with shorter bipolar dendrites and loss of dendritic tip
terminals. Immunostaining of retinal sections with Bassoon also
showed a reduction in the density and size of synaptic ribbons in
the OPL of GCAPs2/2GCAP2+ mice respect to wildtype mice,
while no variation in OPL thickness is observed in GCAPs2/2
mice versus wildtype mice.
Together these results show that mice that express GCAP2 in
the absence of GCAP1 have a severe reduction in the thickness of
the OPL, with a decrease in the density of synaptic ribbons.
GCAP2 expression effect on retinal morphology is specific to the
outer plexiform layer, and is not accompanied by photoreceptor
cell loss by postnatal day 40. These OPL alterations are more
dramatic when mice are raised in constant darkness than when
they are raised under cyclic light conditions, and are accompanied
by remodeling changes that reduce the density of connecting
horizontal and bipolar cell processes.
Overexpression of GCAP2 in Rod Photoreceptors Leads
to Shorter Synaptic Ribbons and Increases the
Abundance of Ribbon Assembly Intermediates
To study whether GCAP2 overexpression in rods leads to the
shortening of synaptic ribbons at the ultrastructural level, the OPL
region of retinal ultrathin sections from transgenic mice expressing
GCAP2 to 2.5 or 4-fold the endogenous GCAP2 levels [GCAP2+
or GCAP2+/+ transgenic mice respectively, see Table 1] was
examined by transmission electron microscopy. The lengths of
transversal rod synaptic ribbons contained in two to eight 16616-
mm frames of OPL per specimen from at least two specimens per
phenotype were determined and averaged, and compared to those
of C57Bl control mice [Fig. 5 and Table S1, see Methods]. Mice
were reared in complete darkness and sacrificed at p40 under
dark-adapted conditions or following a 1–5 h period of light
exposure.
C57Bl mice that were raised in constant darkness to postnatal
day 40 and were processed in darkness presented ribbons that
measured on average 0,291560,0066 mm (n= 103 synaptic
ribbons from 5 mice), whereas littermate mice that were processed
after 1–5 h of light exposure showed ribbons that measured on
average 0,253460,0082 (n = 98 synaptic ribbons from 5 mice),
Table S1. This represents a 13% reduction of ribbon length in
age a normal retinal morphology. D. Expression of bGCAP2 transgene in the GCAP1/GCAP2 double knockout background (GCAPs2/2 background).
Western blot shows expression of transgenic bGCAP2 in the absence of endogenous GCAP2 in the GCAPs2/2GCAP2+ mice. E. Light micrographs of
vertical sections of the retina from GCAPs2/2 and GCAPs2/2GCAP2+ at 1, 3 or 5 months of age, when reared in standard cyclic light. Mice lacking
GCAP1 and GCAP2 retain the normal thickness of outer nuclear layer, that is, the normal number of photoreceptor cells for up to 8 months of age.
Mice in which GCAP2 expression is restored in the GCAPs2/2 background do not show obvious signs of retinal degeneration at the light microscopy
level.
doi:10.1371/journal.pone.0042994.g001
Table 1. transgene expression levels in the different mouse
lines.
Mouse strain GCAP1 expression * GCAP2 expression *
WT (C57Bl) 1 -fold 1 -fold
GCAPs2/2 0 0
GCAPs2/2GCAP2+ 0 1.5 -fold
GCAP2+ 1 -fold 1.5+1= 2.5 -fold
GCAP2+/+ 1 -fold 3+1= 4 -fold
*expressed respect to the endogenous protein level (1 -fold).
doi:10.1371/journal.pone.0042994.t001
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Figure 2. Mice that express GCAP2 in the GCAPs2/2 background show a reduction of outer plexiform layer (OPL) thickness
compared to wildtype mice. A. Immunolabeling of vertical retinal sections from WT, GCAPs2/2 and GCAPs2/2GCAP2+ mice with rabbit
polyclonal antibodies anti-GCAP2 and a monoclonal antibody against Ribeye(B)/CtBP2. GCAP2 antibodies give a strong immunolabeling signal at the
outer segment (os), inner segment (is) and outer plexiform layer (opl) of the retina. This signal is absent in GCAPs2/2 mice, and is restored in
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C57Bl mice following a 1–5 h period of light exposure, that was
statistically significant [Fig. 5A and 5C].
Transgenic expression of GCAP2 led to a shortening of synaptic
ribbons that correlated with transgene dosage, independently of
whether the mice were sacrificed in the dark or following light
exposure. GCAP2+ mice presented a 9,6% reduction whereas
GCAP2+/+ mice presented a 13,7% reduction in ribbon length
versus the C57Bl control when processed under dark-adapted
conditions [representative ribbons shown in Fig. 5A, statistical
analysis shown by black bars in Fig. 5C, see Table S1]. Under
light-adapted conditions the reduction was of 4% for GCAP2+
and of 17% for GCAP2+/+ when compared to the C57Bl light
value [Fig. 5A, grey bars in Fig. 5C].
Because illumination-dependent changes of photoreceptor
ribbon structure were shown to differ between mouse strains
[17] it was important to discard that minor variations in the
genetic background between GCAP2-transgenic and C57Bl mice
may account for the phenotype observed, given that the analysis of
GCAP2 gene dosage effect on ribbon length could not be
performed on littermate mice. Although the GCAP2-expressing
transgenic mice used in this study were back-crossed to C57Bl/6
GCAPs2/2GCAP2+ mice, in which the GCAP2 transgenic protein reproduces the endogenous GCAP2 intracellular localization. GCAP2 partially
colocalizes with Ribeye at ribbon synapses, as pointed by white arrows in WT magnified OPL panel, as previously reported [19]. This figure shows that
the expression of GCAP2 in the GCAPs2/2 background, that is, GCAP2 expression in the absence of GCAP1, leads to a substantial shortening of the
OPL: compare immunolabeling intensity and thickness of the OPL in WT and GCAPs2/2GCAP2+ panels. B. Statistical analysis of the outer plexiform
layer thickness in the WT, GCAPs2/2 and GCAPs2/2GCAP2+ phenotypes. Measurements of OPL thickness were taken at four different regions along
vertical sections of the central retina (A, B, C and D in inset) for each phenotype. WT, GCAPs2/2 and GCAPs2/2GCAP2+mice were raised in constant
darkness and processed at p40. OPL thickness was determined at each position based on measurements of the anti-GCAP2 Ab immunolabeled
region (left histogram) or anti-Ribeye mAb immunolabeled region (right histogram) at the laser scanning confocal microscope. In GCAPs2/2GCAP2+
mice the OPL thickness is reduced to 60–65% of the wildtype OPL. Values in histograms are the mean 6 standard deviation from measurements
taken from four mice per phenotype. * denotes P,0.01; ** denotes P,0.001 in the Student’s t-test. C. Mice that express GCAP2 in the absence of
GCAP1 (GCAPs2/2GCAP2+) retain the normal quantity of photoreceptor cells at p40 when raised in constant darkness. The retinal morphometry
analysis shows that outer nuclear layer thickness (in mm) at 200 mm intervals covering the whole length of the vertical central retina (left diagram) is
undistinguishable in GCAPs2/2 and GCAPs2/2GCAP2+ mice at p40 (overlapping graphs). Mean values 6 standard error were obtained from at
least three littermate mice per phenotype.
doi:10.1371/journal.pone.0042994.g002
Figure 3. Outer plexiform layer reduction in GCAPs2/2GCAP2+ mice takes place regardless of whether the mice are raised in
constant darkness or in 12 h dark : 12 h light cyclic light. Immunolabeling of synaptic active zones (arciform densities) with a monoclonal
antibody anti-Bassoon (in red), and cone pedicules with a polyclonal antibody anti-transducin c (in green) in WT, GCAPs2/2 and GCAPs2/2GCAP2+
retinas. Mice were either raised in darkness (two upper rows) or were raised in standard 12 h dark : 12 h cyclic light (two lower rows) and processed at
p40. OPL thickness in GCAPs2/2GCAP2+ mice was reduced to about 65% of wildtype thickness independently of the light-rearing conditions
[compare OPL thickness in WT and GCAPs2/2 GCAP2+ panels, arrows].
doi:10.1371/journal.pone.0042994.g003
GCAPs Effect on the Ribbon at Rod Synapses
PLOS ONE | www.plosone.org 8 August 2012 | Volume 7 | Issue 8 | e42994
Figure 4. Reduction in the density of horizontal and bipolar cell dendritic processes in mice that express GCAP2 in the GCAPs2/2
background. A. Immunolabeling of horizontal cells by indirect immunofluorescence with anti-Calbindin polyclonal antibodies [green signal] and
rod and cone synaptic terminals with a monoclonal antibody anti-Synaptophysin [SYP, red signal] in WT, GCAPs2/2 and GCAPs2/2GCAP2+ mice
raised in constant darkness. Note the reduction in density and complexity of horizontal cell processes in GCAPs2/2 and GCAPs2/2GCAP2+ retinas
compared to WT samples. B. Immunolabeling of bipolar cells with a polyclonal antibody against PKCa [blue signal] and detection of arciform densities
in rod and cone synaptic terminals with a monoclonal antibody anti-Bassoon [red signal]. Note the remodeling of bipolar cell dendrites that is taking
place at p40 in GCAPs2/2GCAP2+ samples associated to a reduction in the number and dimensions of synaptic ribbons and arciform density
structures at rod and cone synaptic terminals.
doi:10.1371/journal.pone.0042994.g004
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for at least four generations, they were originally obtained in a
C57Bl6DBA mixed genetic background [27].
To discard the contribution of genetic background effects,
synaptic ribbon length was compared in GCAP2+ versus
transgene-negative control mice [herein called WT] in the same
litter, raised in the same cage under standard cyclic light and
analyzed at p60. GCAP2 transgene expression led to a 10%
reduction in ribbon length compared to WT mice
[0,262160,0059 mm in transgene-positive mice, n = 131 from
four mice; versus 0,290260,0067 mm in WT mice, n= 135 from
three mice; Student’s t = 3,114, 264d.f., P = 0,002] [Fig. 5D].
Taken together these results indicate that the overexpression of
GCAP2 promotes the loss of ribbon material, both in dark-
adapted and light-adapted retinas.
It has been reported that as synaptic ribbons loose material in
the light adaptation process, different morphologies are observed
at the ultrastructural level, such as club-shape ribbons (csr) or
ribbons with a spherical form (sr) in tangential sections. This is
probably due to the fact that the ribbons, laminar in nature,
assemble and disassemble material in preformed spherical blocks
at focal points[14–16].
To study whether the overexpression of GCAP2 led to a higher
abundance of these ‘‘assembly intermediate’’ morphologies, the
percentage of club-shape and spherical ribbons was determined in
GCAP2+ and GCAP2+/+ versus C57Bl mice [Histogram in
Fig. 5E, Table S1]. While C57Bl mice that were raised in darkness
showed less than 1% of club-shaped/spherical ribbons, GCAP2+
and GCAP2+/+ mice raised in darkness showed a 4.8% and 3.6%
of these structures respectively, which represents at least a four-fold
increase in their relative abundance [Table S1]. In C57Bl mice
that were light-adapted for 1–5 h the percentage of club-shaped/
spherical ribbons increased to 8%, while in GCAP2+ or
GCAP2+/+ mice exposed to these same light conditions the
increase was even higher [14% and 18% of assembly intermedi-
ates respectively, Table S1].
Fig. 5B shows two representative visual fields from light-adapted
GCAP2+ and GCAP2+/+ samples, in which two and three club-
shape/spherical ribbons are present per visual field, respectively
[shown by arrows and magnified in subsequent panels]. This
density of club-shaped/spherical ribbons is not observed in the
C57Bl samples.
Taken together, the reduction of ribbon length and the increase
in the frequency of ribbon morphology intermediates indicate that
GCAP2 overexpression causes ribbon disassembly in vivo.
Occasionally, accumulations of electrodense particles that seem
like clusters of small vesicles (smaller in diameter than synaptic
vesicles) were observed in the vicinity of the ribbon and horizontal
cell processes [Fig. 5A, GCAP2+/+ panel, dark condition]. These
clouds of particles of unknown nature, that appear in synaptic
terminals irrespective of whether a synaptic ribbon is observed or
not, were more voluminous and appeared more frequently in
GCAP2+/+ mice than in wildtype mice. We speculate that they
might represent debris resulting from bulk membrane retrieval in
the process of synaptic vesicle recycling. This observation suggests
that GCAP2 might somehow interfere with their clearance.
GCAP2 and Ribeye Partially Colocalize at Synaptic
Ribbons
In order to study whether GCAP2 colocalizes with Ribeye at
synaptic ribbons at the ultrastructural level and whether it localizes
to ribbon assembly intermediates, we performed immunohisto-
chemistry at the electron microscopy level. For these studies we
used an affinity purified polyclonal antibody anti-GCAP2 gener-
ated in rabbit against recombinant GCAP2 protein. This antibody
is highly specific, recognizing a single protein band at 24 kDa in
Western blots (data not shown).
Immunolocalization of GCAP2 was assayed in sections from
GCAPs2/2GCAP2+ mice. Fig. 6A shows that the anti-GCAP2
antibody decorates the disc membranes at the rod outer segment
compartment, as expected. At the synaptic terminal, GCAP2 was
observed sparsed in the cytosolic space and occasionally associated
to synaptic ribbons, to the plasma membrane and to the
presynaptic membrane apposing horizontal cell processes [5nm-
gold particles, arrows in Fig. 6B and 6C]. This staining pattern
reproduces the GCAP2 immunostaining reported by confocal
microscopy, although the density of GCAP2 signal is much lower
at the ultrastructural level.
In order to assess the specificity of the occasional immuno-
staining of synaptic ribbons and the presynaptic membrane
apposing horizontal cell processes, the gold particles were counted
in more than 70 randomly selected synaptic terminals in the
GCAPs2/2GCAP2+ sample [e.g. synaptic terminals presented in
Fig. 6B and C] and GCAPs2/2 control sections. In the
GCAPs2/2GCAP2+ sample 16% of the analyzed synaptic
terminals presented at least one gold particle associated to the
ribbon, whereas only 6% of the synaptic terminals analyzed in the
GCAPs2/2 control presented gold particle association to the
ribbon. About 27% of synaptic terminals in GCAPs2/2GCAP2+
sections presented association of the gold particles to the plasma
membrane surrounding horizontal cell processes, whereas only
16% presented this association in the GCAPs2/2. Panels 6E-G
show longitudinal sections of synaptic ribbons in which GCAP2
immunostaining is observed in clusters [Fig. 6E-F, 5nm-gold
particles, arrows; Fig. 6G, 15nm-gold particles, arrows] colocaliz-
ing with Ribeye, that selectively marks the ribbon (arrowheads in
all panels). In tangential sections, GCAP2 is occasionally observed
Figure 5. Overexpression of GCAP2 in transgenic mice leads to shortening of ribbon length and to an increase in the fraction of
club-shape and spherical morphologies representing disassembling ribbons. A. Electron micrographs of rod synaptic terminals of dark-
reared C57Bl, GCAP2+ or GCAP2+/+ mice at p40 that were processed in darkness or immediately after 1–5 h of light exposure, showing transversal
sections of synaptic ribbons. Notice the difference in length in C57Bl [left], GCAP2+ [middle] and GCAP2+/+ [right panel] ribbons. In addition to
synaptic vesicles, vesicle-like particles that are smaller in diameter than synaptic vesicles were seen forming clusters in the cytosol [GCAP2+/+ panel].
These clusters found in the vicinity of the ribbons were more extensive in GCAP2+/+ samples than in C57Bl samples. B. Club-shape ribbons were
more abundant in GCAP2+ and GCAP2+/+ than in C57Bl samples. Two examples of the density of club-shape and spherical-ribbons are shown in
8,0006 visual fields of GCAP2+ and GCAP2+/+ retinal sections. Club-shape and spherical ribbons pointed by arrows are shown at higher
magnification in the right panels. C. Statistical analysis of ribbon length in C57Bl, GCAP2+ and GCAP2+/+ mice that were either raised in constant
darkness (D); or raised in constant darkness and subsequently exposed to 1–5 h light (L). A minimum of forty synaptic ribbons were measured from at
least two mice per phenotype. Plotted in the histogram are mean values 6 standard error. *** denotes P,0.0001 in Student’s t-test. ** denotes
P#0,001 in Student’s t-test. *denotes PP#0,01 in Student’s t-test. D. Statistical analysis of ribbon length in GCAP2+ and WT littermate control mice
raised in standard cyclic light and processed at p60. GCAP2-expressing mice showed a 10% reduction in ribbon length compared to WT littermate
controls. Notice the difference in the Y-axis scale. *** denotes P#0,0001 in Student’s t-test. E. Histogram comparing the percentage of club-shape and
spherical ribbons [of total synaptic ribbons] in C57Bl, GCAP2+ and GCAP2+/+ at p40 processed in darkness [D] or immediately after 1 h or 5 h of light
exposure.
doi:10.1371/journal.pone.0042994.g005
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in the ribbon [Fig. 6I, arrow] and/or in the proximity of the
arciform density [Fig. 6J, arrow]. Pictures showing GCAP2
association to the membrane apposing invaginating dendritic
processes of horizontal cells are shown in Fig. 6H-J. Club-shaped
ribbons that were extensively labeled with anti-Ribeye antibody
did not show labeling with the anti-GCAP2 antibody [Fig. 6K,L].
The fact that GCAP2 appears to be occasionally associated with
the ribbon in clusters rather than showing a more extensive and
homogeneous ribbon distribution might reflect a transient nature
of the interaction of GCAP2 with the ribbon structural compo-
nents.
GCAP1/GCAP2 Double Knockout Mice have Unaltered
Ribbons, but the Effect of GCAP2 Overexpression at
Shortening Synaptic Ribbons is Magnified in the Absence
of GCAP1
In order to study how the loss-of-function of both GCAP1 and
GCAP2 affected synaptic ribbon length, ribbon length measure-
Figure 6. Immunoelectron microscopic localization of GCAP2 and Ribeye at rod synaptic terminals of GCAPs2/2GCAP2+ mice. A.
Localization of GCAP2 in ultrathin sections of the retina at the outer segment layer region, as an intrinsic control of the immunoelectron microscopic
localization protocol. GCAP2 [5nm-gold particles, arrows] associates to the disc membranes, as expected. B-C. View of entire synaptic terminals, to
show GCAP2 immunoreactivity sparsed in the cytosolic space and also associated to the plasma membrane, the membrane apposing invaginating
horizontal processes and the ribbon. D. Gold-particles decorating the border of an invaginating horizontal process. E-G. Selected examples of
longitudinal ribbons showing GCAP2 [5nm-gold particles in E, F, 15-nm gold particles in G, pointed by arrows in all panels] colocalizing with RIBEYE
[arrowheads in all panels]. H-J. Selected ribbon transversal sections showing GCAP2 localization at the ribbon or its proximity [arrows point to GCAP2
associated particles, arrowheads to RIBEYE associated particles]. K, L. Representative examples of club-shape ribbon transversal sections, densely
immunolabeled for Ribeye but not GCAP2. Scale bar corresponds to 200 nm in all panels.
doi:10.1371/journal.pone.0042994.g006
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ments were taken in rod terminals from GCAPs2/2 and
compared to those of wildtype mice. For the comparison in
Fig. 7 mice were reared in constant darkness. GCAP1 and GCAP2
ablation leads to an increase in light sensitivity, due to suppression
of the Ca2+-feedback loop to cGMP synthesis [27]. This would
have the effect of magnifying the change in cell membrane
potential and Ca2+ dynamics upon light exposure. However, dark-
adapted GCAPs2/2 mice show a similar dark current value to
that of wildtype mice. Therefore, we reasoned that by rearing the
mice in darkness any difference detected in ribbon length between
wildtype and GCAPs2/2 mice could be assigned to their direct
effect on ribbon dynamics at the synaptic terminal. However, no
significative differences in length were observed between
GCAPs2/2 ribbons (0,279160,0175 mm, n=256) and WT
ribbons (0,291560,00665 mm, n= 103), Fig. 7A-B, Histogram in
Fig. 7F and Table S1, which indicates that GCAP1 and GCAP2
are both dispensable for the normal development and basic
structural maintenance of synaptic ribbons, at least when raised in
darkness.
Surprisingly, GCAPs2/2GCAP2+ mice raised in darkness
showed a remarkable reduction in ribbon length at p40
(0,179860,004 mm, n=178), Fig. 7F and Table S1. This
represents a 36% reduction of ribbon length in GCAPs2/
2GCAP2+ compared to GCAPs2/2 littermate controls. This
36% reduction of ribbon length in GCAPs2/2GCAP2+ mice
that express GCAP2 to 1,5-fold the endogenous level is much
higher than the 14% reduction of ribbon length observed in
GCAP2+/+ mice, that overexpress GCAP2 to 4-fold the
endogenous levels in the wildtype genetic background. These
results suggest that endogenous GCAP1 somehow counteracts
GCAP2 effect at shortening synaptic ribbons.
We have observed that GCAP1 also localizes at the synaptic
terminal, by immunolocalizing GCAP1 with an affinity-purified
anti-GCAP1 polyclonal antibody raised against the whole
recombinant protein [Fig. 8]. GCAP1 immunolocalization signal
partially overlaps with Ribeye at the synaptic ribbon, indicating
that GCAP1 could have a role at the synaptic terminal.
To study whether there are other ultrastructural changes at the
synaptic terminal between GCAPs2/2GCAP2+ mice and their
GCAPs2/2 littermate controls, the dimensions of individual
synaptic terminals were determined in five 16616 mm2 visual
fields in the OPL region. The size of the synaptic terminals was
determined to be smaller in GCAPs2/2GCAP2+ mice than in
GCAPs2/2 littermate controls, that were in turn smaller than the
Figure 7. Expression of GCAP2 in the absence of GCAP1 exacerbates the effect of GCAP2 at promoting ribbon disassembly. A-C.
Electron micrographs from WT (A), GCAPs2/2 (B) and GCAPs2/2GCAP2+ (C) ultrathin retinal sections obtained from dark-reared mice at postnatal
day 40, showing a representative rod synaptic ribbon from each phenotype. While GCAPs2/2 mice show ribbons that are undistinguishable in
length from wildtype ribbons, GCAPs2/2GCAP2+ mice show ribbons that are on average about 40% shorter than wildtype ribbons. hc: horizontal
cell process; bc: bipolar cell process; sr: synaptic ribbon. D, E. Examples of GCAPs2/2GCAP2+ synaptic terminals containing accumulations of vesicle-
like particles in the vicinity of the active zone (arrows). These aggregates, that might appear in terminals with or without ribbons, might generate as
by-products in the bulk endocytosis for synaptic vesicle recycling process. F. Histogram of synaptic ribbon length in WT, GCAPs2/2 and GCAPs2/
2GCAP2+ mice. Plotted are mean values 6 standard errors. * denotes P,0.001 in ANOVA analysis [F(2, 196532) = 97,37, P = 0.000] using the PASW
program package (IBM).
doi:10.1371/journal.pone.0042994.g007
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wildtype. A Duncan’s test established the size of the synaptic
terminals as follows: GCAPs2/2GCAP2+ (2.4760.09 mm2,
X+SE, n= 69) , GCAPs2/2 (3.1860.12 mm2, n= 88) , WT
(3,5860,13 mm2 n= 69), with P,0,05 [Fig. S1]. The percentage
of synaptic terminals that contained a synaptic ribbon was also
reduced in GCAPs2/2GCAP2+ versus the two other groups.
Mean values were [WT 70,161,8 n= 69; GCAPs2/267,362,3
n= 88; GCAPs2/2GCAP2+57,662,3 n= 69]. An ANOVA
analysis showed a statistically significant difference between the
GCAPs2/2GCAP2+ values and the two other groups, F [2,12]
= 9,36, P= 0,004 [Fig. S1C].
That is, synaptic terminals are smaller in GCAPs2/2GCAP2+
mice, and there is a lower percentage of synaptic terminals that
contain a ribbon. This figure explains our observation in Fig. 2
that OPL thickness is substantially reduced in GCAPs2/
2GCAP2+ mice, and reflects that the integrity of the ribbon
synapse is compromised to some extent in these mice. However,
neurodegeneration in these mice appears to be milder than the
neurodegeneration described for other mouse models with
mutations in presynaptic proteins[30–36], and signs of autophagia
like vacuolization or mitochondria swelling were not appreciated
in GCAPs2/2GCAP2+ mice compared to GCAPs2/2 or WT
controls [Fig. S1].
When GCAPs2/2GCAP2+ mice were raised in 12 h:12 h
dark:light standard cyclic light they showed a similar reduction in
ribbon length at p40 (0,178860,007 mm, n= 43) than when raised
in darkness, whereas GCAPs2/2 littermate control mice raised
under the same cyclic light conditions showed a more subtle
reduction in ribbon length (0,241260,01 mm, n= 29).
Taken together, these results indicate that abolishing the
expression of both GCAP1 and GCAP2 does not alter the length
or morphology of synaptic ribbons in dark-reared mice, or
substantially affect the thickness and connectivity of the OPL.
However, expressing GCAP2 in the absence of GCAP1
Figure 8. GCAP1 localizes to the synaptic terminal and partially overlaps with Ribeye. Immunolabeling of vertical retinal sections from WT
and GCAPs2/2GCAP2+ mice with rabbit polyclonal antibody anti-GCAP1 and a monoclonal antibody against Ribeye/CtBP2. GCAP1 is found at the
outer segment (os) inner segment (is) and outer plexiform layer (opl) of the retina, where it colocalizes with Ribeye at synaptic ribbons (white arrows).
GCAP1 antibody immunolabeling signal was absent in GCAPs2/2GCAP2+ sections when identical laser power and acquisition gain parameters were
used at the confocal microscope, excluding that the signal originates from cross-reactivity of anti-GCAP1 antibody with GCAP2 at this working
dilution.
doi:10.1371/journal.pone.0042994.g008
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(GCAPs2/2GCAP2+ mice) had a severe effect at shortening the
ribbons, lowering the number of synaptic ribbons, reducing the
dimensions of synaptic terminals and ultimately causing a thinning
of the OPL. We conclude that altering the ratio of GCAP1 to
GCAP2 in rod photoreceptor cells in vivo leads to morphological
alterations at the synaptic terminal including a substantial
shortening of the synaptic ribbon. Because alteration of GCAP1
to GCAP2 relative levels has a bigger effect than the overexpres-
sion of GCAP2, we infer that it is the balanced action of these
proteins in rods that is required to maintain the integrity of
synaptic terminals.
Mice that Express GCAP2 in the Absence of GCAP1 and
are Raised in Darkness have Severely Impaired Light
Responses in the Scotopic Range
To study whether the phenotype observed at the ultrastructural
level in these mouse lines correlates with a functional phenotype,
electroretinogram responses to a family of flashes of increasing
intensities were recorded in the scotopic and the photopic range.
Rod b-wave amplitudes in the scotopic range (I =24 to l =22
Log cd.s/m2), as well as a-wave and b-wave amplitudes from rod
and cone mixed responses (l = 1,5 Log cd.s/m2) and pure cone
responses (I = 2,0 Log cd.s/m2) were averaged for the different
mouse lines, and are presented in Table 2. Representative
recordings are shown in Fig. 9. While dark-reared GCAPs2/2
mice presented minor reductions in the amplitude of the rod b-
wave and the a-wave from mixed responses (compare blue traces
to red traces), dark-reared GCAPs2/2GCAP2+ mice showed
very diminished responses in the scotopic range as well as
diminished a-wave amplitudes in the rod-cone mixed responses
(compare black traces to red traces). In contrast, pure-cone
responses in the photopic range were unaffected [Table 1, Fig. 9
bottom traces]. Photopic responses in GCAPs2/2GCAP2+ mice
are not expected to differ from GCAPs2/2 responses because the
transgene is not expressed in cones.
The reduction in the magnitude of the rod component of the
ERG response was more severe in GCAPs2/2GCAP2+ rods
when mice were raised in constant darkness than when mice were
raised in standard 12 h:12 h dark:light cycles [Fig. 9, compare
superimposed traces in left and middle panels].
Because both the a-wave and b-wave are reduced in dark-reared
GCAPs2/2GCAP2+ ERG responses, this visual impairment
cannot be solely attributed to ribbon shortening. Furthermore, the
same shortening of the ribbons takes place when GCAPs2/
2GCAP2+ mice are raised in cyclic light, but ERG responses are
indistinguishable from GCAPs2/2 responses. These results
indicate that the rod component of the ERG response is very
diminished in dark-reared GCAPs2/2GCAP2+ mice; and, on
the other side, that a shortening of 40% of ribbon length in cyclic-
light reared GCAPs2/2GCAP2+ mice has little effect on the
amplitude of the B-wave of ERG responses in the scotopic range.
That is, ribbon shortening has a limited effect on synaptic strength.
The decreased contribution of the rod component of the ERG
response to dark-reared GCAPs2/2GCAP2+ responses is not
due to the loss of rod photoreceptor cells. GCAPs2/2GCAP2+
mice that have been raised in constant darkness show at p40 the
same number of photoreceptor nuclei rows that wildtype mice, as
shown by morphometric analysis of outer nuclear layer thickness
at different regions covering the whole length of the retina in these
mice [Fig. 2C]. Therefore, we infer that the rods in GCAPs2/
2GCAP2+ mice raised in darkness have a diminished contribu-
tion to ERG responses because they are unable to respond to light,
likely due to electrical saturation (see Discussion).
Discussion
Guanylate Cyclase Activating Proteins (GCAPs) are neuronal
Ca2+ sensors from the calmodulin superfamily. They play a
fundamental role in the recovery of the light response by
conferring Ca2+ modulation to retinal guanylate cyclase at the
membrane discs of rod and cone outer segments where
phototransduction takes place [37]. The main isoforms GCAP1
and GCAP2 also localize to the inner segment and synaptic
terminal of photoreceptor cells, where their function is unknown
[28]. A recent study has demonstrated that GCAP2 interacts with
Ribeye, a unique and major protein component of synaptic
Table 2. ERG response parameters in the different mouse lines.
ERG wave amplitude b - rod a - mixed b - mixed b - cone
Intensity (cd?s?m-2) 22,0 1,5 1,5 2,0
WT [D-D] n = 4 304,08615,39 277,90634,30 529,48634,29 188,7568,84
GCAPs 2/2 [D-D] n = 4 230,98622,62 177,01618,07 380,65632,78 140,81619,78
GCAPs 2/2 GCAP 2+ [D-D] n = 10 69,91616,57*** 54,44619,18*** 228,38624,65*** 180,69613,77
WT [L-D] n = 4 255,84611,53 203,6267,83 474,29614,46 188,7568,84
GCAPs 2/2 [L-D] n = 4 158,8167,04 183,5969,28 446,52653,77 237,84628,33
GCAPs 2/2 GCAP 2+ [L-D] n = 6 178,76637,57 185,89631,38 455,33668,24 256,87631,43
GCAP 2+ [L-D] n = 3 224,31625,01 175,22612,54# 420,08633,97 234,2568,04
Statistical analysis: Statistical analysis of ERG data was performed using GraphPad InStat software; each experimental group was considered independent. A general
linear model procedure with analysis of the variance (ANOVA) was carried out. Post hoc multiple comparisons Tukey test was used. Data are expressed as mean 6 SEM.
The results were considered significant at p,0.05.
WT [D-D] vs.
- GCAPs 2/2 [D-D]: n.s.
- GCAPs 2/2 GCAP 2+ [D-D]:
***p,0.001.
WT [L-D] vs.
- GCAPs2/2 [L-D] : n.s.
- GCAP 2+ [L-D] : n.s.
- GCAPs 2/2 GCAP 2+ [L-D]: n.s.
doi:10.1371/journal.pone.0042994.t002
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Figure 9. Comparison of electroretinogram responses from WT, GCAP2+, GCAPs2/2 and GCAPs2/2GCAP2+mice that were either
raised in constant darkness or in 12 h:12 h dark:light standard cyclic light. Left panel, superimposed representative responses of WT (red),
GCAPs2/2 (blue) and GCAPs2/2GCAP2+ (black) mice at p40 that were reared in constant darkness, in the scotopic and photopic range. The a-wave
amplitude is severely reduced in GCAPs2/2GCAP2+ mice (black trace) compared to wildtype and GCAPs2/2 traces in the scotopic range. This
difference is absent in the photopic range, since the transgene is only expressed in rods. Central panel, superimposed representative responses of the
same phenotypes, but raised in 12h:12h dark:light standard cyclic light and dark-adapted previous to the experiment. ERG responses from GCAPs2/
2GCAP2+ mice were similar to GCAPs2/2 and wildtype responses. Right panel, superimposed traces of cyclic light reared wildtype and GCAP2+
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ribbons, and partially colocalizes with Ribeye at these structures,
and pointed to GCAP2 as a candidate that might mediate the
Ca2+-dependent disassembly of synaptic ribbons [19].
In this study we set to test this hypothesis in vivo, by analyzing
alterations in the density and morphology of synaptic ribbons in
GCAP2 models of gain-of-function (GCAP2 overexpression) and
loss-of-function (GCAP1/GCAP2 double knockout, GCAPs2/2)
and their correlation with a functional phenotype. We here report
that mice that lack GCAP1 and GCAP2 develop synaptic ribbons
that are similar in length and morphology to wildtype ribbons,
indicating that the GCAP2-Ribeye interaction is not required for
the initial assembly or anchoring of the ribbon to the active zone.
By characterizing transgenic mice that overexpress GCAP2 in rods
(GCAP2+ and GCAP2+/+ mice) or mice in which GCAP2
expression was restored in the GCAPs2/2 genetic background
(GCAPs2/2GCAP2+ mice) we have confirmed that GCAP2
overexpression leads to the shortening of synaptic ribbons. This
phenotype is manifested when mice are reared either in standard
cyclic light or in constant darkness, and it worsens when GCAP2 is
expressed in the absence of GCAP1, in which case it severely
impairs visual function when mice are dark-reared. We also
demonstrate GCAP2 colocalization with Ribeye at the ultrastruc-
tural level. Based on our results we suggest that both GCAP1 and
GCAP2 isoforms, and particularly the relative levels of GCAP1 to
GCAP2, might contribute to mediate the ribbon morphological
changes triggered by light through a combination of effects: a
secondary effect on the ribbon due to their role at regulating
cGMP synthesis at rod outer segments; and a more direct effect on
the ribbons exerted at the synaptic terminal. We here analyze our
findings and their physiological significance in the context of the
current knowledge of GCAP1 and GCAP2 function and
biochemical properties.
GCAP1 and GCAP2 are not Required for the Early
Assembly of Photoreceptor Ribbon Synapses
The group of Frank Schmitz has identified GCAP2 as an
interacting partner of Ribeye. In their localization assays,
Venkatesan and collaborators showed that the GCAP2 immuno-
fluorescence signal filled the cytosolic space of the synaptic
terminal, partially overlapping with Ribeye at the ribbons [19].
Synaptogenesis in rod photoreceptors of the mouse retina is
initiated at P6–P8, and is completed by the time mice open their
eyes at P13–P14. The assembly of photoreceptor ribbons during
synaptogenesis involves the formation of sphere-like structures
from protein aggregates of ribbon cytomatrix proteins: Bassoon,
Ribeye, Piccolo and RIM1. These non-membranous electrodense
‘‘precursor spheres’’ were proposed to be the transport units of the
ribbon cytomatrix active zone (CAZ) proteins that assemble into
immature floating ribbons and subsequently give rise to mature
anchored ribbons [38]. Mice that lack Bassoon show impaired
aggregation of ribbon cytomatrix proteins at early stages, delayed
formation of precursor spheres [39] and a failure to form anchored
ribbons [31]. The fact that GCAP2 interacts with Ribeye raises the
question of whether GCAP2 might be required for the develop-
mental assembly of synaptic ribbons. In this study we have
observed that the GCAP1/GCAP2 double knockout mice
(GCAPs2/2) present a largely normal OPL at p40 with the
typical pattern of Ribeye staining [Figs 2, 3, and 4]; and the usual
number of synaptic ribbons, with standard size and morphology
by transmission electron microscopy [Fig. 7 and Fig. S1].
Measurements of synaptic ribbon length in GCAPs2/2 mice
were initially taken from mice that were reared in constant
darkness [Fig. 7]. The reason for this is that GCAPs2/2 rod
photoreceptors show a higher sensitivity to light than wildtype rods
and, and the same prolonged light stimuli could have different
effects on WT and GCAPs2/2 mice [27]. Nevertheless, we have
subsequently observed that either dark-reared or cyclic-light
reared GCAPs2/2 mice yielded similar to wildtype ERG
responses in a range of light intensities that covered the scotopic
and photopic ranges [Fig. 9]. These results indicate that GCAP1
and GCAP2 are not required for the developmental assembly of
synaptic ribbons in rod photoreceptors. However, they do not
exclude that these proteins play more subtle roles: e.g. at
regulating ribbon dynamic turn-over (see below).
Ultrastructural Localization of GCAP2 at the Synaptic
Terminal
Original immunolocalization studies of GCAP1 and GCAP2
reported that GCAP1 localized more abundantly to cone outer
segments whereas GCAP2 appeared to be present in the outer
segment, the inner segment and the synaptic terminals of both
rods and cones in different species [28,29]. Venkatesan’s study has
shown that the GCAP2 immunofluorescence signal filled the
synaptic terminal and to some extent overlapped with synaptic
ribbons [19]. Our localization data at the confocal microscopy
level confirms this observation [Fig. 2], which is relevant because
our assays overcome two previously identified limitations in GCAP
localization studies. First, the fact that antibodies raised against
one specific isoform might cross-react with the other (e.g.
Antibodies raised against GCAP2 typically crossreact with
GCAP1, and vice versa). Second, the fact that antibodies raised
against a particular species isoform yield different results in retinal
tissue from different species [40,41]. Our antibodies were raised
against the bovine isoform of GCAP2, and they were used to
immunolocalize the bovine isoform of GCAP2 expressed in
transgenic mice. The bovine GCAP2 isoform has been shown to
restore endogenous GCAP2 localization and function in
GCAPs2/2 mice [27].
Our immunoelectron localization study revealed for the first
time at the ultrastructural level that GCAP2 co-localizes with
Ribeye in about 16% of the synaptic ribbons analyzed in the
GCAPs2/2GCAP2+ mice [Fig. 6]. Instead of a homogeneous
distribution along the ribbon, we found that GCAP2 was present
in clusters, easier to detect in longitudinal sections [with up to two
or three clusters per ribbon, Fig. 6E-G] than in tangential sections.
That GCAP2 appears associated to the ribbon in only 16% of the
ribbons analyzed might be indicative of a transient interaction. It
has been described that, following the in vitro EGTA treatment of
retinas, ribbon disassembly begins with the formation of protru-
sions and the pinching off of spherical ribbon material [14,38],
that are seen as club-shaped ribbons and as floating spheres in
tangential sections. Therefore, in our immunolabeled ultrathin
sections we thoroughly looked for clusters of Ribeye and GCAP2
outside the ribbon that might reflect modules of disassembly
containing both proteins, but could not detect them. Taken
together, our results confirm GCAP2 localization at the ribbons at
the ultrastructural level, and would sustain GCAP2 involvement in
the regulation of ribbon morphological changes triggered by
changes in Ca2+.
mice at p40. There were no statistically significant differences in the a-wave and b-wave amplitudes of these responses, whether the mice were raised
in constant darkness or in 12h:12h dark:light standard cyclic light (cyclic reared mice results shown).
doi:10.1371/journal.pone.0042994.g009
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In addition to the synaptic ribbon, GCAP2 was also associated
to the plasma membrane and particularly to the presynaptic
membrane apposing the invaginating processes of horizontal cells
[Fig. 6D,H-J]. The whole delimiting membrane was decorated,
and not just the active zone. This result points to GCAP2 having
additional functions at the synaptic terminal, where it could be
imparting Ca2+ sensitivity to new molecular targets. Future
experiments will attempt to identify GCAP2 molecular targets in
this compartment.
GCAPs Effect on Ribbon Length
Synaptic ribbons in photoreceptor cells of the mouse retina in
the albino strain Balb/c tend to disassemble in response to
illumination by releasing ribbon material in spherical modules;
and elongate by regaining ribbon material during dark-adapta-
tion[14–16,18,38,42]. Although the physiological significance of
this ribbon remodeling with light is not yet clear and strong
variations in the extent of these changes have been reported
between different mouse strains [17], we have observed in this
study that 1 h of light exposure can cause a 13% reduction of
ribbon length in pigmented C57Bl/6 mice [Fig. 5 and Table S1].
While we doubt that this might be a relevant mechanism to
regulate synaptic strength or serve to extend the operational range
of rods, it might represent a turn-over mechanism of the ribbon set
in place by light, e.g. following photic damage.
It has been shown in albino mice that ribbon disassembly
depends on the drop in intracellular Ca2+ at the synapse caused by
the light-triggered hyperpolarization of the cell [14,18]. Because
GCAP2 has been shown to interact with Ribeye and localize to the
ribbon [19], we here wanted to test whether GCAP2 might
mediate the Ca2+ -dependent structural changes of ribbons as
proposed [19].
Our findings indicate that, although both GCAP1 and GCAP2
isoforms are dispensable for developmental ribbon formation and
basic structural maintenance, altering the GCAP1 to GCAP2 ratio
does have an effect on the morphology of synaptic terminals and
does alter ribbon length.
Mice that express GCAP2 to 2,5-fold the endogenous levels
[GCAP2+ line, Table 1] presented a 10% reduction in ribbon
length compared to wildtype mice when both transgenic and
wildtype mice were raised in constant darkness, or in standard
cyclic light [Fig. 5, Table S1]. Mice that express GCAP2 to 4,5-
fold the endogenous level [GCAP2+/+] showed a 14% reduction
in ribbon length when mice were raised in constant darkness and a
24% reduction when they were raised in constant darkness and
subsequently exposed to light for 1–5 h. In addition, the
percentage of ribbon shapes that identify a disassembling ribbon
(club-shaped and spherical ribbons versus bar-shaped ribbons in
transversal sections) was higher in transgenic mice than in wildtype
mice. These ultrastructural effects on the synaptic ribbons show
that GCAP2 overexpression causes ribbon disassembly. This
noticeable change in ribbon dimensions, however, had only minor
effects on the functional response to light, as measured by
electroretinogram (ERG). GCAP2+ mice elicited light responses
by ERG that were similar to wildtype responses in a-wave and b-
wave amplitude and kinetics, when they were raised either in
constant darkness or in standard cyclic light (traces from cyclic
light-reared mice shown in Fig. 9; traces from dark-reared mice
not shown). This indicates that a 10% reduction in ribbon length is
not enough to produce a significative change in the b-wave of the
ERG response, and that more extensive remodeling of the ribbon
might be necessary to affect synaptic strength.
As discussed above, GCAPs2/2 synaptic ribbon length did not
differ from wildtype synaptic ribbons at p40, and ERG responses
of GCAPs2/2 mice at p40 were similar to wildtype.
Intriguingly, mice in which GCAP2 expression was selectively
restored in the GCAPs2/2 background (GCAPs2/2GCAP2+)
showed synaptic ribbons that were 40% shorter than wildtype
ribbons at p40 when raised in constant darkness [Fig. 7].
GCAPs2/2GCAP2+ mice, when raised in constant darkness,
had severely impaired rod visual function at p40. Both the a-wave
and b-wave amplitudes of ERG responses were severely reduced in
the scotopic range. Because the a-wave amplitude of the ERG
reflects the change in membrane potential elicited by the
phototransduction cascade and the inverted-sign b-wave reflects
postreceptoral activation of rod on-bipolar cells, genetic defects
affecting synaptic transmission typically affect predominantly the
b-wave[43–46]. Therefore the GCAPs2/2GCAP2+ visual im-
pairment could not be solely attributed to the shortening of rod
ribbons. Instead, the ERG phenotype of dark-reared GCAPs2/
2GCAP2+ mice revealed a diminished capacity to respond to
light at the rod outer segment (ROS) level.
The ratio of the Ca2+-bound inhibitory state to the Mg2+-bound
stimulatory state of each GCAP isoform is what determines the
rate of cGMP synthesis by retinal guanylate cyclase in rod outer
segments at any given [Ca2+]i. Given the well characterized
difference in the Ca2+ sensitivities of GCAP1 and GCAP2, there is
a narrow range of [Ca2+]i -around the [Ca
2+]i typical of the dark-
adapted steady state- for which GCAP1 molecules would be in the
stimulatory state while most GCAP2 molecules would be
inhibitory state of the cyclase, and these antagonistic effects would
cancel each other [27]. It is therefore not surprising that chronic
darkness might result in an alteration in the free cGMP levels at
ROS in GCAPs2/2GCAP2+ mice in which GCAP2 is expressed
in the absence of GCAP1, reducing cGMP levels gradually over
time. Abnormally low levels of free cGMP would cause the closure
of cGMP-gated channels and the electrical saturation of rods, and
could explain the diminished rod component of the ERG despite
retention of a normal number of rods in these retinas [Fig. 9 and
Fig. 2C]. Therefore it cannot be excluded that shortening of the
ribbons might result from a chronic alteration of [Ca2+]i at the
synapse due to abnormally low levels of cGMP. That is, when
GCAPs2/2GCAP2+ mice are raised in constant darkness,
alterations in ribbon morphology could be a secondary conse-
quence of GCAP2 effect on cGMP metabolism. The involvement
of the phototransduction cascade and cGMP metabolism on the
light-triggered morphological changes of ribbons has been
established [14].
In contrast to mice raised in constant darkness, GCAPs2/
2GCAP2+ mice reared in 12 h:12 h dark:light cycles preserved
scotopic ERG traces at p40 similar to wildtype in magnitude and
kinetics [Fig. 9, Table 2]. Noteworthy, synaptic ribbons in
GCAPs2/2GCAP2+ mice raised in cyclic light at p40 are
shortened to the same extent as GCAPs2/2GCAP2+ mice raised
in darkness [Table S1]. These mice have been reported to have
dark current values similar to wildtype, in association with normal
free cGMP levels [27]. This makes it unlikely that changes in
ribbon length observed in these animals are secondary to altered
cGMP metabolism at ROS. Strikingly, the absence of GCAP1
exacerbates the effect of GCAP2 at shortening ribbon length, even
when mice are raised in cyclic light. We infer that altering the
balance between GCAP1 and GCAP2 leads to the shortening of
the ribbons.
Altering the balanced action of GCAP1 and GCAP2 also
compromises the ribbon synapse integrity, as shown by the
reduction in the size of the synaptic terminals in GCAPs2/
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2GCAP2+ mice [Fig. S1]. Therefore, we cannot completely rule
out that ribbon disassembly might be a secondary consequence of
a presynaptic defect caused at some other level. There are
numerous examples in the literature of mutations in presynaptic
proteins that cause presynaptic defects that are accompanied by
changes in ribbon structure. Mutations in Cav1.4, bassoon,
complexin, synaptojanin and laminin produce floating ribbons
[30,31,33,36,47]. Mutations in tubby-like protein 1 (TULP1),
which impairs rhodopsin trafficking to the outer segment, also
affect synaptic ribbon morphology [32]. Mutations in cysteine
string protein alpha, a chaperone required for SNAP25 and
SNARE complex assembly cause photoreceptor degeneration and
the appearance of floating ribbons [34,35]. Myosin Va mutant
mice have both anatomical and physiological abnormalities at rod
synapses [48]. However some of these mouse models [e.g. Tulp1
ko, CSPa ko] manifest a rapid retinal degeneration with a
substantial loss of photoreceptor cells that is accompanied by
severe functional defects before one month of age [34,49].
GCAPs2/2GCAP2+ transgenic mice, in contrast, preserve the
normal number of photoreceptor cells for months [Fig. 2] and do
not present obvious signs of neurodegeneration like vacuolization
or mitochondria swelling at the synapse [Fig. S1]. The fact that the
absence of GCAP1 exacerbates the effect of GCAP2 at shortening
ribbons argues against a non-specific toxic effect of overexpressed
GCAP2 at the synaptic terminal. Rather, it seems that the
balanced action of GCAP1 and GCAP2 might be needed to
preserve the integrity of the synapse and the ribbon.
Together with Venkatesan’s report that GCAP2 interacts with
Ribeye, our observation that GCAP2 can appear associated to the
ribbon at the ultrastructural level and the marked reduction in
ribbon length that is observed in GCAPs2/2GCAP2+ mice leads
us to suggest that GCAPs might be involved in mediating the
morphological changes at the ribbons triggered by changes in
Ca2+.
Further genetic and biochemical experiments will be needed to
confirm the direct implication of GCAP2 and GCAP1 in this
process, and to study whether GCAP1 and GCAP2 might have
new molecular targets and new functions at the synapse.
Conclusion
The central observation of this study is that the overexpression
of GCAP2 in rods in vivo has an impact at shortening synaptic
ribbons that is exacerbated in the absence of GCAP1. These
results, together with the lack of phenotype when both GCAP1
and GCAP2 isoforms are absent in the double knockout, point to
the balanced action of GCAP1 and GCAP2 having an effect on
the ultrastructure of the synaptic terminals and on synaptic ribbon
length, likely through a combination of mechanisms: i) an indirect
or secondary effect on the ribbon would be caused by their
primary effect on cGMP metabolism at rod outer segments,
manifested in this study when GCAP2 is expressed in the absence
of GCAP1 and mice are reared in constant darkness; and ii) an
effect on the ribbon through a mechanism independent of cGMP
metabolism, manifested when GCAP2 is overexpressed or
expressed in the absence of GCAP1 and mice are reared in cyclic
light. We have observed that a 40% reduction of ribbon length in
vivo in GCAPs2/2GCAP2+ mice raised in cyclic light had only
subtle effects on ERG responses in the scotopic range, indicating
that ribbons can withstand dimensional restrictions without a
severe functional effect.
Supporting Information
Figure S1 GCAPs2/2GCAP2+ mice present smaller
synaptic terminals than GCAPs2/2 and WT mice, and
fewer synaptic terminals that contain a ribbon. A. Low
magnification micrographs of the opl region of WT, GCAPs2/2
and GCAPs2/2GCAP2+ mice. Scale bar, 2 mm. B. Histogram
comparing the percentage of synaptic terminals with ribbon in the
three phenotypes. The number of synaptic terminals that contain a
synaptic ribbon was determined in five representative visual fields
per phenotype and expressed as the percentage of the total [Mean
6 Standard Error]. Mean values were [WT 70,161,8 n= 69;
GCAPs2/267,362,3 n= 88; GCAPs2/2GCAP2+57,662,3
n= 69]. The ANOVA analysis showed a statistically significant
difference between the GCAPs2/2GCAP2+ values and the two
other groups of values, F [2,12] = 9,36, P = 0,004. Asterisc in
histogram denotes P,0,01. No statistically significant difference
was observed between WT and GCAPs2/2 values [Duncan’s
test]. C. Histogram comparing synaptic terminal size in WT,
GCAPs2/2 and GCAPs2/2GCAP2+ mice. Statistically signif-
icant differences were observed among groups by ANOVA
analysis F [2,223] = 20,37, P= 0,000. A Duncan’s test established
GCAPs2/2GCAP2+ mice synaptic terminals (2.4760.09 mm2,
X+SE, n= 69,) , GCAPs2/2 (3.1860.12 mm2 n= 88) , WT
(3,5860,13 mm2 n= 69), with P,0,05.
(TIF)
Table S1 Ribbon length and percentage of club-
shaped/spherical ribbons at ribbon synapses of the
different mouse lines. Two to ten 16616 mm frames at
8,0006 magnification were delimited in the opl region of each
specimen. Each frame typically contained 10 to 22 rod synaptic
terminals. Every synaptic terminal in the frame was individually
scanned at 100,0006 magnification, and length measurements
were determined in ribbons resulting from tangential cuts (ImageJ
software). Values are expressed as the Mean 6 Standard error.
The percentage of club-shaped/spherical ribbons is expressed as
the ratio of club-shaped ribbons and spherical ribbons to total rod
synaptic ribbons (tangential, longitudinal and sagital). Cone
synaptic terminals were excluded from the analysis.
(DOC)
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